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I   Zusammenfassung 
 
In dieser Arbeit wurde die Regulation der Translation des Hepatitis C Virus (HCV) durch die Interne 
Ribosomen-Eintrittsstelle (IRES) und die 3´-untranslatierte Region (3´-UTR) untersucht. Die 3´-UTR 
stimuliert die Translation, und einige bekannte zelluläre RNA-bindende Proteine wie auch ein neu 
entdecktes 210 kDa-Protein binden an die 3´-UTR und sind möglicherweise an der Regulation der 
Translation von HCV beteiligt.  
HCV, der Erreger der non-A, non-B-Hepatitis (NANBH), ist einziger Vertreter des Genus Hepacivirus in 
der Familie Flaviviridae. HCV hat mehr als 170 Millionen Menschen infiziert. Etwa 80 % von ihnen sind 
nicht in der Lage, das Virus zu eliminieren, und tragen ein hohes Risiko, chronische Leberkrankheiten wie 
Zirrhose und Hepatozelluläres Karzinom zu entwickeln. Ein seit kurzem verfügbares Replikon-System hat 
die HCV-Forschung stark beschleunigt, aber es gibt noch kein Zellkultursystem, das einen kompletten 
Infektionszyklus von HCV erlaubt, ein Umstand, der die Untersuchung des viralen Lebenszyklus wie auch 
die Entwicklung von Impfstoffen und Medikamenten noch erheblich verlangsamt.   
In dieser Arbeit wurde die Interaktion einiger bekannter zellulärer RNA-bindender Proteine, des 
Polypyrimidine Tract-Binding Protein (PTB), des heterogeneous nuclear Ribonucleoprotein L (hnRNP L) 
und des Proteins, das "upstream of N-ras" codiert wird (Unr), mit der HCV IRES und der 3´-UTR 
untersucht. PTB bindet nicht an die IRES, aber an die 3´-UTR. Im Gegensatz dazu bindet hnRNP L nur an 
die IRES. Darüber hinaus fördert hnRNP L die Bindung von PTB an die 3´-UTR, was darauf hindeutet, 
dass beide Proteine synergistisch an die HCV-RNA binden. Allerdings konnte nur eine sehr geringe 
Stimulation der HCV-Translation durch hnRNP L in vitro festgestellt werden. Auch rekombinantes Unr-
Protein bindet an die HCV 3´-UTR, aber in den hier durchgeführten in vitro-Experimenten konnte kein 
signifikanter Effekt auf die Translation festgestellt werden.  
Aufgrund etlicher widersprüchlicher Berichte über eine mögliche Funktion der HCV 3´-UTR bei der 
Translation wurde hier festgestellt, dass mehrere Aspekte der Struktur der Reporter-Konstrukte wichtige 
Parameter beim Test der Funktion der 3´-UTR sind. Die 3´-UTR stimuliert die Translation nur dann, wenn 
monocistronische Reporter-mRNAs mit einem präzisen, authentischen 3´-Ende der 3´-UTR verwendet 
werden. Diese Stimulation ist stärker in Zelllinien, die von Leberzellen abgeleitet sind, als in anderen 
Zelllinien. In der 3´-UTR sind die Variable Region, der poly(U/C)-Trakt und der am weitesten 3´-terminal 
gelegene Stem-Loop 1 der hoch-konservierten 3´-X-Region für die Stimulation wichtig, weniger aber die 
Stem-Loops 2 und 3. Die Signale für die Stimulation der Translation überlappen also zum Teil mit denen 
für die Initiation der RNA-Minusstrang-Synthese, so dass diese Sequenzen möglicherweise zusammen mit 
viralen und/oder zellulären Proteinen an einer Interaktion der 5´- und 3´-Enden des viralen Genoms und 
einer Umschaltung von der Translation zur RNA-Minusstrang-Synthese beteiligt sind.  
Die Suche nach Proteinen, die an der Translations-Initiation von HCV beteiligt sind, ergab zunächst kein 
neues Protein, das an die HCV IRES bindet. Aufgrund des Befundes dieser Arbeit, dass die 3´-UTR die 
Translation stimuliert, wurde dann eine Regulation der Translation auch durch Proteine, die an die 3´-UTR 
binden, erwogen. Deshalb wurde das Design der Reporter-Konstrukte überdacht, mit dem Resultat, dass ein 
bisher unbekanntes Protein entdeckt wurde, das spezifisch an die HCV-RNA bindet. Dieses 210 kDa-
Protein bindet an die Variable Region der 3´-UTR nur dann, wenn eine RNA mit einem authentischen 3´-
Ende der 3´-UTR verwendet wird. Dies legt die Vermutung nahe, dass das 210 kDa-Protein möglicher-
weise im Zusammenhang mit der Termination der Translation an die HCV-RNA oder an das Ribosom 
bindet und an der Umschaltung von der Translation zur RNA-Minusstrang-Synthese beteiligt ist.  
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II   Summary 
 
In this study, the regulation of translation of Hepatitis C Virus (HCV) by the internal ribosome entry site 
(IRES) and the 3´-untranslated region (3´-UTR) was investigated. The 3´-UTR stimulates HCV IRES-
directed translation, and some known cellular RNA-binding proteins as well as a newly discovered 210 
kDa protein specifically binding to the 3´-UTR may be involved in HCV translation regulation. 
HCV, the main causative agent of non-A, non-B hepatitis (NANBH), belongs to the unique genus 
Hepacivirus in the family Flaviviridae. HCV has infected more than 170 million people worldwide, about 
80 % of whom are unable to eliminate the virus, and those are at high risk to develop chronic liver diseases 
including cirrhosis and hepatocellular carcinoma. The recent development of replicon systems has largely 
accelerated HCV research, but there is still no tissue culture system supporting a complete replication cycle 
of HCV, a circumstance that has slowed down studies on the basic understanding of the viral life cycle as 
well as drug and vaccine development. 
The interactions of some known cellular RNA-binding proteins, including polypyrimidine tract-binding 
protein (PTB), heterogeneous nuclear ribonucleoprotein L (hnRNP L) and the protein encoded upstream of 
N-ras (Unr), with the HCV IRES and the 3´-UTR were examined. There is no direct interaction of PTB 
with the HCV IRES, but PTB binds specifically to the 3´-UTR. In contrast, hnRNP L binds to the IRES 
only. In addition, the binding of PTB to the 3´-UTR can be strengthened by hnRNP L, indicating that there 
is a synergistic interaction between PTB and hnRNP L. However, only a very slight positive effect of 
hnRNP L on HCV translation was observed in vitro. The recombinant Unr protein used in this work binds 
to the HCV 3´-UTR, but no significant effect of Unr on HCV translation could be observed in vitro. 
Considering previous conflicting reports on a possible function of the HCV 3´-UTR in translation 
stimulation, it was found that reporter construct design is an important parameter in experiments testing 3´-
UTR function. A translation enhancer function of the HCV 3´-UTR was detected only after transfection of 
monocistronic reporter RNAs and depends on a precise 3´-terminus of the HCV 3´-UTR. The 3´-UTR 
strongly stimulates HCV IRES-dependent translation in human hepatoma cell lines but only weakly in non-
liver cell lines. Within the 3´-UTR the variable region, the poly(U/C)-tract and the most 3´-terminal stem-
loop 1 of the highly conserved 3´-X region contribute significantly to translation enhancement, whereas the 
stem-loops 2 and 3 of the 3´-X region are involved only to minor extents. Thus, the signals for translation 
enhancement and the initiation of RNA minus-strand synthesis in the HCV 3´-UTR partially overlap, 
supporting the idea that these sequences along with viral and possibly also cellular factors may be involved 
in an RNA 3´-5´-end interaction and in a switch between translation and RNA replication. 
In an initial attempt to search for trans-acting factors possibly involved in the translation initiation of HCV, 
no new protein was detected to bind to the HCV IRES. From the finding that the 3´-UTR stimulates 
translation, it was assumed that the translation initiation could be positively regulated by proteins binding 
to the 3´-UTR. This gave rise to a reconsideration of the experimental design of the HCV RNA constructs 
used for the search for new proteins, finally resulting in the discovery of a novel, yet unknown protein that 
binds to the HCV RNA. This unknown 210 kDa protein binds to the variable region of the HCV 3´-UTR 
only when a reporter RNA with exact 3´-terminus of 3´-UTR was used. This suggests that the protein may 
be involved in the regulation of translation stimulation by interacting, perhaps together with other yet 
undiscovered proteins, with the 3´-end of the HCV 3´-UTR, and the protein(s) may be involved in a switch 
from translation to negative-strand RNA synthesis in the life cycle of HCV. 
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1   Introduction 
 
Viruses (from the latin "virus", meaning "poison") are small infectious particles that consist of proteins and only 
one type of nucleic acids, either DNA or RNA, which is packaged in a protein capsid. In 1898, Friedrich Loeffler 
and Paul Frosch found that the causative agent of foot-and-mouth disease in livestock is an infectious particle 
smaller than any bacterium. This was the first clue to the nature of the viruses (Loeffler & Frosch, 1964). In 
order to replicate, viruses must infect a suitable host cell since they lack most of the internal structure and 
machinery which characterize "life", including the biosynthetic machinery that is necessary for reproduction. 
Viruses infect bacteria (then the virus is called a bacteriophage), plants, animals and humans, and they are the 
cause of a very wide range of human diseases like the common cold, hepatitis, AIDS, smallpox, flu, 
poliomyelitis, the lethal haemorrhagic disease caused by ebolaviruses, and the latest disease of severe acute 
respiratory syndrome (SARS) which was first recognized in March 2003 and subsequently found to be caused by 
a new type of coronavirus (SARS-CoV) (WHO data). 
The present study focuses on the internal initiation of translation, a characteristic mechanism of translation used 
by Hepatitis C Virus (Family: Flaviviridae, Genus: Hepacivirus) and foot-and-mouth disease virus (Family: 
Picornaviridae) to initiate their own polyprotein synthesis. Some cis- and trans-acting factors possibly involved 
in the process of HCV translation were principally highlighted. 
 
 
1.1   The history of non-A, non-B hepatitis 
 
The first evidence for the existence of a non-A, non-B (NANB) hepatitis agent came from studies of multiple 
attacks of viral hepatitis in narcotic addicts in the 1950s (Havens, 1956). The existence of two forms of hepatitis, 
‘infectious’ (type A) and ‘serum’ (type B), had been recognized in the 1940s and further reports revealed that no 
patient had more than one attack of either form of hepatitis. In a study of 30 episodes of acute viral hepatitis in 
patients, two of 30 (7 %) were found to be caused by hepatitis A, and 12 (40 %) by hepatitis B (Mosley et al., 
1977). Thus there were 16 cases (53 %) not attributable to either of the two known hepatitis viruses. Exclusion of 
Epstein-Barr virus (EBV) and cytomegalovirus (CMV) in these patients strengthened the argument for the 
existence of NANB hepatitis agents. 
The discovery of "Australia antigen" in 1964, by Blumberg, and its association with viral hepatitis led to detailed 
studies of post-transfusion hepatitis (PTH) (Blumberg, 1964). The first studies were carried out in the 1960s, 
prior to the screening of blood for hepatitis B surface antigen (HBsAg), when approximately 50 % of multiply 
transfused patients developed PTH in the USA. Most of the available blood at that time came from commercial 
blood donors and the equivalent rate for PTH from voluntary blood donors was much lower with one study 
reporting that none of 28 patients receiving volunteer blood developed hepatitis (Walsh et al., 1970). The 
introduction of screening and exclusion of commercial blood donors led to a dramatic fall in PTH from 30.6 
cases/1000 units to 3.7 cases/1000 units of blood transfused (Alter et al., 1972). Although it was not possible to 
estimate the individual effects, it was generally thought that the exclusion of the commercial donor was the most 
significant determinant in the decrease in PTH. However, the findings that PTH had not been eradicated by these 
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measures, as well as evidence that the presence of "Australia" (HBsAg) antigen could not prevent PTH (Holland 
et al., 1969), led to the search for alternative hepatitis agents. In one study in the early 1970s the majority of 
cases of PTH following cardiac surgery were not caused by HBV, and could not be explained by infection with 
EBV or CMV viruses (Purcell et al., 1971). Another study revealed that 12 of 108 (11 %) prospectively followed 
multiply transfused cardiac surgery patients developed PTH, despite receiving volunteer blood tested for HBsAg 
(Alter et al., 1975). Four of these 12 patients developed hepatitis B virus (HBV) infection. The other eight cases 
of PTH were shown not to be related to HBV, hepatitis A virus (HAV), EBV or CMV, suggesting that NANB 
hepatitis was the major cause of PTH in this group of patients. Studies of hepatitis in drug addicts also identified 
a separate type of hepatitis, which was characterized by the absence of HBsAg and of high levels of 
immunoglobulin M (IgM), suggestive of HAV infection (Iwarson et al., 1973). 
By the late 1970s, 7-10 % of blood transfusion recipients still developed hepatitis. Serological tests failed to 
implicate hepatitis A or B in 90 % of these patients and the term "non-A, non-B (NANB) hepatitis" was used to 
describe this condition. The tendency for this condition to become chronic with progression to cirrhosis was 
soon recognized (Realdi et al., 1982; Dienstag, 1983). Both infectious and non-infectious causes of NANB 
hepatitis had to be excluded and, in the late 1970s, transmission of the agent from humans to chimpanzees was 
reported (Alter et al., 1978; Tabor et al., 1978). The NANB agent appeared to be present at low levels in humans 
and led to chronic infection in about 50 % of chimpanzees, causing distinctive histological appearances in their 
livers. This agent was shown to be sensitive to organic solvents, and to pass through filters of 80 nm pore-size, 
suggesting that it was a small enveloped virus (Bradley et al., 1983; Bradley et al., 1985). 
In the 1980s the exclusion of donors with abnormal liver function tests (LFTs) or with antibody to hepatitis B 
core antigen (HBcAb), two surrogate markers of NANB post-transfusion hepatitis, almost halved the rate of 
PTH. Despite the knowledge of a distinct PTH syndrome and evidence to show successful serial transmission of 
these agents, by the mid 1980s the agent responsible for NANB hepatitis remained frustratingly elusive. 
 
 
1.2   The discovery of Hepatitis C Virus 
 
Most of the early studies on NANB hepatitis had focused on chimpanzee transmission investigations, showing 
that the putative agent was present in most patients with NANB hepatitis at a low titre of 102-103 chimpanzee 
infectious doses per ml (CID·ml-1). The agent was known to cause the appearance of distinctive, membranous 
tubules within the hepatocytes of experimentally infected chimpanzees. Buoyant density studies with the tubule-
forming agent suggested that it is a small enveloped RNA virus because transmission to chimpanzees could be 
prevented by heat, β-propiolactone, and formalin or by organic solvent inactivation of the infectious fraction 
(Bradley et al., 1985). 
Initial studies by Choo and his colleagues at the Chiron Corporation were hampered by the inability to extract 
sufficiently concentrated nucleic acids from infectious material. Therefore, plasma was pooled from infected 
animals and, by titrating infectivity in other animals, a plasma pool was obtained with a titre of approximately 
106 CID·ml-1. Following ultracentrifugation, total nucleic acid was extracted, rendered single-stranded and then 
both RNA and DNA were reverse transcribed using random primers. A cDNA expression library was created by 
cloning the random fragments into the vector λgt11, and this was then screened with serum derived from patients 
diagnosed with chronic NANB hepatitis. After screening more than a million clones, one (5-1-1) was found to 
react with serum from several NANB hepatitis patients and also with serum from experimentally infected 
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chimpanzees following the onset of hepatitis (Choo et al., 1989). Three further overlapping clones were isolated 
by using the 5-1-1 cDNA as a hybridization probe to screen the original library and a 1089 nucleotide continuous 
open-reading frame (ORF) was reconstructed. The antigen (C100-3) used in the first-generation enzyme-linked 
immunosorbent assay (ELISA) was prepared by expressing this ORF as a fusion polypeptide with human 
superoxide dismutase in yeast (Kuo et al., 1989). Most cases of NANB hepatitis were found to be associated 
with C100-3 antibody and this response was used to define infection with a new virus, hepatitis C virus (HCV) 
(Alter et al., 1989; Bruix et al., 1989; Colombo et al., 1989). Although the virus was first cloned in 1989, it was 
not before 1994 that there have been claims of visualization of the virus by immunoelectron microscopy (Kaito 
et al., 1994).  
Up to date, Hepatitis C virus is the first virus detected before its viral particle is found through electron 
microscopy. Furthermore, the discovery of HCV is the first example achieved by way of an unprecedented use of 
modern molecular cloning techniques, which came to the world in the late of 1980s, rather than by the 
conventional method of virus isolation (Choo et al., 1989). 
 
 
1.3   The Family of Flaviviridae 
 
Based on the phylogenetic sequence comparisons, HCV appears to be more closely related to pestiviruses than to 
the flaviviruses. For instance, both HCV and pestiviruses contain a relatively long 5´-untranslated region (5´-
UTR),  or also called 5´-nontranslated region (5´-NTR), with several AUG codons, whereas flaviviruses contain 
a short 5´-UTR of about 95-132 nucleotides in length without an AUG (except tick-borne encephalitis virus) 
(Rice et al., 1986; Collett et al., 1988b; Pletnev et al., 1990). Like pestiviruses, HCV does not have a cap-
structure at the 5´ terminus of the genomic RNA (Collett et al., 1989; Brock et al., 1992; Tsukiyama-Kohara et 
al., 1992). The translation of flaviviral RNAs is mediated by a cap-dependent scanning mechanism, and usually 
initiated at the 5´ end proximal AUG triplet (Chambers et al., 1990). In contrast to flaviviruses, multiple AUG 
triplets have been found in the long 5´-UTR of HCV and pestiviruses. The methyltransferase gene found in the 
flavivirus NS5 region has not been found in the HCV genome. Several experimental approaches have failed to 
detect a cap structure at the 5´ end of pestivirus genomic RNA (Collett et al., 1988b; Brock et al., 1992). By 
analogy to pestiviruses, it is likely that the HCV genomic RNA is uncapped. While several AUG codons are 
located upstream of the translation initiation site of the HCV polyprotein, they do not appear to function as 
alternative start sites (Tsukiyama-Kohara et al., 1992).  
 
 
 
Table 1: Classification of Flaviviruses. The numbers in brackets represent the tentative strains and isolates. 
(Source: International Committee Taxonomy of Viruses, 2002) 
 
 
Genus Number of serotypes Members 
Flavivirus 10 12(79) 
Pestivirus 1 3(12) 
Hepacivirus 6 1(10) 
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In the end, on the basis of several criteria including genomic organization, molecular features, and biochemical 
properties, HCV has been classified as the sole member of a distinct genus called Hepacivirus in the family 
Flaviviridae, which includes the flaviviruses and the animal pathogenic pestiviruses (Kato et al., 1990; Choo et 
al., 1991; Inchauspe et al., 1991; Okamoto et al., 1991; Takamizawa et al., 1991). Table 1 shows some 
fundamental information on the family of Flaviviridae. 
Flaviviral virions are spherical, 40-50 nm in diameter. They are with a lipid envelope and fine peplomers that do 
not show any structure or symmetry. The genome consists of a single molecule of linear, positive-sense, single-
stranded RNA, 10.7 kb (flaviviruses), 12.5 kb (pestiviruses), or 9.6 kb (hepatitis C virus) in size. The 
pestiviruses and HCV do not have cap structure at 5´-end of RNA genome, whereas the 5´-end structure of the 
RNA of flaviviruses consists of a type 1 cap. A type 1 cap structure (m7GpppAmp) has been found at the 5´ end 
of flavivirus RNA (Chambers et al., 1990) which may have resulted from the action of the proposed 
methyltransferase activity in the flaviviral NS5 protein (Koonin & Dolja, 1993). Except for some tick-borne 
flaviviruses, the RNA does not contain a 3´-terminal poly (A) tail. Virons contain two or three membrane-
associated proteins, a core protein, lipids derived from host cell membranes, and carbohydrates in the form of 
glycolipids and glycoproteins as well. 
There are about 70 recognized diseases caused by members of the Flaviviridae family. 13 cause disease in 
humans, such as Yellow Fever, Dengue, and Japanese Encephalitis. Common manifestations are febrile illnesses, 
encephalitis, hemorraging, and hepatitis. Most of theses viruses are transmitted by mosquitoes. However, 
Hepatitis C is transmitted by sexual contact and blood contact like other Hepatitis B virus. It has a very narrow 
host range, and infects only human and chimpanzee. However, it is obviously different from the diseases of 
hepatitis A or hepatitis B. That is the reason why it was called non-A, non-B hepatitis (NANBH) before 1989 
when Hepatitis C Virus was isolated and named. So far, HCV infects more than 170 million people worldwide 
and causes rising rates of liver diseases such as chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. 
The only therapy currently available is combination treatment with a high dose of interferon-α (IFN-α) and the 
nucleoside analogue ribavirin. However, only ~ 40% of all patients benefit from this treatment and develop a 
sustained response. For this reason, HCV has become a focus of intensive research worldwide since the 1990s. 
 
 
1.4   The structure and genomic organization of HCV 
 
Morphologically, the HCV viral particle has a spherical shape which is about 40-80 nm in diameter, with fine 
spike-like surface projections and an inner core measuring 30 to 35 nm in diameter. It consists of an envelope 
derived from host membranes into which are inserted the virally encoded glycoproteins surrounding an 
icosahedral nucleocapsid and a single-stranded RNA genome (Fig. 1). The viral capsid gives the hepatitis C 
virus characteristic shape and size, and protects the infectious viral RNA from ribonucleases in the environment. 
Unlike picornaviruses carrying a small viral protein (virion protein genome-linked; VPg) which is attached to the 
5´-end through a phosphodiester linkage, HCV does not contain such a special protein. The VPg appears to play 
an important role in initiation of picornaviral RNA synthesis, and it is believed that this protein is cleaved off by 
cellular proteinases soon after the entry into infected cell. The VPg is not essential for infectivity, since full-
length in vitro synthesized RNA (without VPg) is still infectious. As every enveloped virus, HCV is sensitive to 
detergents and dehydration. 
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Fig. 1: Electron microscope morphology of HCV associated particles and model structure of HCV. (A) EM 
photos of HCV particle. Top panels: 60-70 nm virions; lower panels: 30-40 nm putative defective interfering 
particles. (B) Model structure of HCV. The left side of the illustration shows the viral surface of envelope lipids 
and glycoproteins; the right side shows the RNA genome encased by capsid proteins. 
 
 
The viral genome of HCV is represented as a single-stranded RNA molecule with positive polarity, composed of 
about 9600 nucleotides that are flanked by non-translated regions at the 5´- and 3´-end, respectively. The viral 
RNA contains only one single large open reading frame (ORF) encoding a polyprotein of 3010-3033 amino 
acids that is processed into individual viral proteins by both viral and cellular proteases (Fig. 2) (Selby et al., 
1993; Hijikata et al., 1993b; Grakoui et al., 1993c; Bartenschlager & Lohmann, 2000a). Besides the polyprotein, 
the expression of a novel HCV protein has been reported (Walewski et al., 2001; Xu et al., 2001; Boulant et al., 
2003). Translation of this additional viral gene product also initiates at the core gene AUG start codon, but 
ribosomes shift into an alternative reading frame in the vicinity of the 11th codon. The resulting 17-kDa protein is 
therefore called the frameshift (F) or alternative reading frame (ARF) protein (Varaklioti et al., 2002). However, 
the exact role of the F protein remains to be defined (Bartenschlager et al., 2004). 
The HCV polyprotein is cleaved co- and post-translationally by cellular and viral proteinases into eleven 
different products, with the structural proteins located in the amino-terminal one-third and the non-structural 
replicative proteins in the remainder (Fig. 2). The first cleavage product of the polyprotein is the highly basic 
core protein, forming the major constituent of the nucleocapsid (Yasui et al., 1998). In addition, a number of 
other functions like modulation of several cellular processes or induction of hepatocellular carcinoma in 
transgenic mice have been attributed to the core protein (Chen et al., 1997; Matsumoto et al., 1997; Chang et al., 
1998; Moriya et al., 1998). Envelope proteins (E1 and E2) are highly glycosylated type 1 transmembrane 
proteins, forming two types of stable heterodimeric complexes: a disulfide-linked form representing misfolded 
aggregates and a non-covalently linked heterodimer corresponding most likely to the pre-budding complex 
(Deleersnyder et al., 1997). In addition, E2 was shown to interact with the IFN-induced double-stranded RNA-
activated protein kinase PKR. Upon induction by IFN-α, this enzyme reduces protein synthesis via 
phosphorylation of translation initiation factor eIF2-α, but in cells containing E2, PKR is inhibited, allowing 
continuation of translation in the presence of IFN (Taylor et al., 1999). 
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Fig. 2: Genomic organization of HCV and processing pathways of the polyprotein. A schematic 
representation of the HCV genome with the 5´- and 3´-UTR is shown in the top, the translation products are 
given below. Proteinases involved in processing of the polyprotein are indicated by arrows that are specified in 
the bottom of the figure. The major cleavage pathways leading to distinct processing intermediates, most notably 
E2-p7-NS2 and NS4B-5A are indicated. The hyperphosphorylation of NS5A probably occurs after full 
proteolytic cleavage. The F protein generated by ribosomal frameshifting is depicted above the polyprotein. 
 
 
Downstream of the structural region there is a small integral membrane protein, p7, a highly hydrophobic 
polypeptide, which seems to function as an ion channel located at the carboxy terminus of E2 (Griffin et al., 
2003; Pavlovic et al., 2003). Most of the non-structural (NS) proteins, NS2, NS3, NS4A, NS4B, NS5A and 
NS5B, are required for replication of the viral RNA (Lohmann et al., 1999). NS2 and the amino-terminal domain 
of NS3 constitute the NS2–3 proteinase, catalysing cleavage at the NS2/3 site (Hirowatari et al., 1993; Grakoui et 
al., 1993a; Hijikata et al., 1993a). NS3 is a bifunctional molecule carrying, in the amino-terminal ~180 residues, 
a serine-type proteinase responsible for cleavage at the NS3/4A, NS4A/B, NS4B/5A and NS5A/B sites and, in 
the carboxy-terminal remainder, NTPase/helicase activities essential for translation and replication of the HCV 
genome (Eckart et al., 1993; Suzich et al., 1993; Tomei et al., 1993; Bartenschlager et al., 1993b; Grakoui et al., 
1993b; Kim et al., 1995; Gwack et al., 1996; Hong et al., 1996; Tai et al., 1996; Kolykhalov et al., 2000). In 
addition, NS3 may have other properties involved in interference with host cell functions like inhibition of 
protein kinase A-mediated signal transduction or cell transformation (Sakamuro et al., 1995; Borowski et al., 
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1996a). NS4A is an essential cofactor of the NS3/4A proteinase and is required for efficient polyprotein 
processing (Bartenschlager et al., 1994; Failla et al., 1994; Lin et al., 1994b; Tanji et al., 1995a). The function of 
the hydrophobic NS4B is so far unknown. The transmembranous structure of NS4B and the absence of 
enzymatic activities suggest that this protein might play a noncatalytic role. Presumably, its main function is the 
induction of membranous vesicles or membrane invaginations that may serves as scaffolds for the assembly of 
the HCV replication complex (Egger et al., 2002; Bartenschlager et al., 2004).  
 
 HCV proteins Molecular weight (kDa) Function 
F/ARF protein 17 ? 
Core 23 (precursor), 21(mature) RNA binding; nucleocapsid  
E1 31-35 Envelope protein; fusion domain? 
E2 70 Envelope protein; receptor binding 
p7 7 Viroporin (ion channel?) 
NS2 21 Component of NS2-3 proteinase 
NS3 69 Component of NS2-3 and NS3/4A proteinase (N-terminal 
domain); NTPase/helicase (C-terminal domain); Interference 
with IRF-3 
NS4A 6 NS3/4A proteinase cofactor  
NS4B 27 Induction of membranous vesicles 
NS5A 56 and 58 (basal and 
hyperphosphorylated form, 
respectively) 
IFN-α resistance? RNA replication? 
NS5B 68 RNA-dependent RNA polymerase  
 
Table 2: HCV proteins and their presumed functions in the viral life cycle (Cited from Bartenschlager et al., 
2004). 
 
 
NS5A is a fascinating protein. Many cellular proteins interact with NS5A, although their functional relevance is 
largely unclear (He & Katze, 2002; Tellinghuisen & Rice, 2002; Macdonald & Harris, 2004). NS5A is 
phosphorylated on multiple serine residues by cellular kinases and can be found in hypophosphorylated (56 kDa) 
and hyperphosphorylated (58 kDa) forms. Major phosphorylation sites have been determined for a few HCV 
isolates (Reed & Rice, 1999; Katze et al., 2000), and kinases capable of phosphorylating NS5A have been 
identified. These include AKT, p70S6K, MEK1, MKK6, cAMP-dependent protein kinase A-α and casein kinase 
II (Ide et al., 1997; Reed et al., 1997; Kim et al., 1999; Coito et al., 2004). It is not yet clear which kinases are 
involved in generating the different phosphoforms of NS5A, or which phosphorylation sites are functionally 
relevant, and the role of NS5A phosphorylation remains an area of intense interest. For the HCV-H isolate the 
major phosphorylation site has been mapped to serine residue 2321 of the polyprotein and the proline-rich nature 
of the flanking sequence suggests that a proline-directed kinase is responsible for NS5A phosphorylation (Reed 
& Rice, 1999). The role that NS5A might play in RNA replication is so far not known, but based on analogy with 
other RNA viruses where phosphoproteins are important regulators of replication, one could assume that NS5A 
plays a similar role. Apart from such a function, NS5A appears to be involved in resistance of the infected cell to 
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the antiviral effect of IFN. At least for some HCV isolates NS5A is able to bind to PKR, blocking inhibition of 
translation in the IFN-treated cell (Gale et al., 1997; Gale et al., 1998c). 
NS5B is the workhorse of the HCV RNA replication machinery, which has been identified as the RNA-
dependent RNA polymerase (RdRp) (Behrens et al., 1996; Lohmann et al., 1997; Yuan et al., 1997; Al et al., 
1998; Yamashita et al., 1998).  NS5B has a typical ‘right hand’ polymerase structure, with catalytic sites in the 
base of the palm domain, surrounded by thumb and finger domains (Penin et al., 2004). The overall structure of 
NS5B is remarkably similar to the RdRP of bacteriophage Φ6 (Butcher et al., 2001). NS5B also has a low-
affinity GTP-binding site, distal from the active site, which is thought to be involved in allosteric regulation of 
the finger–thumb interaction (Bressanelli et al., 2002). A brief summary of the individual protein products and 
their main function(s) is given in Table 2. 
 
 
1.5   The life cycle of Hepatitis C Virus 
 
The human liver is the main site of HCV replication, but there is strong evidence that it can also replicate in 
peripheral blood mononuclear cells (PBMCs) or in experimentally infected B- and T-cell lines (Esteban et al., 
1998), in epithelial cells in the gut (Deforges et al., 2004) and in the central nervous system (Forton et al., 2004). 
Studies of viral dynamics in patients treated with IFN-alpha revealed a virion half-life of 3-5 hours and a 
clearance and production rate of 10-12 particles per day (Neumann et al., 1998; Zeuzem et al., 1998; Ramratnam 
et al., 1999). Another feature of HCV replication is the rapid generation of virus variants, primarily due to the 
high error rate of the viral RNA dependent RNA polymerase (RdRp) that, based on analogies with RdRps of 
other plus-stranded RNA viruses, is expected to be in the range of 10-4. Indeed, HCV strains isolated from the 
same individual over time (as well as from different individuals) show different biological, serological and 
molecular characteristics, with a significant fraction of defective virus genomes, some of which may yield 
defective interfering particles. Within the host, viral genomes are found as heterogeneous populations termed 
"quasispecies". Owing to the lack of an animal model or a cell culture system able to support efficient virus 
replication, our understanding of the molecular mechanisms of HCV replication comes from the study of closely 
related flavi- and pestiviruses. These viruses enter cells by receptor-mediated endocytosis and low-pH mediated 
membrane fusion in lysosomes. An idealized HCV life cycle is illustrated in Fig. 3. 
Attachment and entry. The first step in a virus life cycle is the attachment of the infectious particle to the host 
cell, for which a specific interaction between a receptor on the cell surface and a viral attachment protein on the 
surface of the particle is required. Although the mechanism of HCV entry into cells is still unknown, the E2 
glycoprotein is thought to play a major role in virus attachment to the target cell. CD81, a member of the 
tetraspanin superfamily of cell surface molecules and expressed on virtually all cells, is the putative receptor for 
HCV entry into the host cell, since this molecule strongly interacts with E2 as well as virus particles in vitro 
(Pileri et al., 1998). Additionally, the virus may also be able to enter the cell by binding to low-density 
lipoprotein (LDL) receptors (Monazahian et al., 1999). But whether interaction with the LDL receptor or CD81 
leads to internalization and a productive infection remains to be determined. Based on comparison with fusion 
peptides of paramyxoviruses, E1 may be involved in membrane fusion (Flint et al., 1999c). The low pH within 
the endosomal compartment may induce a major structural rearrangement of the E1, resulting in exposure of a 
fusion peptide which destabilizes membranes, leading to membrane fusion and particle entry into the cytoplasm. 
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Fig. 3: Hypothetical model of the HCV life cycle. Upon infection of the host cell, the plus-strand RNA genome 
(+) is liberated into the cytoplasm and translated. The polyprotein is processed and viral proteins remain tightly 
associated with membranes of the endoplasmic reticulum (ER). Minus-strand RNA (–) is synthesized by the 
replicase composed of NS3 - 5B and serves as template for production of excess amounts of plus-strand RNA. 
Via interaction with the structural proteins plus-strand RNA is encapsidated. Particles are enveloped by budding 
into the lumen of the ER and virus particles are exported via transit through the Golgi (G) complex. 
 
 
Polyprotein translation and processing. Following decapsidation, the genomic RNA is directly translated in 
the cytoplasm. Since the genome is not capped, translation is mediated by an internal ribosome entry site (IRES) 
element rather than by a cap-dependent mechanism employed by most eukaryotic and cellular mRNA (this issue 
will be described in detail in the following part). This activity does not seem to require most of the canonical 
eukaryotic initiation factors (eIFs) (Pestova et al., 1998b). The very 3´ end of the HCV genome as well as several 
cellular factors (polypyrimidine tract-binding protein, La autoantigen, heterogeneous nuclear ribonucleoprotein 
L and other unidentified proteins) interact with the HCV IRES and may be also involved in translation, but this 
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is still enigmatic (Ali & Siddiqui, 1995; Hahm et al., 1998b; Ito & Lai, 1999; Ali et al., 2000; Lu et al., 2004). 
This stimulation by host factors implies that cellular proteins that vary in abundance or activity during the cell 
cycle might in part regulate HCV translation (Honda et al., 2000). 
Directed by the IRES, the polyprotein is translated at the rough endoplasmic reticulum (rER) and cleaved co- 
and post-translationally by host and viral proteinases. The individual HCV proteins form a stable replicase 
complex associated with intracellular membranes (Tanji et al., 1995a; Wölk et al., 2000). This allows the tight 
coupling of different viral functions as well as the production of viral proteins and RNA in a distinct 
compartment. The proteinase cofactor NS4A further contributes to efficient polyprotein cleavage and replication 
by increasing the metabolic stability of NS3 which is rapidly degraded in its absence, and by anchoring NS3 to 
intracellular membranes so that the enzyme and its substrate are concentrated in very close proximity (Hijikata et 
al., 1993b; Lin et al., 1997; Ishido et al., 1998; Koch & Bartenschlager, 1999; Neddermann et al., 1999). 
RNA replication. The positive strand RNA genome of HCV is copied into a minus strand intermediate that 
serves for synthesis of new genomic plus strands. However, the individual steps underlying RNA replication are 
largely unknown, even though the establishment of a tissue culture system for subgenomic replicons now 
facilitates the related studies (Lohmann et al., 1999). In vitro, the RNA dependent RNA polymerase (RdRp) 
initiates replication by elongation of a primer hybridized to an RNA homopolymer or via a "copy-back" 
mechanism (Behrens et al., 1996; Lohmann et al., 1997; Yuan et al., 1997; Al et al., 1998; Yamashita et al., 
1998; Ferrari et al., 1999). In this latter case, sequences at the 3´ end fold back intramolecularly and hybridize, 
generating a 3´ end that can be used for elongation, resulting in a product about twice the length of the input 
template. However, in the presence of high GTP or ATP concentration, RdRp can initiate RNA synthesis de 
novo, and this probably occurs in vivo (Kao et al., 1999; Oh et al., 1999; Luo et al., 2000; Zhong et al., 2000a). 
Concerning the template specificity, NS5B seems to bind preferentially to a sequence in its own 3´ coding region 
(Cheng et al., 1999). Alternatively, the template specificity may be accomplished by the high local concentration 
of both NS5B and the viral RNA within the replicase complex (Lohmann et al., 1997). Efficient RNA replication 
very likely depends on additional viral and cellular factors, like the NS3 helicase which unwinds stable RNA 
structures or the phosphoprotein NS5A (Lohmann et al., 1997). 
In addition to viral proteins, cellular components are probably involved in RNA synthesis as well. One candidate 
is PTB, found to specifically interact with sequences in the 3´-UTR (Ito & Lai, 1997; Tsuchihara et al., 1997; 
Chung & Kaplan, 1999). Another candidate is glyceraldehyde-3-phosphate dehydrogenase (GAPDH), binding to 
the poly(U)-sequence in the 3´-UTR (Petrik et al., 1999). Finally, cellular proteins provisionally called p87 and 
p130 were identified by UV-cross linking experiments with the X-tail sequence, but the nature of these proteins 
remains to be determined (Inoue et al., 1998a). 
Proteins from other viruses may also affect HCV replication. For example, in most cases, the cell lines co-
infected with other viruses like human T-lymphotropic virus type I (in the case of the MT2 T-cell line), a murine 
retrovirus (in the case of the MOLT4-Ma T-cell line) or Epstein–Barr virus (EBV) (in the case of the Daudi B-
cell line) support HCV replication (Sugawara et al., 1999). Furthermore, Sugawara et al. observed that HCV-
positive patients with a hepatocellular carcinoma frequently have a high EBV load, and presented evidence that 
the enhancement of HCV replication is mediated by EBV nuclear antigen 1 (Sugawara et al., 1999).  
Virion assembly and release. In the absence of systems allowing the production of sufficiently high amounts of 
virus particles, the assembly of HCV cannot be studied in detail. Particle formation may be initiated by the 
interaction of the core protein with the 5´ half of the RNA genome (Shimoike et al., 1999). Such binding of the 
core protein represses translation from the IRES, suggesting a potential mechanism to switch from translation 
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and replication to assembly (Zhang et al., 2002). Whether the core protein forms a distinct nucleocapsid structure 
or a rather non-structured ribonucleoprotein complex with the HCV genome is unknown, but the core protein is 
able to interact with itself (Matsumoto et al., 1996). Viral capsids acquire their envelope by budding through ER 
membranes, where the E1 and E2 protein are inserted (Sato et al., 1993; Dubuisson et al., 1994; Duvet et al., 
1998; Cocquerel et al., 1999). Then, the virions are supposed to be exported via the constitutive secretory 
pathway. 
 
 
1.6   Translation of HCV RNA is mediated by internal ribosome entry 
  
Most eukaryotic and cellular mRNAs are functionally monocistronic and contain a 5´-terminal m7GpppN (where 
N can be any nucleotide) cap structure on which the initiation of translation strongly depends. The initiation 
codon used as the start site for protein synthesis is preceded by a 5´-UTR in which the length, nucleotide 
composition, and structure can determine the efficiency and the mechanism by which a given mRNA is 
translated (Hershey & Merrick, 2000). For the most part, the factors that influence the binding of 40S subunits to 
the mRNA provide the limiting step in translation initiation.  
In eukaryotic cells, transcription and translation are separated in space and time. Before translation occurs in the 
cytoplasm, the primary transcript is modified and processed immediately in the nucleus by capping, splicing and 
addition of about 50 to 200 adenylic residues (poly A) at the 3´end of the mRNA. The cap structure is a 7-
methylguanosine residue which is attached to the first nucleotide at the 5´end of the mRNA by an unusual 5´-to-
5´ triphosphate linkage. This cap structure is essential for efficient protein synthesis, and, in addition, it 
contributes to the stability of the mRNA by protecting the 5´ end from phosphatases and nucleases (Palmer et al., 
1993; Gunnery & Mathews, 1995). Cellular mRNAs contain a relatively short 5´-UTR of about 50 to 100 
nucleotides long located between the cap structure and the open reading frame (ORF) that usually contains the 
authentic initiation codon (AUG). The poly (A) tail at the 3´ terminus influences both mRNA stability and 
translation efficiency. 
 
 
1.6.1   Eukaryotic translation initiation  
 
The translation in eukaryotes is divided into three phases: initiation, elongation and termination. The reactions in 
each step are promoted by soluble protein factors. The rate-limiting step of translation usually occurs during the 
initiation phase. 
The initiation phase of translation is a complex process leading to assembly of a ribosomal 80S complex at the 
initiation codon of an mRNA. This process is promoted by several proteins called eukaryotic initiation factors 
(eIFs) (see Tables 3 and 4). Prior to initiation of translation, the 80S ribosome must dissociate into its 40S and 
60S subunits. This process is facilitated by eIF3 and eIF1A which help to maintain a pool of dissociated subunits 
probably by an allosteric effect due to a change in the structure of the 40S subunit upon eIF3 binding (Benne & 
Hershey, 1976; Srivastava et al., 1992). 
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eukaryotic 
initiation factor 
Molecular weight 
(kDa) 
Function 
eIF1 12.6 AUG recognition 
eIF1A 16.5 Met-tRNAi binding to 40S subunit 
eIF2α 
eIF2β 
eIF2γ 
36.2 
39.0 
51.8 
affects eIF2B binding by phosphorylation 
binds to eIF2B, eIF5 
binds GTP, Met-tRNAi , GTPase 
eIF2Bα 
eIF2Bβ 
eIF2Bγ 
eIF2Bδ 
eIF2ε 
33.7 
39.0 
50.4 
57.8 
80.2 
nonessential, helps to recognize phosphorylated eIF2 
binds GTP, helps to recognize phosphorylated eIF2 
Guanine nucleotide exchange activity 
binds ATP, helps to recognize phosphorylated eIF2 
Guanine nucleotide exchange activity 
eIF3 (see table 4) ~ 700.0 ribosomal dissociation; promotes binding of mRNA and 
Met-tRNAi to 40S subunit 
eIF4A I / II 44.4 / 46.3 ATP dependent RNA helicase 
eIF4B 69.2 binds RNA, stimulates helicase 
eIF4E 25.1 binds m7G-cap of mRNA 
eIF4G I / II 171.6 / 176.5 binds eIF4E, eIF4A, eIF3, PABP·RNA 
eIF5 48.9 stimulates GTPase activity of eIF2 
eIF5B 139 GTPase, promotes subunit joining reaction 
 
Table 3: Overview of the mammalian translation initiation factors (Modified from Hershey & Merrick, 2000 
and Hellen & Sarnow, 2001). 
 
 
Mammalian eIF3 is the largest and most complex eukaryotic translation initiation factor with an apparent 
molecular weight of about 700 kDa. It has been first isolated and purified from rabbit reticulocyte lysate on the 
bases of its ability to stimulate the translation of globin mRNA (Benne & Hershey, 1976; Safer et al., 1976). 
Latest results show that human eIF3 consists of at least twelve non-identical subunits (Table 4). Until now, the 
cDNAs encoding the subunits, p170, p116, p110, p66, p48, p47, p44, p40, p36 and p35 have been cloned and 
sequenced (Asano et al., 1997; Chaudhuri et al., 1997; Johnson et al., 1997; Méthot et al.,o 1997 ; Block et al., 
1998). p69 that was found in 2001 has been identified as an eIF3-associated protein (Morris-Desbois et al., 
2001). Yeast eIF3 contains only five subunits, TiF32, NIP1, PRT1, TIF34 and TIF35(Danaie et al., 1995; Asano 
et al., 1998; Phan et al., 1998; Hanachi et al., 1999) that are homologous to the human eIF3 subunits p170, p116, 
110, p36 and p44, respectively(Asano et al., 1997).  
The first stage in translation initiation is binding of the ternary complex eIF2·GTP·Met-tRNAi to the 40S 
ribosomal subunit bound with eIF3 and eIF1A to form the 43S-preinitiation complex (Benne et al., 1978). eIF2 
selects the initiator tRNA from a pool of elongator tRNAs by recognizing the methionyl residue and the A-U 
base pair at the end of the acceptor stem (Fig. 4). 
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Human Arabidopsis Yeast 
Name Mass Name Mass Name Gene Mass 
 
Comments 
p170 166.5 eIF3a 114.3 p110 111.1 binds RNA 
p116 98.9 eIF3b 81.9 p93 PRT1 88.1 RRM, binds eIF1, eIF5 
p110 105.3 eIF3c 103.0 p90 NIP1 93.4  
p66 64.0 eIF3d 66.2    RRM, binds RNA 
p48 52.2 eIF3e 51.8     
p47 37.6 eIF3f 31.9     
p44 35.4 eIF3g 32.7 p36 TIF35 30.5 RRM, binds RNA, eIF4B  
p40 39.9 eIF3h 38.4     
p36 36.5 eIF3i 36.4 p39 TIF34 38.8  
p35 29.0    HCR1 29.6  
p28 25.1 eIF3k 25.7     
p69 69.0      cell growth controlling 
  eIF3l 56     
    p135 145.2 (also called CLUI) 
 
Table 4: eIF3 subunits from mammalian, plant and yeast cells. The human subunits are named according to 
their apparent masses as determined by SDS-PAGE. The human p69 was reported recently to be an eIF3-
associated protein (Morris-Desbois et al., 2001). The yeast p135 is associated with eIF3 but has not definitely 
been characterized as a subunit of eIF3 (Vornlocher et al., 1999) (Modified from Hershey, 2000). 
 
 
The second stage is the binding of 43S-preinitiation complex to the m7G cap structure at the 5´ end of mRNA. 
The cap structure is recognized by the cap binding protein (eIF4E), a subunit of eukaryotic translation initiation 
factor 4F (eIF4F). Mammalian eIF4F is a heterotrimeric protein complex of 250 kDa composed of eIF4E, eIF4G 
and eIF4A which plays the key role in recruiting the mRNA to the 43S initiation complex (Hershey & Merrick, 
2000). eIF4G is an adaptor protein which binds eIF4E, eIF4A, eIF3, and the 40S ribosome (Hentze, 1997; Sachs 
et al., 1997). eIF4A exhibits RNA-dependent ATPase activity (Grifo et al., 1983) and a bidirectional RNA 
helicase activity which is stimulated by eIF4B and eIF4H (Rozen et al., 1990; Rogers et al., 1999). The binding 
of eIF4F to mRNA further recruits eIF4B and eIF4H. The entire complex in conjunction with the hydrolysis of 
ATP is thought to melt the secondary structures near the 5´ end of the mRNA that would otherwise impair 
ribosome movement from the 5´ proximal region to the AUG codon (Rozen et al., 1990; Rogers et al., 1999). 
Following recognition of the cap structure and unwinding of the secondary structure in the 5´-UTR, the 43S 
preinitiation complex binds to the cap proximal region of the mRNA. This ribosomal binding is thought to be 
mediated by interactions of eIF4G and eIF4B with eIF3-bound 40S subunit (Lamphear et al., 1995; Méthot et al., 
1996). The 40S ribosomal subunit with associated initiation factors then migrates along the 5´-UTR in 5´-3´ 
direction probably in a linear scanning mode until it encounters the initiation codon to form the 48S preinitiation 
complex (Jackson, 2000). Selection of the initiation codon most probably occurs by codon-anticodon base 
pairing with the Met-tRNAi. However, a few nucleotides flanking the initiation codon (–3 and +4 relative to the 
A of AUG) are also important for the selection process. Purines in the context A/GCCAUGA/G are optimal for 
initiation. This special sequence is well-known as “Kozak sequence” (Kozak, 1989a). Both eIF1 and eIF1A 
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participate in the selection of the initiation codon. In their absence, the ribosome binds to the cap structure but is 
not able to reach the initiation codon (Pestova et al., 1998b). 
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Fig. 4: Schematic representation of the translation initiation pathway in eukaryotic cells (Modified from 
Hershey & Merrick, 2000). 
 
 
The last stage of translation initiation is the displacement of initiation factors from the 48S complex and the 
joining of the 60S subunit in a way that the Met-tRNAi is positioned in the P site of the ribosome to form an 80S 
complex at the initiation codon ready to commence the translation of the coding sequence. This step is aided by 
eIF5 and eIF5B (Hershey & Merrick, 2000; Pestova et al., 2000). eIF5 promotes the hydrolysis of the GTP-
bound eIF2 in the presence of the 40S subunit. The binary complex of GDP-bound eIF2 is released from the 
ribosome together with other initiation factors. The continuity of initiation events requires the regeneration of 
GTP-bound eIF2, which is stimulated by the guanine-nucleotide exchange factor (GEF), eIF2B. Liberated 
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initiation factors are then recycled for another cycle of initiation when the translating 80S ribosome encounters a 
termination codon (UAG, UAA or UGA). The termination codon is recognized by release factors eRF1 and 
eRF3 which mediate the release of the peptide chain from the bound tRNA by hydrolysis. Once termination has 
occurred, the 40S subunit is free to continue scanning the mRNA or to leave it. Molecular details of this 
mechanism have not been fully elucidated. However, evidence for ribosomal scanning comes from observations 
that initiation is strongly inhibited by insertion of additional AUG triplets or of stable secondary structures 
between the 5´ end and the initiation codon (Kozak, 1989b). 
 
 
1.6.2 Internal initiation of translation  
 
More than twenty years ago, it was reported that prokaryotic, but not eukaryotic, ribosomes could bind circular 
RNA molecules, suggesting that eukaryotic ribosomes enter mRNAs exclusively via their free 5´ ends (Kozak, 
1979; Konarska et al., 1981). However, it was known that RNA genomes of picornaviruses have properties that 
are incompatible with initiation by 5´end-dependent scanning. Therefore, translation of several eukaryotic 
mRNAs, for example, in picornaviruses, cannot be accounted for by the canonical scanning model mentioned 
above. An alternative mechanism plays a key role for the initiation of viral polyprotein synthesis, which is 
significantly different from the 5´ cap-dependent translation. Translation of the picornaviral RNA is initiated 
cap-independently and occurs by direct ribosomal attachment to a cis-acting element which is known as the 
internal ribosome entry site (IRES) located downstream from the 5´ end of the viral RNA. Internal initiation was 
first discovered in the picornaviruses such as encephalomyocarditis virus (EMCV) and poliovirus (Jang et al., 
1988; Pelletier & Sonenberg, 1988d), and has since been extended to other RNA viruses and a few cellular 
mRNAs (Hellen & Sarnow, 2001; Martinez-Salas et al., 2001). So far, all picornaviral mRNAs have been found 
to contain IRES elements. Table 5 provides a list of RNA viruses and one DNA virus, Karposi´s sarcoma-
associated herpesvirus, whose genomes contain IRES elements. In principle, initiation at internal AUG triplets 
can also occur as a result of leaky scanning or of reinitiation (Hellen & Sarnow, 2001). 
 
Virus reference 
Poliovirus (PV) Pelletier and Sonenberg, 1988d  
Rhinovirus (RV) Borman and Jackson, 1992 
Encephalomyocarditis virus (EMCV) Jang et al., 1988 
Foot-and-mouth disease virus (FMDV) Kühn et al., 1990 
Hepatitis C Virus Tsukiyama-Kohara et al., 1992 
Bovine virai diarrhea virus (BVDV) Poole et al., 1995 
Friend murine leukemia virus gag mRNA Berlioz and Darlix, 1995 
Moloney murine leukemia virus gag mRNA Vagner et al., 1995b 
Classic Swine Fever Virus (CSFV) Rijnbrand et al., 1997 
Rous sarcoma virus Deffaud and Darlix, 2000a 
Human immunodeficiency virus env mRNA Buck et al., 2001 
Plautia stali intestine virus Sasaki and Nakashima, 1999 
Rhopalosiphum padi virus Domier et al., 2000 
Cricket paralysis virus Wilson et al., 2000b 
Karposi´s sarcoma-associated herpesvirus Grundhoff and Ganem, 2001 
 
Table 5:  Internal ribosome entry sites in viral genomes (Cited from Hellen & Sarnow, 2001). 
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1.6.2.1   General organization of viral IRES elements 
 
The IRES elements of the related picornaviruses can be classified into three groups on the bases of their primary 
sequences, predicted secondary structures, and requirements for efficient translation initiation (Jackson & 
Kaminski, 1995) (Fig. 5). First, the entero- and rhinovirus group (type I IRES, e.g., poliovirus, human rhinovirus 
and coxackievirus); second, the cardio- and aphthovirus group (type II IRES, including encephalomyocarditis 
virus (EMCV), theiler’s murine encephalomyelitis virus (TMEV) and foot-and-mouth disease virus (FMDV) and 
third the hepatoviruses (hepatitis A virus). The IRES elements of HCV and pestiviruses which are members of 
the Flaviviridiae family comprise the fourth group of viral IRES elements (Reynolds et al., 1995) (Fig. 5). Also 
several cellular mRNAs that contain IRES elements have been identified including mRNAs that encode the 
immunoglobulin heavy chain binding protein Bip (Macejak & Sarnow, 1991), the human insulin-like growth 
factor II (Teerink et al., 1995), the fibroblast growth factor 2 “FGF-2” (Vagner et al., 1995) and the transcription 
factor c-Myc (Stoneley et al., 2000). 
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Fig. 5: Organization of viral IRES elements. Schematic representation of the IRES elements of entero-
/rhinoviruses (e.g., poliovirus), cardio-/aphthoviruses (e.g., FMDV and EMCV), hepatitis A virus and hepatitis C 
virus. The major domains are indicated according to Niepmann 1999. Pyrimidine-rich sequence elements (Py) 
are shown as solid rectangles, AUG denotes the position of the translation codon (modified from Niepmann, 
1999). 
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The overall structure of picornavirus IRES elements appears to be roughly similar. They contain a large central 
domain consisting of a long stem and a cross-shaped upper part (Fig. 5, groups I, II, and III). Upstream of this 
large central domain, there are different numbers of smaller domains with structures that differ among the 
picornavirus groups. A mid-size domain is located downstream of the central domain. It consists of a domain 
with bulges in the upper part in entero- and rhinoviruses and hepatitis A virus (HAV), or a characteristic Y-
shaped structure in cardio- and aphthoviruses. In contrast, in the HCV and pestivirus IRES elements, one large 
domain appears to replace the central domain and the downstream domains of the picornavirus IRES elements. 
Within each group of picornaviruses, there is strong conservation of the IRES secondary structure but a lower 
degree of conservation of the primary sequence. 
The 5´-UTRs of HCV and the related classical swine fever virus (CSFV), bovine viral diarrhea virus (BVDV), 
and GB virus B (GBV-B) contain IRESes that are ~ 330-390 nucleotides in length and have related structures, 
even though their sequences differ significantly from one another (Lemon, 1997). Sequence differences between 
the IRESes of different genotypes of any one of these viruses consist mostly of compensatory nucleotide changes 
within structural elements that serve to maintain base pairing (Smith et al., 1995). As in the picornaviral IRESes, 
mutations that disrupt helical regions in HCV-like IRESes can substantially reduce their initiation activity, but 
this can be restored by compensatory second-site mutations (Rijnbrand et al., 2000a). These observations are 
consistent with a model for IRES function in which helices form a structural scaffold to orient conserved 
unpaired regions that act as binding sites for factors and ribosomes so that they can assemble functional initiation 
complexes. 
 
 
1.6.2.2   The HCV internal ribosome entry site 
 
1.6.2.2.1   The HCV 5´-untranslated region (5´-UTR) 
 
HCV is now classified as a distinct genus of Hepacivirus, with at least six major genotypes that differ from each 
other in nucleotide sequence by up to 35 %. The viral RNA genome of HCV contains a relative long 5´-
untranslated region (5´-UTR). While remarkable nucleotide diversity exists among HCV subgroups, the 5´-UTR 
maintains a very high degree of nucleotide conservation (> 93 %) (Okamoto et al., 1991). The 5´-UTR varies in 
length from 332 to 341 nucleotides depending on the HCV subtype (Han et al., 1991; Takamizawa et al., 1991; 
Chen et al., 1992; Tanaka et al., 1992). Only the 5´-UTR and the adjacent core protein-encoding sequences are 
highly conserved (Simmonds et al., 1993b; Simmonds, 1995). Sequences from the 5´-UTRs of even the most 
distantly related HCV subtypes do not differ by more than 10 % and are usually much more similar. The HCV 
5´-UTR is longer than that of flaviviruses, but closely resembles the 5´-UTRs of pestiviruses such as bovine viral 
diarrhoea virus (BVDV), border disease virus (BDV) and classical swine fever virus (CSFV) in terms of length, 
sequence and secondary structure (Abastado et al., 1991; Brown et al., 1992; Wang et al., 1995a; Becher et al., 
1997; Becher et al., 1998). The BVDV, BDV and CSFV 5´-UTRs are 385, 372 and 372 nucleotides long, 
respectively, and like the HCV 5´-UTR, contain several AUG triplets upstream of the initiation codon and form 
extensive secondary structures. Although the HCV 5´-UTR differs from those of BVDV and CSFV at over 50 % 
of base positions, many of these nucleotide differences are covariant substitutions, indicative of conserved 
secondary and/or tertiary structure. 
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The HCV 5´-UTR consists of four major structural domains, designated I to IV in the 5´- to 3´- direction, and a 
pseudoknot upstream of the authentic initiation codon (Fig. 6). Support for the existence of these structures has 
come from phylogenetic comparison (Wang et al., 1995a; Bayliss & Smith, 1996), mutational analyses and from 
the results of chemical and enzymatic probing (Brown et al., 1992; Wang et al., 1995a; Honda et al., 1996a). 
BVDV and CSFV 5´-UTRs have similar structures except that residues equivalent to domain IV are unstructured 
(Wang et al., 1995a; Bayliss & Smith, 1996; Sizova et al., 1998). 
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Fig. 6: The secondary and tertiary RNA structure of the complete HCV 5´-untranslated region (5´-UTR) 
followed by the viral open reading frame. The Roman numbers represent the four major domains and six 
subdomains (followed by small English letters). The region comprising the IRES (to be described later) extends 
from domain II to domain IV and thus also includes a short stretch of upstream core protein-encoding sequence. 
The initiator AUG codon is highlighted (Modified from Honda, 1999). 
 
 
1.6.2.2.2   Detection of an internal ribosome entry site element 
 
The most conclusive proof to verify the mechanism of "internal initiation" is the experimental observation that 
insertion of a putative IRES element into the intercistronic spacer of a dicistronic construct with two protein-
coding ORFs promotes efficient translation of the downstream cistron (Fig. 7b). Insertion of a heterologous 
"spacer" at the same position permits leaky scanning and reinitiation but does not promote efficient translation of 
the downstream cistron by internal ribosomal entry (Fig. 7a). Three further approaches show that initiation of 
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translation of the downstream cistron is not simply a consequence of reinitiation after translation of the first 
cistron. First, insertion of a stable hairpin near the 5´ end of the mRNA prevents translation of the upstream 
cistron without affecting IRES-mediated translation of the downstream cistron (Fig. 7e). Second, poliovirus 
encodes a protease 2A that cleaves the eIF4G subunit of eIF4F, thereby abrogating its essential function in cap-
mediated translation initiation of the upstream cistron without affecting IRES-mediated initiation of the 
downstream cistron (Fig. 7c). Third, the size and structure of different IRES elements vary considerably, but a 
common property that distinguishes them from the 5´-UTRs of conventional capped mRNAs is that their activity 
is often impaired by minor sequence changes, including deletions, insertions and substitutions (e.g., Fig. 7d). 
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Fig. 7: Schematic structure of dicistronic mRNAs used for the proof of IRES function by in vitro 
translation, and the pattern of expression of upstream and downstream cistrons. Encoding regions are 
boxed and non-coding regions are shown as lines, except that segments of the hepatitis C virus internal 
ribosomal entry site (IRES) in the intercistronic area are drawn as zig-zag lines. Expression of cistron 1 and 2 is 
as indicated and is based on the results of previous reports for HCV (Tsukiyama-Kohara et al., 1992; Wang et 
al., 1993; Poole et al., 1995; Reynolds et al., 1995; Rijnbrand et al., 1997). PV, poliovirus; RRL, rabbit 
reticulocyte lysate (modified from Hellen & Pestova, 1999). 
 
 
Using these different assays mentioned above, the first line of evidence in demonstrating the presence of an 
internal ribosome entry site (IRES) element within the 5´-UTR of HCV genome came from in vitro translation 
studies by Tsukiyama-Kohara and his colleagues (Tsukiyama-Kohara et al., 1992). In support of the in vitro 
analysis of the translational regulation of the HCV RNA, experiments carried out in another group had employed 
an in vivo system by introducing in vitro synthesized RNA into HepG2, a hepatoblastoma cell line. The 5´-UTR 
of HCV was inserted between two reporter genes, chloramphenicol acetyl transferase (CAT) and Firefly 
luciferase (FLuc). Their results obtained from in vitro and in vivo experiments provided the unequivocal 
evidence for the presence of an IRES element within the HCV 5´-UTR. 
Together with the results obtained from the investigations with other flaviviruses, it has shown unambiguously 
that HCV, together with BVDV and CSFV, all contain an IRES element in their 5´-UTRs (Tsukiyama-Kohara et 
al., 1992; Wang et al., 1993; Poole et al., 1995; Rijnbrand et al., 1996). 
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1.6.2.2.3   Structural features of the HCV IRES 
 
Mutagenesis studies together with biochemical probing analysis revealed that the HCV IRES consists of three 
major structural domains (II, III, and IV) radiating from a complex pseudoknot (Fig. 6). Reconstructions of the 
IRES at ~20 Å resolution produced by cryo-electron microscopy have shown that these domains form an 
extended structure in which the pseudoknot and domain IV are centrally located (Spahn et al., 2001). 
Domain I comprises the extreme 5´ end of the 5´-UTR and is not part of the IRES, but is required for the viral 
replication. Domain II contributes significantly to IRES function, but deletion of this domain does not lead to 
complete loss of translation activity, and domain II is also involved in replication (Reynolds et al., 1996; 
Kolupaeva et al., 2000a, 2000b). Domain III contains several essential elements, including a large four-way 
junction (IIIabc) and two smaller stem-loop structures (IIId and IIIe). The structures of IIId and IIIe have been 
solved by NMR spectroscopy (Klinck et al., 2000; Lukavsky et al., 2000). Domain IV contains the initiation 
codon and is base-paired in the HCV and GBV-B IRESes, but not in those from BVDV or CSFV. HCV coding 
sequences per se are not essential for internal initiation, because they can be replaced completely by heterologous 
sequences (Tsukiyama-Kohara et al., 1992; Wang et al., 1993). However, there has been some controversy as to 
whether HCV sequences located downstream from the initiation codon influence the efficiency of IRES-
mediated initiation (Reynolds et al., 1995; Lu & Wimmer, 1996). If one considers that ribosomal entry occurs at 
the initiation codon without prior scanning (Reynolds et al., 1996; Rijnbrand et al., 1997), and that mutations in 
the IRES that stabilize structures containing the initiation codon inhibit ribosomal attachment and consequently 
IRES-mediated initiation (Honda et al., 1996b; Myers et al., 2001), it then seems likely that the negative 
influence of some heterologous coding sequences on IRES function may be because they interfere sterically with 
ribosomal attachment. 
 
 
1.6.2.3   Only eIF2 and eIF3 are required for translation initiation of HCV RNA  
 
Biochemical reconstitution of the initiation process on the HCV IRES has revealed that the 40S subunit can bind 
specifically and stably to the HCV IRES without any requirement for initiation factors (Fig. 8) in such a way that 
the initiation codon is placed in the immediate proximity of the ribosomal P site (Pestova et al., 1998b). This 
ribosomal attachment does not require any initiation factors, including those (eIFs 4A, 4B, 4F) that are required 
for ribosomal attachment to capped mRNA and to the picornavirus RNA such as EMCV and FMDV (Pestova et 
al., 1996; Saleh et al., 2001). 43S complexes bind the HCV IRES directly to form 48S complexes in which the 
initiation codon and the anticodon of initiator tRNA are base-paired. These 48S complexes are competent to 
complete the remaining stages in initiation. Assembly of 48S complexes is enhanced by (but does not require) 
eIF3, so eIF2 is the only essential initiation factor up to this stage. In the final stage of initiation, eIF3 is 
absolutely required for subsequent joining of the 60S subunit to the 48S complex to form an 80S ribosome 
capable of polypeptide synthesis (Pestova et al., 1998b). Fig. 8 also shows IRES binding can induce a profound 
conformational change in the 40S subunit (indicated with an asterisk in Fig. 8B) and close the mRNA binding 
cleft (Spahn et al., 2001), and subsequent addition of the ternary eIF2/GTP/initiator-tRNA complex to IRES/40S 
subunit complexes is necessary and sufficient for formation of 48S complexes. 
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Direct ribosomal attachment to eukaryotic mRNAs without a requirement for initiation factors is unprecedented 
in eukaryotes but is characteristic of translation in prokaryotes. Prokaryotic mRNAs bind to small (30S) 
ribosomal subunits as a result of base pairing between the Shine-Dalgarno (SD) sequence and complementary 
anti-SD sequences in the 16S rRNA (Shine & Dalgarno, 1974). The sequences in the HCV IRES that are 
recognized by the 40S ribosomal subunit have not yet been identified. However, nucleotides 1-39, 26-67, 172-
227, 229-238 and 332-341 of the HCV 5´-UTR and all of the coding sequences can be deleted without 
preventing binary [40S subunit-IRES] complex formation, so these sequences do not contain primary 
determinants of ribosomal binding. Binding of the IRES to the 40S subunit therefore appears to require the base 
of the stem-loop III including subunit IIId through IIIf and the stem-loop IV. HCV IRES-mediated initiation 
appears to involve sequential IRES-40S subunit interactions: a primary binding step is followed by interaction(s) 
that promote entry and accurate orientation of the initiation codon and flanking sequences in the mRNA-binding 
cleft. In contrast to attachment of prokaryotic ribosomes to the linear SD sequence, attachment of eukaryotic 
ribosomes to the HCV IRES is therefore likely to involve interactions with multiple discontinuous sites on this 
highly structured RNA.  
 
 
D HCV IRES
HCV 
IRES
C
eIF3
contacts
pt
BA
 
 
Fig. 8: The HCV IRES recruiting the 40S ribosomal subunit, visualized by cryo-electron microscopy. (A) 
Surface representation of the vacant 40S ribosomal subunit. Some landmarks of the 40S subunit are indicated: b, 
body of 40S subunit; bk, beak; h, head; pt, platform; sh, shoulder. "Entry" and "exit" label the proposed entry 
and exit path, respectively, of the mRNA. h18 and h34 indicate the positions of helices 18 and 34, respectively, 
of the 18S rRNA as identified by comparison with a cryo-EM map of the 80S ribosome from yeast. (B) The 40S 
subunit in complex with the HCV IRES RNA viewed from the 60S side of the 40S subunit, and from the 
platform (pt) side (C), respectively. The cryo-EM maps are shown in yellow. The map corresponding to the full-
length HCV IRES RNA is superposed and shown in purple. The conformation change in the IRES-40S subunit 
complex is indicated with an asterisk in (B). The contacting point of eIF3 with the HCV IRES is squared. (D) 
The full-length HCV IRES RNA helix (Modified from Spahn et al., 2001). 
 
 
eIF3 is stoichiometrically associated with free 40S ribosomal subunits in the cytoplasm and is therefore 
effectively a constitutive component of native 40S subunits (Sundkvist & Staehelin, 1975). eIF3 binds 
specifically to BVDV, CSFV and HCV IRESes (Pestova et al., 1998b), and chemical and enzymatic foot-
printing has localized its binding site to an internal bulge between subdomain IIIa and IIIb of the HCV IRES, 
and to an identical position in the CSFV IRES (Sizova et al., 1998). Mutations in the HCV IRES that impair 
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binding of eIF3 all reduce the activity of the IRES (Buratti et al., 1998; Sizova et al., 1998; Pestova et al., 
1998b).  
The affinity of 40S subunit and of eIF3 for distinct structural elements in HCV IRES may enhance binding of 
native 40S subunits to the viral RNA in the cytoplasm where it competes with cellular mRNAs for the translation 
apparatus. The presence of binding sites for two different components of native 40S subunits on the IRES is also 
likely to promote ribosomal attachment to them in an orientation that promotes entry of the initiation codon into 
the ribosomal P site. 
The binding site for eIF3 has been mapped by using cross-linking, toe- and foot-printing to the apical half of 
domain III (Buratti et al., 1998; Sizova et al., 1998; Pestova et al., 1998b; Pestova & Hellen, 1999; Odreman-
Macchioli et al., 2000; Kieft et al., 2001). Although eIF3 is not needed for 48S complex formation, it binds 
specifically to the IRES and is likely to be a constituent of 40S/IRES complexes in vivo. UV cross-linking of 
eIF3 to [α-32P]-UTP labelled HCV and CSFV IRES elements resulted in strong labelling of four (p170, 
p116/110, p66, p47) of the twelve subunits of eIF3 (Buratti et al., 1998; Sizova et al., 1998; Ji et al., 2004), but it 
is not yet known which subunit(s) are primary determinants of this interaction. Presumably, eIF3 may destabilize 
incorrectly assembled 48S complexes (Kolupaeva et al., 2000b) and play a role in stages of initiation after 48S 
complex formation (Pestova et al., 1998b). The independent interaction of eIF3 and eIF2/GTP/initiator-
tRNA/40S subunit complex with the HCV-like IRESes is likely to enhance the affinity and specificity of binding 
and to stabilize the resulting 48S IRES/mRNA complexes.  
 
 
1.6.2.4   Cellular trans-acting factors interacting with the HCV IRES 
 
In addition to eIF3, the HCV IRES element also recruits additional cellular host RNA-binding proteins that are 
not involved in normal cellular cap-dependent translation to commence efficient internal translation initiation 
(Niepmann, 1999; Belsham & Sonenberg, 2000). Up to present knowledge, these cellular proteins include:  
(1) Human La autoantigen (52 kDa), an RNA-binding protein that belongs to the RNA recognition motif 
superfamily, which is involved in initiation and termination of RNA polymerase III transcription (Gottlieb & 
Steitz, 1989; Maraia et al., 1994; Maraia, 1996). In poliovirus translation, La was the first cellular factor 
identified to bind the IRES in close proximity of the conserved AUG codon (Meerovitch et al., 1989). Addition 
of La protein to rabbit reticulocyte lysate (RRL) greatly enhances the translation of poliovirus mRNA at the 
correct initiation site and inhibits translation initiation at incorrect sites (Meerovitch et al., 1993; Svitkin et al., 
1994). 
(2) The polypyrimidine tract-binding protein (PTB, 57 kDa) is one of the most studied non-standard cellular 
factors which plays a role in translation initiation of most picornaviruses. It was initially characterized as a 
component of splicing complexes (Garçia-Blanco et al., 1989) that is involved in the differential splice site 
selections with various cellular mRNAs (Valcárcel & Gebauer, 1997). PTB binds the IRES elements of most 
picornaviruses (Table 6) like EMCV (Jang & Wimmer, 1990), FMDV (Luz & Beck, 1990), Poliovirus (Hellen et 
al., 1994) and rhinovirus (Borman et al., 1993). By the use of depletion and reconstitution systems it has been 
shown that PTB stimulates the translation of EMCV (Borovjagin et al., 1994; Kaminski et al., 1995), FMDV 
(Niepmann, 1996; Niepmann et al., 1997) and rhinovirus (Hunt & Jackson, 1999b). PTB binds to two separate 
regions in the FMDV IRES RNA, the domain 2 near the 5´ end of the IRES and a second binding region 
including the polypyrimidine tract and the domain 4 in the 3´ part of the IRES. Moreover, it has been 
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demonstrated that PTB is a component of both 48S and 80S ribosomal initiation complexes formed with FMDV 
IRES RNA (Niepmann et al., 1997). Very recently, PTB has been proven to a monomer rather than a dimer 
which challenges the previous concept of PTB dimerization (Simpson et al., 2004; Amir-Ahmady et al., 2005; 
Song et al., 2005). The actual mode of function of PTB in picornavirus translation is not yet understood. 
However, the influence of PTB on EMCV translation varies with the sequence context of the IRES (Kaminski & 
Jackson, 1998). This leads to the idea that PTB may act as an “RNA chaperone” that aids to maintain an 
appropriate tertiary structure of the IRES. In the case of HCV IRES element, it is still controversial if PTB binds 
to the HCV IRES element or not (Ali & Siddiqui, 1995; Kaminski et al., 1995; Ito & Lai, 1999). 
(3) Heterogeneous nuclear ribonucleoprotein L (hnRNP L, 68 kDa) binds to a region about nucleotides between 
the authentic HCV AUG codon at position 342 and 402 in the HCV core protein-encoding sequence, i.e., directly 
downstream of the binding site for La mentioned above (Hahm et al., 1998b). This sequence partially represents 
the 3´ border of the IRES and contributes to IRES function. Binding of hnRNP L to this sequence correlates with 
IRES activity, suggesting that hnRNP L might also be involved in the regulation of HCV IRES activity. The 
close vicinity of the binding sites for La and hnRNP L points to a possible interaction between these two proteins 
in HCV translation, and even hnRNP L and PTB may interact each other since the N-terminal RRM domain of 
PTB was shown to bind to hnRNP L (Hahm et al., 1998a). 
(4) The Poly(rC) binding protein (PCBP, 39 kDa), also known as hnRNP E, is another cellular protein, which 
binds specifically to the poliovirus (Blyn et al., 1996; Gamarnik & Andino, 1997; Parsley et al., 1997) and the 
hepatitis A virus IRES RNA (Graff et al., 1998). PCBP exists in two isoforms, PCBP1 and PCBP2. Both 
isoforms of PCBP specifically interact with two domains of the poliovirus 5´-UTR, the 5´-terminal cloverleaf 
structure of the viral plus-strand RNA and the domain IV of the IRES. Depletion of PCBPs from HeLa cell 
extracts inhibits the IRES activity to support the translation of poliovirus, rhinovirus and coxsackie B virus, but 
translation of EMCV and FMDV was not affected. Recombinant PCBP2 but not the closely related PCBP1 (> 80 
% amino acid identity) restored the activity of entero-/rhinovirus IRES elements (Blyn et al., 1997; Walter et al., 
1999). In the case of HCV, PCBP-1 and PCBP-2 were found to bind specifically to the HCV 5´-untranslated 
region (Spangberg & Schwartz, 1999b). However, no functional involvement of PCBP in HCV IRES function 
was reported so far. 
 
IRES Translation initiation factors Trans-acting cellular factors 
EMCV eIF4G-Ct, eIF4A, eIF3, eIF2 PTB, La 
FMDV eIF4B, eIF4G-Ct, eIF4A, eIF2, eIF3 PTB, ITAF45 
Poliovirus eIF4B, eIF3, eIF4G-Ct PTB, PCBP2, La, Unr 
Rhinovirus not investigated PTB, PCBP2, La, Unr, Unrip 
HCV eIF2 and eIF3 only PTB (controversial), La, hnRNP L, PCBP1 and 2, NSAP1 
 
Table 6:  Functional RNA-protein interactions in viral IRES elements. (Ct, C-terminal) 
 
 
Also, other cellular RNA-proteins were reported to interact with HCV IRES element, such as ribosomal proteins 
(Fukushi et al., 1999; Fukushi et al., 2001; Otto et al., 2002), the proteasome subunit PSMA7 (Krüger et al., 
2001), nucleolin (Izumi et al., 2001), NS1-associated protein 1 (NSAP1) (Kim et al., 2004) and some other 
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proteins that were only qualitatively observed but not yet further confirmed (Lu et al., 2004). These 
considerations suggest that the role of these RNA-binding proteins, which bind at multiple sites, may somehow 
stabilize the complex secondary and tertiary structure of the IRES to allow the conserved motifs to interact with 
the cellular translation machinery. 
 
 
1.6.3   The HCV 3´-untranslated region (3´-UTR) 
 
Unlike most of the viruses carrying a poly (A) tail at the 3´ terminal end of their RNA genomes, the HCV 
genome contains an unusual specific untranslated region at the 3´ end. This is a very characteristic region in the 
HCV RNA genome. The length of it is usually shorter, about 221-225 nucleotides, than that of the 5´-UTR. This 
3´UTR also contains significantly ordered RNA structures with three distinct regions: (1) an upstream variable 
region (VR) within which substantial sequence diversity is evident between different genotypes of HCV; (2) a 
poly(U)-poly(UC) [poly-(U/UC)] tract; and (3) a very highly conserved, 98-nucleotide 3´ terminal segment 
(called 3´X-region or X-tail) which putatively forms three stem-loop structures (designated SL1, SL2 and SL3, 
in the 3´- to 5´- direction) (Fig. 9) (Tanaka et al., 1995; Kolykhalov et al., 1996; Ito & Lai, 1997). The poly-
(U/UC) tract and the downstream 3´-X are both required for infectivity of synthetic, genome-length RNA 
inoculated into chimpanzees (Morita et al., 1999; Kolykhalov et al., 2000). 
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Fig. 9: Potential secondary structure of the 3´-UTR of the HCV genotype 1a. Modified from the references 
(Blight & Rice, 1997) and (Kolykhalov et al., 2000) with the two stem-loops in the variable region (VSL1 and 
VSL2) and the other two domains as described in the text. The VSL1 includes the very 3´-end sequences of 
NS5B coding sequence and the very beginning part of variable region sequences. The stop codon of the 
polyprotein ORF is highlighted in bold.  
 
 
In addition, the VR segment also contributes to efficient RNA replication, shown by using subgenomic replicons 
derived from the Con1 strain of HCV (Friebe & Bartenschlager, 2002; Yi & Lemon, 2003a). In a recently 
published paper, Friebe and co-workers have shown that a nucleotide sequence complementarity between the 
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upper loop of the non-structural protein NS5B and the loop region of SL2 in the 3´ X-region, which is called a 
pseudoknot (kissing-loop) structure, is essential for the replication (Lee et al., 2004; You et al., 2004; Friebe et 
al., 2005). Furthermore, the 3´-UTR of HCV was also reported to play putatively a stimulating role in the HCV 
RNA translation activity although some conflicting data have been reported (Ito et al., 1998; Ito & Lai, 1999; 
Fang & Moyer, 2000; Michel et al., 2001; Murakami et al., 2001; Friebe & Bartenschlager, 2002; Kong & 
Sarnow, 2002; McCaffrey et al., 2002; Imbert et al., 2003). In this work, the 3´-UTR has been found to play a 
very important role in the HCV translation, which will be described in the third part of the Results section. 
 
 
1.7   Aims of this work 
 
In the work presented in this thesis, the functional interactions of several known cellular factors with the 
Hepatitis C Virus and FMDV internal ribosome entry site elements and the possible role of the 3´-UTR of HCV 
in the IRES-dependent translation have been studied in detail.  
The aim of the first part of this work was to attempt to search for some other cellular proteins that might bind 
specifically to the IRES of HCV in order to achieve a better understanding of the translation initiation pathway 
directed by HCV internal ribosome entry sites. Using a combination of several techniques such as 
electrophoretic mobility shift assay (EMSA), UV cross-linking assay and western blot, the interaction of several 
proteins with HCV IRES RNA has been investigated. The possible binding sites for those unknown proteins that 
may bind to the HCV IRES element were tentatively determined as well.  
The main goal of the present study was to address whether and how the 3´-UTR of HCV RNA influences the 
HCV translation activity directed by the HCV internal ribosome entry site, either in vitro or in vivo, since many 
conflicting effects of the HCV 3´-UTR on the HCV translation have been reported previously. Besides, the 
effects of HCV mutants introduced into the 3´-UTR structure on the HCV translation efficiency were also 
determined. 
In the last part of this work, promoted by the profound positive results derived from the translation stimulation 
by the HCV 3´-UTR, a very promising observation - the binding of a novel, but as yet not known protein of 
about 210 kDa - has been detected by using a new HCV clone. This 210 kDa protein binds specifically to the 3´-
UTR of HCV and may be involved in the stimulation of translation by the 3´-UTR. 
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2   Materials and Methods 
 
2.1   Materials 
 
2.1.1   Bacterial strains and cell lines 
 
2.1.1.1   Bacterial strains 
 
BL21-CodonPlus-RIL 
BL21-CodonPlus-RIL (E. coli B F -, ompT, hsdS(rB- mB-), dcm+, Tetr, gal, endA, Hte, (argU, ileY,  leuW, Camr)). 
This strain, a derivative of E. coli B, is a general protein expression strain that lacks both the Lon protease and 
the Omp T protease which can degrade proteins during the purification process. 
 
E. coli DH5 α 
E. coli DH5 α is highly transformable and usually used for large-scale production of plasmid DNAs. This strain 
also generates low endonucleases during incubation. 
 
E. coli XL1-Blue  
E. coli XL1-Blue (F -::Tn10, proA+B+lac9, (lacZ), M15/recA1end, A1gyrA96, (Nalr)thi, hsdR17 (rk- mk-), supE44, 
relA1lac), is a strain with the EndA- phenotype that allows the production of large amounts of DNA with a high 
quality. 
 
2.1.1.2   Mammalian cell lines 
 
The following four cell lines were kindly provided by Dr. D. Glebe, Dr. M. Kann and Dr. S. Kanse, respectively: 
Huh-7    (Human hepatocellular carcinoma cells)  
Hep G2   (Human caucasian hepatocyte carcinoma cells) 
HeLa  (Human negroid cervix epitheloid carcinoma cells)    
BHK-21  (Baby hamster kidney cells) 
 
2.1.2   Materials for bacterial growth and cell culture 
 
2.1.2.1   Materials for bacterial growth 
 
Standard I medium (Merck, Darmstadt) 
 - with 25 µg/ml Kanamycin and/or 150 µg/ml Ampicillin 
 - with 5 µg/ml Tetracycline and/or 150 µg/ml Ampicilli 
 
Luria-Broth (LB) medium 
- 0.5 % (w/v)    Extract of yeast powder 
- 1 %    (w/v)    Peptone from meat, trypsin-digested 
- 1 %    (w/v)    NaCl 
adjusted to pH 7.5, autoclaved 
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LB plates 
- 1.5 % (w/v) Bacto Agar (Difco, Augsburg) high-gel strength in LB medium, autoclaved  
 
Antibiotic plates 
- Standard I plates with 25 µg/ml Kanamycin and/or 150 µg/ml Ampicillin 
- Standard I plates with 5 µg/ml Tetracycline and/or 150 µg/ml Ampicillin 
 
2.1.2.2   Materials for cell culture 
 
Dulbecco's Modified Eagle's Medium (DMEM)   Invitrogen, USA 
Fetal Bovine Serum (FBS)     Invitrogen, Germany 
100× Penicillin-streptomycin solution    Invitrogen, Germany 
(10,000 U/ml penicillin and 10,000 µg/ml streptomycin) 
10× Trypsin-EDTA (0.5 g/L Trypsin, 0.2 g/L EDTA)  Invitrogen, Germany 
Tissue culture petri dishes      BD Labware, USA 
Tissue culture flasks      TPP, Germany 
6-, 12- and 24-well microplates      TPP, Germany 
 
2.1.3   Plasmids 
 
pHCV-FL-1b Kindly provided by  Prof. Dr. R. Bartenschlager, University of Heidelberg.  
pHCV-1a Kindly provided by  Dr. S-E. Behrens, modified by M. Niepmann and Y. 
Song. For plasmid details, see Appendix -- pHCV wt clone map. 
pHCV-FL-1a+1b Modified and constructed by M. Niepmann and Y. Song. 
pHCV ∆1, ∆2                                   Constructed by Dr. S-E. Behrens, modified by M. Niepmann and Y. Song  
All HCV deletion mutants 
used in this study   Constructed by Y.  Song 
pM12    Constructed by K. Ochs (Ochs et al., 1999) 
pM12+HCV 3´UTR  Constructed by Y. Song 
pMPolio   Constructed by K. Ochs (Ochs et al., 2002) 
 
2.1.4 Oligonucleotides  
 
All oligonucleotides used in this work were obtained from Carl Roth GmbH, Karlsruhe. 
Description  Length Sequence (5´ - 3´) 
HCMV_4986_for 27 CCA ATA GGC CGA AAT CGG CAA AAT CCC 
HCMV_Luc_rev 23 TTC ACA ATT TGG ACT TTC CGC CC  
HCV_3X_rev 22 ACA TGA TCT GCA GAG AGG CCA G 
LD_forward 21 CGA TTT AGA GCT TGA CGG GGA 
HCV_439_rev 21 CAC CAA CGA TCT GAC CAC CGC 
Luz_rev 20 GTT CCA TCC TCT AGA GGA TA 
H2099_for 24 GAC ATA GCT TAC TGG GAC GAA GAC 
H3030_rev 21 CGA ACG ACC GAG CGC AGC GAG 
PBS_172_for 24 CGT GGA CTC CAA CGT CAA AGG GCG  
HCV_D3_rev 26 TAT CAG GCC CCG GGA GGG GGG GTC CT 
HCV_D3_for 23 CTC CCG GGG CCT GAT AGG GTG CT 
HCV_D3a_rev 23 GGC AAT TCG TTC CGC AGA CCA CT 
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Description  Length Sequence (5´ - 3´) 
HCV_D3a_for 23 TGC GGA ACG AAT TGC CAG GAT GA 
HCV_D3b_rev 26 ACG CCC AAT CCG GTG TAC TCA CCG GT 
HCV_D3b_for 26 ACA CCG GAT TGG GCG TGC CCC CGC GA 
HCV_D3c_rev 23 CTC GCG GGC AAA TCT CCA GGC AT 
HCV_D3c_for 23 GAG ATT TGC CCG CGA GAC TGC TA 
HCV_D3d_rev 28 CCA CAA GGC TAG CAG TCT CGC GGG GGC A 
HCV_D3d_for 23 ACT GCT AGC CTT GTG GTA CTG CC 
HCV_D3e_rev 26 TCG CAA GCA GTA CCA CAA GGC CTT TC 
HCV_D3e_for 26 GTG GTA CTG CTT GCG AGT GCC CCG GG 
HCV_D3f_rev 23 TCC CGG GGC ACC CTA TCA GGC AG 
HCV_D3f_for 23 ATA GGG TGC CCC GGG AGG TCT CG 
HCV_aug_rev 29 GAG GTT TAG GCT ACG AGA CCT CCC GGG GC 
HCV_aug_for 23 TCT CGT AGC CTA AAC CTC AAA GA 
3X_Gen_for 21 GGG CGT GGA TAG CGG TTT GAC 
3X_Gen_rev 22 CGC AGC GAG TCA GTG AGC GAG G 
D3SL1_rev 21 GGC TCA CGG ACC TTT CTC TGC 
D3SL2_rev 23 CAT GCG GCC TAG GGC TAA GAT GG 
D3SL2_for 23 AGC CCT AGG CCG CAT GAC TGC AG 
D3SL1+2_rev 22 CTA GGG CTA AGA TGG AGC CAC C 
D3SL3_rev 25 GCC GTG ACT TAA AGA AGG GAA AAA G 
D3SL3_for 24 TTC TTT AAG TCA CGG CTA GCT GTG 
D3VR_rev 24 CCG GGA AAT GGT CAC AAT TTG GAC 
D3VR_for 26 CCA AAT TGT GAC CAT TTC CCG GTT TT  
D3UC_rev 20 AGC CAC CAC CGG GAA ATG GC 
D3UC_for 21 TTT CCC GGT GGT GGC TCC ATC 
D3VUC_rev 26 GAG CCA CCT TCA CAA TTT GGA CTT TC 
D3VUC_for 26 ATT GTG AAG GTG GCT CCA TCT TAG CC 
D3UCX_rev 24 CCG GGA AAT GGC TTA AGA GGC CGG 
D3SL2+3_rev 25 CAT GCG GCT TAA AGA AGG GAA AAA G 
D3SL2+3_for 23 TTC TTT AAG CCG CAT GAC TGC AG 
FL_RD15_rev 33 ACA TAA CAA ATC TAA TCA CAA TTT GGA CTT TCC 
HCMV_Dcore_rev 22 ATC TGC ATG ACG TCC TGT GGG C 
HCMV_Dcore_for 23 AGG ACG TCA TGC AGA TCT TCA TG 
Up_kpn_for 25 GTC AGA TCT ACG GGG CCT GTT ACT C 
Dn_kpn_rev 23 ACC CCA ACC TTC ATC GGT TGG GG 
Up_spe_for 28 AAC CGA TGA AGG TTG GGG TAA ACA CTC C 
Af_spe_rev 27 GGC GAC TAG TAC ATG ATC TGC AGA GAG 
Up_afl_for 22 GAC CCC GCT GGT TCA TGT GGT G 
Dn_afl_rev 24 ATG CCG GCC ACA TGA TCT GCA GAG 
Up_hdv_for 22 GAT CAT GTG GCC GGC ATG GTC C 
Dn_spe_rev 21 GGT TCC GCG CAC ATT TCC CCG 
5B_rev 21 ATG CCG GCC TCA TCG GTT GGG 
Hdv_for 22 AAC CGA TGA GGC CGG CAT GGT C 
Seq_spe_rev 21 ATT TCC CCG AAA AGT GCC ACC 
Seq_kpn_for 23 ATG TAT GCG CCC ACC TTG TGG GC 
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2.1.5   Enzymes 
 
2.1.5.1   Restriction endonucleases 
 
All restriction enzymes used in this work were provided from Fermentas (MBI), Luckenwalde; New England 
Biolabs (Bio), Schwalbach; Boehringer Mannheim (Boehringer), Mannheim and Promega (Pro), Heidelberg. 
Reactions were performed according to protocols provided by the suppliers. Arrows indicate the cleavage site. 
 
Enzyme U/µl  Buffer Supplier    Recognition Sequence 
Aat II   20  NEB-4   Bio  GACGT↓C 
Afl II(BspT I)  2  NEB-2   Bio  C↓TTAAG 
Bam HI   20  NEB-2   Bio  G↓GATCC 
Bgl I   10  NEB-3   Boehringer GCC(N4)↓NGGC 
Bgl II   10  NEB-3   Pro  A↓GATCT 
BsiW I   15  NEB-3   Bio  C↓GTACG 
Bsm I   5  NEB-2   Bio  GAATG↓CN 
Bst XI   10  NEB-3   Bio  CCAN5↓NTGG 
EcoN I   15  NEB-4   Bio           CCTNN↓NNNAGG 
EcoR I   20  spec. NEB-buffer Bio  G↓AATTC 
EcoR V   20  spec. NEB-buffer Bio  GAT↓ATC 
Hind III   20  NEB-2   Bio  A↓AGCTT 
Kpn I   10  NEB-1   Bio  GGTAC↓C 
Nco I   5  NEB-4   Bio  C↓CATGG 
Nde I   20  50 mM NaCl  Bio  CA↓TATG 
NgoM IV  10  NEB-4   Bio  G↓CCGGC 
Nhe I   10  50 mM NaCl  Boehringer G↓CTAGC 
Pst I   20  NEB-3   Bio  CTGCA↓G 
Sac I   10  NEB-Sac  Bio  AGT↓ACT 
Sal I   20  Buffer H  Bio  G↓TCGAC 
Sma I   10  NEB-4   Bio  CCC↓GGG 
Spe I   10  NEB-2   Bio  A↓CTAGT 
Van 91I   10  MBI-red  Fermentas CCAN4↓NTGG 
Xba I   60  NEB-2   Bio  T↓CTAGA 
Xho I   20  NEB-2   Bio  C↓TCGAG 
---------------------------------------------------------------------------------------------------------------------------------------- 
 
2.1.5.2   Modifying enzymes 
 
Enzyme U/µl  Supplier  
Alkline Phosphatase, Shrimp (SAP)  1   Roche, Mannheim 
DNA-Polymerase (Klenow-fragment)  2   Boehringer, Mannheim 
DNase I (RNase free)    10   Boehringer, Mannheim 
Guanylyltransferase    5   Ambion 
Poly(A) polymerase    750   USB Corporation, USA 
Polynucleotide kinase (T4)   10   Biolabs, Schwalbach 
Proteinase K (10 mg/ml)  10 µg/µl   Merck, Darmstadt 
RNase A     10 µg/µl   Boehringer, Mannheim 
SP6 RNA Polymerase    25   Fermentas, Oldendorf 
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Enzyme U/µl  Supplier  
Taq DNA Polymerase    5   Promega, Heidelberg 
T3 RNA Polymerase    1.6   AGS, Heidelberg 
T4 DNA Ligase     6 Weiss Units               Biolabs, Schwalbach 
T7 RNA-Polymerase    20   Fermentas, Oldendorf           
* 1 Weiss Unit = 66.6 New England Biolabs Units. 
 
2.1.6   Nucleotides  
 
2.1.6.1   Radioactive nucleotides 
 
All radiochemicals used in this study were obtained from Amersham Biosciences, Freiburg. 
 
[α-32P]-rATP: > 400 Ci/mmol, 10 mCi/ml 
[α-32P]-rCTP: > 400 Ci/mmol, 10 mCi/ml 
[α-32P]-rGTP: > 400 Ci/mmol, 10 mCi/ml 
[α-32P]-UTP:  > 400 Ci/mmol, 10 mCi/ml 
 35S-Met: > 600 Ci/mmol, 15 mCi/ml 
[14C]-Protein Marker, 5 µCi/ml  
 
2.1.6.2   Non-radioactive nucleotides 
 
Ribonucleoside triphosphates (rNTPs): Pharmacia LKB GmbH, Freiburg  
Deoxyribonucleoside triphosphates (dNTPs), Boehringer, Mannheim 
 
2.1.7   Size markers 
 
2.1.7.1   Protein size markers  
 
Protein (14C)-methylated proteins (kDa) (Amersham) 
Myosin               220.0     
Phosphorylase B (rabbit muscle)        97.4     
Bovine serum albumin              66.0     
Ovalbumin               45.0     
Carboanhydrase               30.0     
Lysozyme (hen egg white)               14.3                           
 
10 kDa protein ladder, Invitrogen, USA 
 
Protein Prestained  (kDa) (New England Biolabs)  
MBP-β-Galactosidase     175.0 
MBP-Paramyosine     83.0 
Glutamine dehydrogenase     62.0 
Aldolase     47.0 
Triosephosphate isomerase     32.0 
β-Lactoglobuline A     25.0 
Aprotinin     6.0 
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2.1.7.2   DNA size markers 
 
DNA ladder marker: 10 kbp, 8000 bp, 6000 bp, 5000 bp, 4000 bp, 3000 bp, 2500 bp, 2000 bp, 1500 bp,  
(BioLine) 1000 bp, 800 bp, 600 bp, 400 bp, 200 bp. 
 
Another DNA marker was obtained from R. Füllkrug, Gießen: pSP64 is cleaved with Hind III, Dra I and Hinf I, 
(a mixture with 1:2:4 of corresponding restricted plasmid was used). 
DNA fragments: 2999 bp, 2288 bp, 1198 bp, 692 bp, 517 bp, 396 bp, 354 bp, 218 bp, 176 bp, 75 bp, 65 bp. 
 
2.1.8   Recombinant proteins 
 
--Human PTB fused to (His)6 at N-terminus (59.1 kDa) Kindly provided by Dr. M. Niepmann, Giessen 
 
--His-Unr protein Kindly provided by Dr. H. Jacquemin-Sablon, 
Bordeaux, France  
 
--GST-hnRNP L protein Kindly provided by Prof. A. Bindereif,  Giessen 
 
2.1.9   Chemicals and reagents 
 
Acrylamide solution (40 %) Roth  
Ammonium persulfate (APS) Serva 
Bovine serum albumin (BSA)  Merck  
5-Bromo-4-chloro-3-indolyl-phosphate (BCIP) GERBU 
Bromophenol blue (RNase free) Sigma-Aldrich 
Collagen Sigma-Aldrich 
Coomassie brilliant blue R-250 Serva 
Dimethyl sulfoxide (DMSO) Merck 
Dithiothreitol (DTT) (RNase free) Biozyme 
Ethylene diamine tetra acetic acid (EDTA) Merck 
Ethidium bromide Fluka 
Formamide Gibco-BRL 
Glycerol Roth 
L-Glutathione (reduced form) Serva 
Glutathione sepharose  4B Pharmacia 
HEPES (N-[2-Hydroxyethyl]piperazine- N´-[2-ethanesulfonic acid])   Roth 
Imidazole Sigma 
MOPS Serva 
Ni-NTA agarose  Qiagen  
Nitro blue tetrazolium (NBT)  GERBU 
N,N,N´,N´-Tetra methyl ethylene diamine (TEMED)  Sigma-Aldrich 
Poly(U)-sepharose  Pharmacia 
Phenylmethylsulfonylfluoride (PMSF)   Boehringer 
D(+)-Sucrose  Roth 
TALON  CloneTech 
Transfer-RNA (tRNA)  Sigma 
Tris (Hydroxymethyl)-aminomethan  Roth 
Tween 20 (Polyoxyethylenesorbitan monolaurate)  Sigma 
 
Other inorganic chemicals, organic substances and solvents were purchased from Sigma-Aldrich, Merck, 
Boehringer Mannheim GmbH, Serva, Difco and ICN Biochemicals GmbH. 
2   Materials and Methods                                                                                           32                      
2.1.10   Kits 
 
Easy pure DNA purification kit, Biozyme, Oldendorf 
GFX Micro Plasmid Prep Kit, Amersham Biosciences 
GFX PCR DNA and Gel Band Purification Kit, Amersham Biosciences 
Materials for DNA affinity purification of plasmid DNA, Nucleobond, Macherey-Nagel GmbH & Co KG 
Materials for DNA affinity purification of plasmid DNA, Jetstar, Genomed GmbH, Bad Oeynhausen 
Plasmid purification midi kit, Qiagen 
Poly(A) tailing kit, USB Corporation 
RNA Capping kit, Ambion 
RNA TransMessenger® transfection Kit, Qiagen 
RNeasy Purification kit, Qiagen 
 
2.1.11   Cell culture flasks and pipets 
 
T-50 cell culture flasks, Greiner 
5-ml plastic pipets, Falco 
10-ml plastic pipets, Falco 
 
2.1.12   Photo materials and X-ray films 
 
Cronex MD-Developer, Du Pont, Bad Homburg 
Cronex MF-E Fixer, Du Pont, Bad Homburg 
Film Cassettes Cronex Lightning Plus, Du Pont, Boston, USA 
Kodak Biomax BMS X-ray film, Eastman Kodak, Rochester, NY, USA 
Kodak Biomax BMR 1 X-ray film, Eastman Kodak, Rochester, NY, USA 
Kodak X-omat XAR5 X-ray film, Eastman Kodak, Rochester, NY, USA 
Polaroid 667 Professional, Polaroid Corporation, Cambridge, MA, USA 
 
2.1.13   Equipments 
 
All equipments needed for this work are listed as following: 
 
Centrifuges 
Low speed centrifuge: J2-21 with rotors JA 10, JA 14, JA 17, JA 20, Beckman Instruments, Summerset, USA 
Table centrifuge: Eppendorf centrifuge 54156. 
Ultracentrifuge: Optima LE-80K with SW41 Ti rotor, Beckman Instruments, Summerset, USA 
 
Gel-electrophoresis systems 
Horizontal minigel-system, AGS, Heidelberg 
Mini-gel chamber, Keutz, Reiskirchen 
Power supply, EPS 500/400, Pharmacia LBK, Freiburg 
 
Shakers  
Diffusions-Destain apparature, Desaga, Heidelberg 
Mixer 54322, Eppendorf, Hamburg 
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Mixer, Ikamag Ret, Ika-Werk, Staufen i.Br. 
Vortex Genie2, Scientific Industries Bohemia, New York 
 
Other equipments 
Fast-Blot-Apparatur, Biometra, Göttingen 
Luminometer (Lumat LB9507), Berthold, Germany 
PCR instrument, Biometra GmbH, Göttingen 
Polaroid MP-4 Land Camera, Polaroid Corporation, Cambridge, USA 
Robocycler, Stratagen, Gebouw, California  
Transilluminator, Herolab GmbH, Wiesloch 
TRI-CARB 1500, Liquid Scintillation Analyser, PACKARD, A Canberra Company 
Ultraviolett light (hand lamp) Konrad Benda, Wiesloch 
 
2.1.14   Buffers and solutions 
 
For all buffers, the final concentrations are given and stock solutions are indicated in brackets. 
 
2.1.14.1   Buffers for DNA and RNA gel electrophoresis 
 
TAE-buffer (E-buffer)   40.0 mM  Tris-OH, pH 8.0 
(20× stock solution)   40.0 mM  Sodium acetate   
    2.0 mM  EDTA 
 
TBE-buffer    90.0 mM  Tris-borate, pH 8.3 
(10× stock solution)   2.5 mM  EDTA 
 
Gel-loading buffer (FM), native  75.0 % (v/v)  Glycerol 
Stock solution    0.1 mM  EDTA 
     0.1 %  Bromophenol blue 
     0.1 %  Xylene cyanol FF 
 
Gel-loading buffer (FA), denaturing 80.0 %  Formamide 
Stock solution    1.0 mM  EDTA  
     0.1 % (w/v)  Bromophenol blue 
     0.1 % (w/v)  Xylene cyanol FF 
 
Staining solution    2.0 µg/ml  Ethidium bromide in TAE buffer 
(5,000× stock solution) 
 
2.1.14.2   Buffers for protein gel electrophoresis 
 
Acrylamide solution (40:1)  30.0 % (w/v)  Acrylamide 
     0.75 % (w/v)  Bisacrylamide 
 
Stacking gel buffer   125.0 mM  Tris-HCl, pH 6,8 
(4× stock solution)   0.1 % (w/v)  SDS 
 
Seperating gel buffer   375.0 mM  Tris-HCl, pH 8.8 
(4× stock solution)   0.1 % (w/v)  SDS 
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Loading buffer     125.0 mM  Tris-HCl, pH 6.8 
     20.0 %  Glycerol   
     10.0 %  ß-Mercaptoethanol (added freshly) 
     4.0 % (w/v)  SDS 
     0.02 % (w/v)  Bromophenol blue 
 
Loading buffer with urea   125.0 mM  Tris-HCl, pH 6,8   
     7.0 M  Urea 
     20.0 %  Glycerol 
     10.0 %  ß-Mercaptoethanol (added freshly) 
     4.0 % (w/v)  SDS 
     0.02 % (w/v)  Bromophenol blue 
 
Running buffer (TG)   25.0 mM  Tris-OH, pH 8.3 
(10× stock solution)   192.0 mM  Glycine 
     0.1 % (w/v)  SDS 
 
Coomassie blue staining solution  50.0 %  Ethanol 
     10.0 %  Acetic acid 
     0.1 % (w/v)  Coomassie brilliant blue R-250 
 
Destaining solution   7.5 %  Acetic acid 
     5.0 %  Ethanol 
 
 
2.1.14.3   Buffers for molecular biological methods 
 
Ligase buffer    20.0 mM  Tris-HCl, pH 7.5 
(10× stock solution)   5.0 mM  MgCl2 
     5.0 mM  DTT 
     50.0 µg/ml  BSA 
     0.5 mM  ATP (added separately) 
 
Transcription buffer   50.0 mM  Tris-HCl, pH 7.5 
(5× stock solution)   10.0 mM  MgCl2 
     10.0 mM  Spermidine 
 
Alkaline phosphatase-(SAP) buffer 50.0 mM  Tris-HCl, pH 8.5 
(10× stock solution)   0.1 mM  EDTA 
 
Proteinase K buffer   50.0 mM  Tris-HCl, pH 7.5 
(10× stock solution)   10.0 mM  CaCl2 
      0.5 % (w/v)  SDS  
 
 
2.1.14.4   Buffer for plasmid DNA preparations 
 
Phenol buffer    80.0 % (w/v)  Phenol 
     50.0 mM  Tris-OH 
     0.1 %  Hydroxy chinoline 
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TE-buffer    10.0 mM  Tris-HCl, pH 8.0 
     0.1 mM  EDTA 
 
TELT buffer    50.0 mM  Tris-HCl, pH 7.5 
     62.5 mM  EDTA 
     2.5 M  Lithium chloride 
     0.4 %  Triton-X-100 
 
2.1.14.5   Buffers and solutions for DNA purification with affinity columns 
 
Sol A     5.0 mM  Tris-HCl, pH 8.0 
     10.0 mM  EDTA 
     50.0 mM  Glucose 
     10.0 µg/ml  RNase A (added freshly before use) 
 
Sol B     0.2 M  NaOH 
     1.0 %  SDS 
 
Sol C     3.0 M  Sodium acetate 
     2.0 M  Acetic acid 
 
QBT     50.0 mM  MOPS, pH 7.0 
     750.0 mM  NaCl 
     15.0 %  Ethanol 
     0.15 %  Triton X-100 
 
Wash buffer    50.0 mM  MOPS, pH 7.0 
     1.0 M  NaCl 
     15.0 %  Ethanol 
 
Elution buffer    50.0 mM  MOPS, pH 8.2 
     1.25 M  NaCl 
 
2.1.14.6   Buffers for immunological methods 
 
TBST 150-buffer    10.0 mM  Tris-HCl, pH 8.0 
(20× stock solution)   150.0 mM  NaCl 
     0.05 %  Tween-20 
 
TBST 500-buffer    10.0 mM  Tris-HCl, pH 8.0 
(20× stock solution)   500.0 mM  NaCl 
     0.05 %  Tween-20 
Block-buffer    10.0 mM  Tris-HCl, pH 8.0 
(TBST 150 + BSA)   150.0 mM  NaCl 
     3.0 %  BSA (added freshly, stir well) 
     0.05 %  Tween-20 
 
Transfer buffer    25.0 mM  Tris-OH, pH 8.3 
(10× stock solution)   192.0 mM  Glycine 
     10.0 %  Ethanol 
     0.1 % (w/v)  SDS (only for large proteins) 
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Alkaline phosphatase buffer  100.0 mM  Tris-HCl, pH 9.5 
     100.0 mM  NaCl 
     5.0 mM  MgCl2 
 
Stop Mix    10.0 mM  Tris-HCl, pH 8.0 
     1.0 mM  EDTA 
 
2.1.14.7   Protein-RNA interaction buffers 
 
Cross-linking buffer (for FMDV)  10.0 mM  HEPES, pH 7.9 
(5× stock solution)   1.0 mM  DTT 
     2.0 mM  MgCl2 
     1.0 µg/µl  tRNA  
     10 %  Glycerol 
     0.05 %  NP-40 
     1.0 mM  ATP (added separately) 
 
EMSA binding buffer (5×)  25.0 mM  HEPES, pH 7.4   
     125.0 mM  KCl 
     10.0 mM  MgCl2 
     10.0 mM  DTT 
     0.5 mM  EDTA 
     19.0  %  Glycerol 
 
EMSA running buffer (1×)  45.0 mM  Tris-borate, pH 8.3  
     1.25 mM  EDTA 
 
2.1.14.8   Buffers for preparation of S10 lysate of HeLa or Huh-7 cells 
 
Isotonic buffer (1×)   35.0 mM  Hepes, pH 7.4 
     146.0 mM  NaCl 
     11.0 mM  Glucose 
 
Hypotonic buffer (1×)    20.0 mM  Hepes, pH 7.4 
     10.0 mM  KCl 
     1.5 mM  MgCl2 
     1.0 mM  DTT 
     0.5 mM  PMSF 
     0.1 mM  EDTA 
0.1 mM  EGTA 
 
S10 buffer (10×)    200.0 mM  Hepes, pH 7.4   
     1.2 M  KCl 
     40.0 mM  MgCl2 
     50.0 µg/ml  DTT 
 
Phosphate-buffered saline (PBS)  4.3 mM  Na2HPO4 
(10× stock solution)   1.4 mM  KH2PO4 
     137.0 mM  NaCl 
     2.7 mM  KCl 
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2.1.14.9   Immunoprecipitation buffers 
 
Binding buffer    20.0 mM  Tris HCl, pH7.5 
     200.0 mM  NaCl 
     10.0 µg/µl  BSA 
 
Wash buffer A    50.0 mM  Tris-HCl, pH 7.5 
     500.0 mM  NaCl 
     1.0 mM  Imidazole 
     100.0 µg/ml  tRNA 
     50.0 µg/ml  BSA 
      
Wash buffer B    50.0 mM  Tris-HCl, pH 7.5 
     500.0 mM  NaCl 
     1.0 mM  Imidazole 
     100.0 µg/ml  tRNA 
     100.0 µg/ml  BSA 
     0.25 %  Tween-20 
     0.25 %  NP-40 
 
Phosphate-buffered saline (PBS)  8.0 mM  Na2HPO4 
(10× stock solution)   2.0 mM  NaH2PO4 
     140.0 mM  NaCl 
 
2.1.14.10   Buffers for in vitro translation 
 
Firefly Luciferase-assay reagent  20.0 mM  Tricine 
(Promega)    1.07 mM  (MgCO3)4Mg(OH)2 x 5 H20 
     2.67 mM  MgSO4 
     0.1 mM  EDTA 
     33.3 mM  DTT 
     270.0 µM  Coenzyme A 
     470.0 µM  Luciferin 
     530.0 µM  rATP 
        pH 7.8 
 
Dilution buffer for Firefly luciferase reagents    
25.0 mM  Glycylglycine, pH 7.8 
     15.0 mM  MgSO4 
     0.1 mM  EDTA 
     33.3 mM  DTT 
     1.0 mM  rATP 
 
Renilla Luciferase-assay reagent  1.0 mg/ml  Coelenterazine in Methanol 
(Roche)      
 
Dilution buffer for Renilla luciferase reagents    
     0.1 M  Potassium Phosphate, pH 7.4 
     0.5 M  NaCl 
     1.0 mM  EDTA 
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2.1.14.11   Buffers for purification of His6-tag proteins under native conditions (Ni-NTA) 
 
Lysis buffer     50.0 mM  NaH2PO4  
     300.0 mM  NaCl  
10.0 mM  Imidazole 
adjust to pH 8.0 using NaOH 
 
Wash buffer    50.0 mM  NaH2PO4  
     300.0 mM  NaCl  
20.0 mM  Imidazole 
adjust to pH 8.0 using NaOH 
 
Elution buffer    50.0 mM  NaH2PO4  
     300.0 mM  NaCl  
250.0 mM  Imidazole 
   adjust to pH 8.0 using NaOH 
 
Dialysis buffer    10.0 mM  Tris-Cl, pH 7.5 
(set up freshly)    0.1 mM  DTT 
     10.0 mM  NaCl 
     3.0 %  Glycerol 
 
2.1.14.12   Buffers for RNase Protection Assay (RPA) 
 
Hybridization buffer   80.0  %  Formamide 
     40.0 mM  Tris-Cl, pH 7.5 
     400.0 mM  NaCl 
     1.0 mM  EDTA 
 
RNase digestion buffer   10.0 mM  Tris-Cl, pH 7.5 
     5.0 mM  EDTA 
     300.0 mM  NaCl 
     40.0 µg/ml  RNase A (added freshly) 
     2.0 µg/ml  RNase T1(added freshly, if needed) 
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2.2   Methods 
 
2.2.1   Microbiological methods 
 
2.2.1.1   Preparation of competent bacterial cells -- Classical CaCl2 method 
 
Preparation of competent bacterial cells using the CaCl2 procedure is performed according to (Sambrook et al., 
1989). The cells from an overnight culture are diluted in 1:50 or 1:100 with standard–I or LB medium containing 
appropriate antibiotics, and incubated further for 90 to 120 min at 37°C with vigorous shaking until the density 
of 1~2 × 108 cell/ml (or OD = 0.8 ~ 1) is reached. The culture is centrifuged at 5,000 rpm for 10 min at 4°C, cell 
pellets are resuspended gently in 1/5 volume (based on the original culture volume) of ice-cold 30 mM CaCl2 and 
incubated on ice for 30 min. Bacterial cells are recovered by centrifugation for 10 min at 5000 rpm at 4°C and 
resuspended in 1/20 volume (based on the original culture volume) of ice-cold 30 mM CaCl2. The competent cells 
are either used immediately for transformation or are prepared for freezing at -80°C by adding a certain volume 
of glycerol stock solution (final concentration of glycerol in cell suspension is 20 %). This procedure is less 
efficient but commonly used for transformation of supercoiled plasmid DNA or ligation solution. 
 
2.2.1.2   Transformation of competent cells 
 
For the transformation, 0.01-0.001 pmol of plasmid-DNA or ligation reaction (0.05-0.1 pmol) are added to 100 
µl of competent cells and incubated on ice for 30 min. Cells are heat-shocked for 60-90 seconds at 42°C. After 
cooling for 3-5 min on ice, 900 µl of pre-warmed standard-I-medium or LB medium are added and incubated at 
37°C for at least 1 hr. Transformed bacterial cells are pelleted by centrifugation and plated on selective 
antibiotics-containing plates. 
 
2.2.2   Molecular biological methods 
 
2.2.2.1   Preparation of plasmid DNA 
 
Small-scale preparation of plasmid DNA 
 
Plasmid DNA mini-preparation is usually done according to the following protocol: A single plasmid-containing 
bacterial colony is inoculated into 2-3 ml of LB medium containing corresponding amount of antibiotics 
(ampicillin, tetracyclin, kanamycin, etc) in a loosely capped 10 ml glass test-tube. The tube is incubated 
overnight at 37°C on shaking-bed. These cultures are collected by centrifugation at maximum speed for 20 sec. 
Supernatants (medium) are removed and cell pellets are completely resuspended in 300 µl of solution I by 
vigorous vortexing, until the pellets are completely dispersed. Then 300 µl of solution II (containing SDS and 
NaOH; SDS denatures bacterial proteins, and NaOH denatures chromosomal and plasmid DNA) is added. The 
content is mixed by inverting the tube a few times. After incubation for < 5 min at room temperature, the mixture 
is then neutralized by treatment with 600 µl of solution III (the plasmids then remain in solution containing 
potassium acetate, which causes the covalently closed plasmid DNA to reanneal rapidly to its supercoiled 
structure, while the bacterial chromosome and other components aggregate). The tube is inverted gently for 10-
30 seconds until the precipitate is evenly dispersed. The tube is centrifuged at 13,000 rpm for 5 min at room 
temperature in a microcentrifuge (Heraeus, Germany). After centrifugation, the supernatant is transferred by 
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gentle aspiration to a GFX-column placed in a collection tube, and incubated at room temperature for 1-2 
minutes. Then this column is centrifuged at full speed for 1 min. and the flow-through is discarded. Another 400 
µl of wash buffer is loaded on the column and spun at 13,000 rpm for 1 min. The column with plasmid DNA is 
dried and then placed in a new microcentrifuge tube. Then the plasmid DNA is eluted by centrifugation for 1 
min after incubation with a desired volume of TE buffer (pH 8.0) or sterilized double-distilled H2O and stored at 
-20 °C. 
 
Large-scale preparation of plasmid DNA  
 
Large quantities of high quality plasmid DNA are purified from bacterial cultures by using Nucleobond® AX 
100-affinity cartridges (Macherey-Nagel GmbH & CoKG, Düren). Bacterial cells from 100 ml of overnight 
plasmid-bearing bacterial cell cultures are harvested by centrifugation at 4,000 rpm for 10 min at 4°C.  
The supernatants are discarded and bacterial cell pellets are resuspended carefully with 4 ml of buffer S1. 
Bacterial cells are lysed by addition of 4 ml of buffer S2, the suspensions are mixed gently by inverting the tube 
4 to 6 times. Vigorous mixing should be avoided to prevent shearing of bacterial genomic DNA and subsequent 
contamination of plasmid DNA. After incubation for ≤ 5 min at room temperature, 4 ml of pre-cooled buffer S3 
are added. This results in a precipitate containing chromosomal DNA and other cellular compounds. The 
suspension is gently mixed by inverting the tube 4 to 6 times until a homogeneous suspension is formed. The 
mixture is then incubated on ice for 5 min. Plasmid DNA is separated from SDS-protein complexes and 
chromosomal DNA by centrifugation at 14,000 rpm for 20 min at 4°C. The supernatant is removed carefully 
from the precipitate and further clarified by filtration using a Nucleobond® filter moisted with water. Clarified 
flow-through is loaded directly onto a Nucleobond® AX 100 affinity cartridge pre-equilibrated with buffer N2. 
The cartridge is washed three times with buffer N3. Finally, the plasmid DNA is eluted with 5 ml of buffer N5. 
Purified plasmid DNA is precipitated with 0.7 volume of isopropanol at room temperature. The DNA is pelleted 
by centrifugation for 30 min (13,000 rpm) at 4°C, pellets are washed two times with 80 % ethanol, air dried and 
redissolved in 100-120 µl of ddH2O or TE buffer. 
 
Extraction of plasmid DNA from agarose gel 
 
For the elution of plasmid DNA from agarose gel, the easy pure DNA purification kit (Biozyme) is used. The 
desired DNA band is excised from ethidium bromide stained gel under long-wave length UV light. The 
approximate volume of the gel slice is determined by weight estimation of the agarose slice (100 µg is equal 
approximately to 100 µl binding buffer). The slice is then transferred to an eppendorf tube. The agarose gel slice 
is incubated for 5 min at 55°C with three volumes of "Salt Buffer" solution until the agarose gel is completely 
dissolved. DNA from the solution is allowed to bind to "Bind Matrix" at room temperature for 5 min with 
gentle rocking. For 1.5 µg of expected DNA, 1.5 µl of "Bind Matrix" is added. The matrix (with the bound 
DNA) is recovered by centrifugation for 5 seconds at 14,000 rpm. To wash the DNA, the matrix is resuspended 
in 1 ml of "Wash buffer" and centrifuged for a few seconds (this step is repeated two times). The rest of "Wash 
buffer" is discarded, and the matrix is dried by leaving the tube for 5 to 10 min at room temperature. The DNA 
is eluted using TE buffer. The supernatant containing eluted DNA is carefully removed, placed in a new 
eppendorf tube and stored at -20°C.  
 
Phenol-chloroform extraction and ethanol precipitation  
 
This protocol is used to purify and concentrate the DNA and RNA preparations. An equal volume of equilibrated 
phenol is added to the nucleic acid containing solution, vortexed vigorously and centrifuged at maximum speed 
for 5 min. The upper (aqueous) phase, which contains the nucleic acid, is placed into another centrifuge tube and 
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extracted with an equal volume of phenol : chloroform (1:1). The rest of phenol is removed by extraction with 
another equal volume of chloroform. Nucleic acids are precipitated by addition of 0.1 volume of 3 M sodium 
acetate pH 5.2 and of 2.5 volume of ice-cold 100 % ethanol (calculated after salt addition). After incubation for 
0.5-1 hr on ice or at -20°C, nucleic acids are pelleted by centrifugation for 30 min at 13,000 rpm (4°C). Pellets 
are washed two times with 80 % ethanol, air dried, resuspended in a desired volume of ddH2O or TE buffer (pH 
8.0) and stored at -20°C. 
 
 
2.2.2.2   Enzymatic modifications of DNA 
 
Digestion of DNA with restriction endonucleases 
 
Digestion of DNA with restriction endonucleases is performed according to the standard protocols as described 
by (Sambrook et al., 1989). For each restriction endonuclease, the optimal reaction conditions are chosen as 
recommended by the manufacturer. The amount of enzyme and DNA varies depending upon the specific 
application. 
For most analytical purposes, 1 µg of DNA is digested with 1 unit of endonuclease enzyme in 25 µl reaction 
mixture. After incubation, aliquots of the digested DNA are tested on agarose gels. Digestion reactions are 
terminated by extraction with phenol : chloroform, and cleaved DNA is then ethanol precipitated. 
 
Dephosphorylation of linearized DNA 
 
The terminal 5´-phosphate can be removed from the termini of the linear DNA by treatment with shrimp alkaline 
phosphatase (SAP) (Roche Applied Corp.). This strategy is used to suppress self-ligation and re-circularization 
of the linear vector. To the restriction reaction, 0.1 volume of 10× SAP buffer and an appropriate amount of SAP 
(1 Unit SAP/1 pmol DNA end) are added. The reaction mixture is then incubated for 10 min (for sticky ends) or 
1 hr (for blunt ends) at 37°C and 15 min at 65°C. At the end of the dephosphorylation reaction, SAP is removed 
by digestion with a small amount of proteinase K and the dephosphorylated DNA is then purified by the GFX 
PCR DNA and Gel Band Purification Kit. 
 
Filling in a 5´-overhang with Klenow-fragment enzyme 
 
Following a restriction enzyme digestion that generates 5´-overhang ends, the Klenow fragment of E. coli DNA 
polymerase I that possesses a 3´-5´ polymerase activity is used to fill 5´-overhang ends with deoxynucleotides 
(dNTPs). To the restriction reaction, 2.5 mM (final concentration) of dNTPs plus 100 U/ml Klenow enzyme are 
added and the reaction mixture is incubated for 30 min at 25°C. The DNA is extracted with phenol : chloroform 
and ethanol precipitated. DNA pellets are air dried and resuspended in ddH2O. 
 
Ligation reaction 
 
Ligation of a segment of foreign DNA to a linearized plasmid vector is carried out using the ligase kit (Biolabs). 
To 0.03-0.05 pmol of dephosphorylated vector an appropriate amount of insert DNA is added in a molar excess 
of 3:1 or 5:1 with 1 µl of ligase buffer in a final volume of 10 µl ligation reaction. The ligation is performed at 
12-14°C overnight after addition of 0.5 U T4-DNA ligase. 
 
2   Materials and Methods                                                                                           42                      
Standard ligation reaction 
 1.0  µl  10× Ligase buffer 
 1.0  µl  5 mM ATP (for blunt ends) / 10 mM ATP (for sticky ends) 
  µl Vector (0.03 – 0.05 pmol) 
  µl Fragment (insert) 
 0.5  U T4-DNA ligase 
  µl Sterile ddH2O 
___________________________________________ 
Σ =  10  µl  Final volume 
 
The ligation reaction is incubated overnight at 12-14°C. Following the ligation reaction, ligated DNA is 
transformed into competent cells of an appropriate host strain. 
 
 
2.2.2.3   Proteinase K digestion 
 
Proteinase K is a highly active protease that is used to remove DNA-binding proteins and enzymes such as CIP 
that must be completely removed from DNA preparations if the subsequent ligations should work efficiently. To 
a mixture of dephosphorylated DNA reaction, SDS and EDTA (pH 8.0) are added to the final concentration of 
0.5 % and 5 mM, respectively. After mixing, the reaction mixture is supplemented with 50 µg/ml of proteinase K 
and incubated for minimum 30 min at 56°C or overnight at 37°C. The DNA is recovered by centrifugation, 
phenol : chloroform extracted, ethanol precipitated and resuspended in TE buffer or ddH2O. 
 
 
2.2.2.4   The polymerase chain reaction (PCR) 
 
The polymerase chain reaction is used to amplify in vitro a segment of DNA that lies between two regions of 
known sequence. The PCR simply entails mixing template DNA, two appropriate synthesized DNA 
oligonucleotide primers, thermostable Taq DNA-polymerase, deoxyribonucleotides (dNTPs), and buffer. Once 
assembled, the mixture is cycled many times through temperatures that permit denaturation, annealing, and 
synthesis to exponentially amplify a product of specific size and sequence.  
The initial step in a PCR cycle denatures the target DNA by heating it to 94°C or higher for 15 sec to 2 min. In 
this denaturation process, the two intertwined strands of the DNA double helix separate from one another, 
producing the necessary single-stranded DNA template for the thermostable DNA polymerase. The next step of 
the cycle reduces the temperature to 40-65°C. At this temperature the oligonucleotide primers can anneal with 
the separate target DNA strands and serve as primers for DNA synthesis by the thermostable DNA polymerase. 
Finally, the synthesis of new DNA begins when the reaction temperature raises to 72°C. Extension of the primer 
by the polymerase lasts approximately 1 to 2 min. This cycle will be repeated 20 to 40 times. The amplified 
DNA is then analysed by gel electrophoresis and may be used for cloning. 
 
Preparative PCR 
 
The preparative PCR is performed to amplify DNA fragments for cloning. For preparative PCR, the high-fidelity 
Taq polymerase (Combizyme) is used. The reaction mixtures are prepared as follows: 
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Standard PCR reaction mixture 
    x       µl  Template DNA (final amount of DNA is 1 ng/µl) 
   1.0     µl  10× Taq-buffer 
   1.0     µl  25 mM MgCl2 
   1.0     µl  2.5 mM dNTPs 
   0.5     µl  10 µM Oligonucleotide A 
   0.5     µl  10 µM Oligonucleotide B 
   0.15   µl  Taq DNA-polymerase (5 U/µl) 
   y       µl  Sterile ddH2O 
__________________________________________________ 
Σ =          10      µl  Final volume 
 
The reaction components are mixed in a thin-walled 0.5 ml reaction tube. The PCR reaction mixture is placed in 
a thermal cycler. The PCR machine is basically programmed as follows: 
 
   30 Seconds, 94°C Denaturation of the DNA template  
45 Seconds, 55-60°C Annealing (Hybridization, the exact temperature was decided according to  
the Tm of the two primers) 
   60 Seconds, 72°C    Elongation (extension of primer in 5´→3´ direction by the DNA–polymerase) 
 
This cycle is repeated 19-24 times. The time for the last extension step is extended to 3-5 min to ensure that all 
the PCR products are full length. The amplified PCR product with the desired sequences is then purified by 
agarose gel electrophoresis. The recovered PCR product is digested with two selected restriction endonucleases, 
gel purified, and ligated to the vector previously cleaved with the same endonucleases. 
 
2.2.3   In vitro transcription and translation 
 
2.2.3.1   Preparation of DNA templates for in vitro RNA transcription 
 
Plasmid DNA with either SP6 or T7 promoter is either linearized with an appropriate restriction endonuclease or 
amplified through standard PCR to generate appropriate RNA templates for in vitro transcription to produce 
RNA of defined length. Linearized DNA or PCR DNA fragments are then extracted with phenol : chloroform 
and ethanol precipitated. 
 
2.2.3.2   In vitro transcription with T7- or SP6-RNA polymerase 
 
The protocol for in vitro RNA transcription is based on the RNA synthesis by bacteriophage SP6 polymerase 
using a vector that contains SP6 promoter sequence as described (Melton et al., 1984). The reaction components 
should be kept at room temperature during the addition of each successive component to prevent the 
precipitation of DNA, since DNA can precipitate in the presence of spermidine at lower temperature. The 
transcription components are mixed in the order listed below: 
 
Standard transcription reaction 
   x µl Sterile ddH2O 
2.0 µl  5× transcription-buffer (including DTT) 
1.0 µl 2.5 mM rNTPs (Pharmacia) 
  µl Linearized or PCR DNA template (final concentration 20-40 ng/µl)  
 0.5 µl T7 or SP6-RNA polymerase (20 U/µl)                                                  1 
Σ  = 10 µl Final volume (the volume of this reaction may be scaled up) 
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The reaction mixture is incubated for 60 min at 37°C (for T7 polymerase) or 40°C (for SP6 polymerase). An 
aliquot of the RNA transcript is examined for integrity of the synthesized RNA by 1 % agarose gel 
electrophoresis. The RNA is then extracted with phenol : chloroform and precipitated by addition of 2.5 volumes 
of ice cold 96 % ethanol after addition of 0.1 volume of 3 M sodium acetate pH 5.2. Following centrifugation 
(13,000 rpm) for 30 min at 4°C, the precipitate is washed two times with 80 % ethanol, air dried and 
resuspended in a desired volume of RNase-free H2O. 
 
2.2.3.3   In vitro transcription of radio-labelled RNA 
 
Internally radio-labelled RNA is synthesized in a 10 µl reaction volume. As example, for transcription of [α-32P] 
UTP labelled RNA, 50 µCi [α-32P]-UTP (400 Ci/mmol, 10 mCi/ml) is used, and the concentration of the non-
radio-labelled UTP is adjusted to 12.5 µM. The final concentrations of the three unlabelled nucleoside 
triphosphates (rATP, rCTP, rGTP) are adjusted to 250 µM. 
 
Standard transcription reaction for the synthesis of radio-labelled RNA 
    x µl Sterile ddH2O 
   2.0  µl 5× transcription-buffer (Biozyme) 
   1.0  µl 10 mM DTT 
   1.0  µl 2.5 mM rATP, rGTP, rCTP 
   1.0  µl 100 µM unlabelled UTP 
   1.0  µl [α-32P]-UTP (400 Ci/mmol, 10 mCi/ml) (final concentration = 2.5 µM) 
     Linearized or PCR DNA template (20-40 ng/µl) 
   0. 5 µl T7- or SP6-RNA Polymerase 
__________________________________________________________________________________________ 
Σ  =          10 µl Final volume 
 
The transcription reaction is incubated at 37°C (for T7 RNA polymerase) or 40°C (for SP6 RNA polymerase) for 
60-90 min. An aliquot of the RNA transcript is examined for the integrity of the synthesized RNA with 
denaturing 6 % polyacrylamide gel electrophoresis containing 7 M urea. Subsequently, the reaction mixture is 
phenol : chloroform extracted, and the RNA is precipitated by addition of 2.5 volumes of ice cold 100 % ethanol 
after addition of 0.1 volume of 3 M sodium acetate pH 5.2. The precipitate is washed two times with 80 % 
ethanol, air dried and resuspended in RNase-free H2O. The RNA is separated from unincorporated nucleotides 
by gel filtration on Sephadex G-50 column (Pharmacia), ethanol precipitated, and redissolved in a desired 
volume of RNase-free H2O. 
 
2.2.3.4   In vitro translation 
 
Unlabelled RNA is synthesized in the presence of 250 µM unlabelled nucleotides. Translation reactions contain 
0.20 µg of RNA in a 10 µl reaction including 50 % rabbit reticulocyte lysate (Promega). 
 
Standard reaction for in vitro translation 
 4.4 µl Rabbit reticulocyte lysate (Promega) 
0.85 µl 1 M KCl 
0.2 µg RNA (directly from in vitro transcription) 
   Sterile ddH2O 
______________________________________________________ 
 Σ = 10 µl Final volume 
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RNAs (ca. 0.20 µg) are translated in RRL as described above in 10 µl reaction volume. The final concentration 
of K+ in the reaction system should usually be adjusted to the physiological salt concentration (~135 mM K+). 
The reaction mixtures are incubated for 60 min at 30°C and reactions are terminated by transferring the reaction 
mixture directly on ice. Aliquots of translation reactions are then used for measuring the translation efficiency. 
 
2.2.4   Capping and poly(A) tailing of in vitro transcribed RNA 
 
2.2.4.1   Capping of in vitro transcribed RNA 
 
Mammalian mRNAs contain a 5´ terminal structure m7GpppX found to be involved in many aspects of a cellular 
mRNA´s life cycle, including mRNA stability, mRNA transport and mRNA translation. Placing a 5´-cap analog 
onto an in vitro synthesized RNA transcript can be performed in vitro using cap analog and a phage RNA 
polymerase. The enzyme incorporates the cap analog onto the 5´-end of the RNA as it is being transcribed. 
However, a native 5´-cap can be added to an RNA transcript using the endogenous enzyme, guanylyltransferase. 
This reaction has the benefits of allowing researchers to specifically label their mRNA at the 5´-end so that they 
can study the translational efficiency using this modified mRNA transcript. 
Guanylyltransferase, the vaccinia virus capping enzyme, is composed of two components, the D1 component (95 
kDa) and the D12 component (33 kDa). It transfers GMP from GTP to RNA processing a di- or triphosphate 
terminus. The enzyme has three activities: (1) a 5´ RNA triphosphatase activity removes the 5´-terminal 
phosphate of a 5´-triphosphate RNA; (2) a guanylyltransferase activity transfers GTP to the 5´-end of the RNA 
in 3´→5´ orientation producing a 5´-5´ bond; and (3) a guanine-7-methyltransferase activity transfers the methyl 
group from a donor SAM (S-Adenosyl Methionine) to the 7 position of guanosine. The resulting capped RNA is 
said to have a cap 0 (zero) structure. 
The reaction condition is listed as follows: 
 
 x   µl  RNA substrate (final concentration is 5-10 pmol/µl) 
 1   µl  10× capping buffer  
1   µl  S-Adenosyl Methionine (Ado-Met) 
 1   µl  Guanylyltransferase (usually the final concentration is 0.05 U/µl) 
 3   µl   rGTP or [α-32P]-rGTP (400 Ci/mmol, 10 mCi/ml) 
   Nuclease-free H2O 
_______________________________________________________________________ 
   Σ  =    10  µl  Final volume 
 
The reaction mixture is incubated for 60 min at 37°C (alternatively, 1 U/µl RNase inhibitor could be also added 
if necessary). The reaction product is then purified by Qiagen RNeasy Kit for the next step. 
 
2.2.4.2   Poly(A) tailing of in vitro transcribed RNA 
 
Poly(A) polymerase catalyzes the incorporation of adenine residues into the 3´-termini of various kinds of 
polyribonucleotides. Its salt optimum is high as seen by its maximum activity at 300-400 mM NaCl. This 
enzyme uses various kinds of single-stranded RNA as a primer. However, double-strand RNA, synthetic 
polyribonucleotides and short oligonucleotides are not recommended for use as primers, and DNA cannot be 
used as a primer. This enzyme incorporates adenine residues and uses ATP as its only substrate. ADP and dADP 
cannot be used as substrates. The incorporation of CTP and UTP is less 5 % than that of ATP, and the enzyme 
cannot incorporate GTP into the 3´-termini of polyribonucleotides. This enzyme requires Mg2+ or Mn2+ for 
reaction, and the activity becomes maximal when both are present (2.5 mM Mn2+, 10 mM Mg2+). 
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The standard protocol of adding poly(A) tailing to RNA is as follows: 
 
  2 µl 5× Poly(A) tailing reaction buffer 
   RNA substrate (final concentration is ~ 0.008 pmol) 
  1 µl 10 mM rATP 
   Poly(A) Polymerase (final concentration is 25U/µl reaction) 
   RNase-free H2O                                 1 
______________________________________________________________________ 
    Σ  =      10  µl Final volume 
 
The mixture is incubated at 37°C for 20 min. The reaction is terminated by heating at 65°C for 10-15 min. Then 
the poly(A) tailing RNA is purified by RNeasy kit and redissolved in a desired volume of RNase-free H2O for 
immediate use or stored at -20°C. 
 
 
2.2.5   Detection of reporter gene 
 
2.2.5.1 Detection of Firefly luciferase (FLuc) reporter gene 
 
In this work, the efficiency of internal translation initiation directed by the complete HCV IRES or deletion 
mutants was measured using a monocistronic reporter system that contains the Firefly luciferase (Fluc) reporter 
gene detecting the IRES-dependent translation. The luciferase gene is derived from the coding sequence of the 
luc gene cloned from the Firefly Photinus pyralis. The luciferase is an enzyme that catalyzes the oxidation of D-
luciferin in the presence of ATP, Mg2+ and coenzyme A to generate the light emission (De Wet et al., 1987). The 
light output from the luciferase reaction is quantitated using a luminometer. The total amount of light measured 
is proportional to the amount of luciferase reporter activity in the sample. Firefly luciferase is widely used as a 
reporter gene for studying gene regulation and function, and for pharmaceutical screening. It is a very sensitive 
genetic reporter due to the lack of any endogenous luciferase activity in mammalian cells or tissues and the very 
nature of bioluminescence (Wood et al., 1984; Wood, 1991). Firefly luciferase is a 62,000 Da protein which is 
active as a monomer and does not require subsequent processing for its activity. The enzyme catalyzes ATP-
dependent D-luciferin oxidation by oxygen into oxyluciferin with emission of light centred on 560 nm. As with 
many enzymes, Firefly luciferase follows Michaelis-Menten kinetics, and as a result maximum light output is 
not achieved until the substrates and co-factor are present in large excess. When assayed under these conditions, 
light emitted from the reaction is directly proportional to the number of luciferase enzyme molecules. For in 
vitro translation, luciferase activity is measured directly after reaction by addition of 4 µl of the translation 
reaction mixture to 100 µl of substrate solution (25 mM glycylglycine pH 7.8, 15 mM MgSO4, 0.1 mM EDTA, 
33 mM DTT, 1 mM rATP, 85 µM coenzyme A, 120 µM beetle luciferin) at room temperature and measuring the 
emitted light intensity for 20 sec in a Berthold Lumat 9507 luminometer. A similar translation reaction mixture 
without RNA is used as a blank. 
For in vivo translation, the transfected cells are harvested and washed once with 1x PBS. Then about 150 µl of 
pre-cooled 1× Passive Lysis Buffer (PLB) is added onto the cells and incubated on a shaker for 10-15 min. at 
room temperature. The cytoplasmic lysate is transferred to a microcentrifuge tube and spun at 13,000 rpm for 1 
min. at 4°C. The supernatant is transferred to another new microcentrifuge tube. Then the luciferase activity is 
measured by addition of 15-20 µl of the translation lysate to 100 µl of substrate solution (mentioned above) at 
room temperature and measuring the emitted light intensity for 20 sec in a Berthold Lumat 9507 luminometer. A 
similar translation lysate without RNA is used as a blank. 
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2.2.5.2   Detection of Renilla luciferase (RLuc) reporter gene 
 
Renilla luciferase has been used as a reporter gene for studying gene regulation and function in vitro and in vivo. 
Recently, Renilla luciferase has been widely used in multiplex transcriptional reporter assays or as a normalizing 
transfection control for Firefly luciferase assay. Renilla luciferase, a monomeric 36,000 Da protein, catalyzes 
coelenterazine oxidation by oxygen to produce light. The enzyme does not require post-translational 
modification for its activity and may function as a genetic reporter immediately following translation. 
Coelenterazine (native) is the natural substrate for Renilla luciferase. However, over a dozen of coelenterazine 
analogs have been synthesized, many of which are now commercially available. These coelenterazine analogs all 
function as substrates for Renilla luciferase with different properties in terms of emission wavelength, cell 
membrane permeability and quantum efficiency. Coelenterazine also emits light from enzyme-independent 
oxidation, a process known as autoluminescence. The autoluminescence is enhanced by superoxide anion and 
peroxynitrite in cells and tissues.  
For in vivo translation, the transfected cells are harvested and washed once with 1x PBS. Then about 150 µl of 
pre-cooled 1× Passive Lysis Buffer (PLB) is added onto the cells and incubated on a shaker for 10-15 min. at 
room temperature. The cytoplasmic lysate is transferred to a microcentrifuge tube and spun at 13,000 rpm for 1 
min. at 4°C. The supernatant is transferred to another new microcentrifuge tube. Then the luciferase activity is 
measured by addition of 15-20 µl of the cytosol lysate to 100 µl of substrate solution (Coelenterazine substrate is 
diluted in 1:100 in RLuc buffer) at room temperature and measuring the emitted light intensity for 20 sec in a 
Berthold Lumat 9507 luminometer. A similar translation lysate without RNA is used as a blank. 
 
2.2.6   RNA-protein interactions 
  
2.2.6.1   UV cross-linking reaction 
 
The UV cross-linking assay is performed essentially as described previously (Pelletier & Sonenberg, 1985b). 
The idea of the UV cross-linking assay is to specifically transfer the radioactive label from a RNA binding site to 
the binding protein. Irradiation of RNA with UV light produces purine and pyrimidine free radicals. If a protein 
molecule is in close proximity to the free radical, a covalent bond can be formed, cross-linking the protein to the 
RNA. 
 
Standard reaction for cross-linking of proteins to radio-labelled IRES RNA: 
 x µl Sterile ddH2O 
 2.0 µl 5× cross-linking buffer or nothing 
 y µl 1 M KCl (adjusting the final concentration of potassium to about 130 mM) 
 4.0 µl Rabbit reticulocyte lysate (Promega) or cytoplasmic extract of Huh-7 cells 
1 z µl Internally radio-labelled IRES RNA (ca. 0.06 pmol)                                       1 
Σ = 10 µl Final volume (the volume of this reaction may be scaled up) 
 
Internally radio-labelled RNA (ca. 0.06 pmol) is incubated for 10 min at 30°C with 4 µl of micrococcus 
nuclease-treated rabbit reticulocyte lysate (RRL; Promega) or cytoplasmic extract of Huh-7 cells (S10 lysate) in 
10 µl total volume. The endogenous potassium acetate in the RRL or extract of Huh-7 cells (S10 lysate) results 
in a final K+ concentration of 38 mM or 54 mM, respectively. Reaction mixtures are irradiated at 254 nm on ice 
at the distance of 2 cm with an 8 W UV-hand lamp for 30 min in an eppendorf microcentrifuge tube or in a 96-
well microtiter plate. Excess RNA is then digested for 60-90 min at 37°C with 10 mg/ml of RNase A, leaving 
fragments of radio-labelled RNAs cross-linked to the polypeptides. Protein samples are boiled for 5-10 min with 
5 µl of electrophoresis sample buffer. Proteins are resolved on SDS-8 % polyacrylamide gels depending on the 
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size of the proteins of interest. The gel is fixed with Coomassie destaining solution three times each for 15 min 
to remove the free radioactive nucleotides, then the gel is dried, and proteins that were radio-labelled by 
covalently bound RNA oligonucleotides are detected by autoradiography. 
 
For cross-linking cellular proteins or any other proteins to radio-labelled HCV IRES RNA, the reaction 
components are mixed as follows:  
   Sterile ddH2O 
 3.3 µl Rabbit reticulocyte lysate (Promega) or 4 µl Huh-7 S10 lysate 
0.85 µl 1 M KCl 
  [α-32P]-UTP labelled HCV IRES RNA (ca. 0.06 pmol) 
__________________________________________________________________________ 
Σ = 10 µl Final volume  
 
The UV cross-linking is performed either in the presence or in the absence of the proteins in a final volume of 10 
µl (or as otherwise indicated). Proteins cross-linked to radio-labelled HCV or FMDV IRES RNA are separated 
on  8 % or 10 % SDS-polyacrylamide gel electrophoresis, the gel is dried, and proteins are detected by 
autoradiography. 
 
 
2.2.6.2   Electrophoretic mobility shift assay (EMSA) 
 
The electrophoretic mobility shift assay (EMSA) or band shift is based on the observation that stable 
peptide•RNA/DNA complexes migrate through polyacrylamide gels more slowly than free RNA/DNA 
fragments. The assay allows us to determine the amount of RNA/DNA bound by the peptide as a function of the 
peptide concentration. This in turn allows the equilibrium dissociation constant (Kd) to be estimated.  
In addition to measuring peptide•RNA/DNA interactions, the band shift method can also be used to study 
complexes between peptides and RNA, RNA and DNA, and RNA and RNA. The only requirement is that the 
species involved form discrete complexes that are stable under the electrophoretic conditions being used. 
Attaining discrete bands often involves varying the gel parameters. Conditions that are easily varied include: gel 
temperature, running buffer, percentage of acrylamide, ratio of bis-acrylamide (the cross-linking agent) to 
acrylamide, reaction buffer and reactant concentrations. 
 
The reaction components in EMSA with RNA were mixed as follows: 
1 µl [α-32P]-UTP labelled RNA substrate (~ 0.003-0.006 pmol/10 µl) 
 2 µl 5× binding buffer 
 1 µl 10 µg/µl tRNA (final concentration is 1 µg/µl) 
                            RNase-free H2O 
____________________________________________________________________                                               
1   Σ = 10 µl Final volume 
 
The mixture solution is incubated at 30°C for 10 min. Then heparin is added to stop the reaction and incubated 
for another 10 min at 30°C. 4-5 µl of 50 % glycerol is added to each sample for loading on the native 
polyacrylamide-TBE gel. 
The gel system used for the EMSA usually is a 4 % polyacrylamide gel without any detergent such as SDS, 
providing native conditions for the RNA-protein complexes also during the gel run. 
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The composition of the native gel is listed as follows: 
 
4 %   Acrylamide/bisacrylamide (30:0.75) 
 5 % (v/v) Glycerol 
 0.5 ×  TBE (autoclaved) 
0.1 %  TEMED 
 0.1 %  APS 
   Sterile ddH2O 
 
The gel should be pre-run about half an hour at the working current before the samples are loaded. The running 
buffer is 1/2 TBE buffer. The loading buffer is only RNase-free glycerol (the final concentration of glycerol in 
the sample is about 12.5 %). The indicator is also RNase-free and loaded on one or both side(s) of the gel. The 
current during gel-running is usually less than 30 mA/gel, voltage is 100 V. The gel run should be performed at 
4°C. After electrophoresis, the gel is fixed in destaining buffer for 30-40 min, and then dried. The protein-RNA 
complexes are detected by autoradiography. 
 
2.2.7   Biochemical methods 
 
2.2.7.1   Purification of recombinant proteins by Ni-NTA His-tag-protein 
  
Purification method: Ni-NTA His-tag-Protein 
 
The purification procedure is performed according to the manufacturer’s instructions (Qiagen). 
 
2.2.7.2   Depletion of PTB from rabbit reticulocyte lysate (RRL) 
 
Endogenous PTB is removed from rabbit reticulocyte lysate (Promega) essentially as described (Niepmann et al., 
1997). Briefly, 1 ml of RRL is adjusted to 250 mM potassium acetate and incubated with 75 µl of poly(U)-
Sepharose, and then centrifuged, the supernatant is saved carefully and stored in liquid nitrogen. Aliquots from 
the poly(U)-Sepharose-treated lysate are tested and compared with untreated Poly(U)-Sepharose lysate for the 
presence of traces of PTB by the cross-linking assay with the FMDV IRES. 
 
2.2.7.3   Preparation of S10 cytoplasmic lysates from HeLa or Huh-7 cells 
 
Monolayer cells are washed once with 10 ml PBS/20 cm cell culture Petri dish. Cells are harvested in 2 ml PBS 
by treatment with Trypsin-EDTA buffer and collected in 15 or 50 ml Falcon tube (depending on the volume of 
the cells). Cell suspension is centrifuged 5 min at 1,000 rpm, 4°C. The volume of the cell pellet (= Packed Cell 
Volume, PCV) is estimated and resuspended in 10 times PCV of isotonic buffer, mixed well and incubated for 5-
10 min on ice. After centrifugation at 1,250 rpm for 5 min, 0°C, the cell pellets are washed two times again with 
isotonic buffer. After the last wash, cells are resuspended in 1.5 times PCV hypotonic buffer, mixed well and 
rotated on a rotater for 10-15 min at 4°C (cold room). An aliquot of the cell suspension is checked under the 
microscope during time. When ~ 90 % of the cells are broken, this cell suspension is transferred into a Douncer. 
The cells are broken by 10 to 15 strokes using a tight pestle. Then the broken cells are transferred to the original 
tube and add 1/10 cell suspension volume of S10 10× buffer, mixed well and aliquoted to 2 ml microcentrifuge 
tube. Cell debris are removed by centrifugation at 2,000 rpm, 4°C. The supernatant is transferred to another 
microcentrifuge tube and centrifuged again at 10,000 rpm for 10 min, 4°C. The supernatant is aspirated to a new 
tube and stored in liquid nitrogen as quickly as possible. This lysate can be used for UV cross-linking assays. 
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2.2.8   Immunological methods 
 
2.2.8.1   Western blot 
 
Immunoblotting provides a reliable method to check any sample for the presence of a protein antigen. The idea 
behind this technique is to separate protein antigens by gel electrophoresis and then transfer the proteins out of 
the gel onto a membrane such as nitrocellulose (Burnette, 1981). The antigen is then characterized on the basis 
of both its interaction with a specific antibody and its relative molecular weight. 
For the identification of initiation factors, protein samples are separated by SDS-polyacrylamide gel 
electrophoresis and then electrophoretically transferred for 3 hrs at 400 mA to a pre-wet nitrocellulose membrane 
with transfer buffer using a Biometra-Fast blot apparatus. After transfer, the gel is stained with Coomassie blue 
to verify transfer efficiency. 
To block non-specific protein binding sites, the membrane is immersed overnight in block-buffer (TBST-150, 3 
% BSA). The binding of primary antibody diluted with block-buffer (1:250, 1:20 for mouse anti-eIF4G and mAb 
324; mouse IgM-hybridoma tissue culture supernatant, respectively) is performed for 1 hr at RT. The blot is 
washed four times for 10 min with TBST-500 and then exposed for 1 hr at RT to (1:1000) blocking buffer 
diluted AP-conjugated secondary antibody directed against the primary antibody (AP-conjugated goat anti-
mouse IgG is directed against mouse anti-eIF4G, and AP-conjugated goat anti-mouse IgM is directed against 
mAb 324-mouse IgM). After washing the membrane (4×, for 10 min.) with TBST-500, the membrane is 
transferred to a freshly prepared staining substrate solution of BCIP/NBT. For preparation of 50 ml of this 
solution, 150 µl of BCIP solution (50 mg/ml 5-Bromo-4-Chloro-3-Indolylphosphate in 100 % 
Dimethylformamid) and 150 µl of NBT solution (50 mg/ml Nitroblue tetrazolium in 70 % Dimethylformamid) 
are mixed with 50 ml of alkaline phosphatase buffer. The staining is stopped by washing the membrane in stop 
solution when the bands have reached the desired intensity.  
 
2.2.8.2   Immunoprecipitation (IP) 
 
The identification of proteins that are covalently bound to radio-labelled RNA in the UV cross-linking assay is 
further verified by immunoprecipitation. First antibody-antigen complexes are allowed to form, then the 
complexes are collected and purified by using protein A-coated Sepharose beads. Protein A specifically interacts 
with conserved regions of the antibodies, thus forming an immobilized antibody-antigen complex bound to the 
beads. Unspecific binding of molecules from the starting solution is prevented by washing the beads. The 
purified antigens are then analyzed by SDS-polyacrylamide gel electrophoresis. 
Protein A-coated Sepharose beads (Pharmacia) are swollen for 1 hr at 4°C in phosphate buffered saline (PBS; 8 
mM Na2HPO4, 2 mM NaH2PO4, 140 mM NaCl) plus 0.1 µg/µl BSA and 0.1 µg/ml of tRNA. Then, 600 µl of 
standard cross-linking reaction are prepared as below: 
Standard cross-linking reaction 
120.0 µl  Cross-linking buffer (5×) 
3.0 µl rATP (100 mM) 
 198.0 µl Rabbit Reticulocyte lysate (Promega) 
   Internally radio-labelled wild type HCV IRES RNA (1.5-2.5 pmol) 
   Sterile ddH2O 
________________________________________________________________________ 
∑ =     600.0  µl Final volume 
 
After the binding reaction and UV irradiation, excess RNA is removed with 15 µl of 3 mg/ml RNase A and 4.0 
µl of 2 mg/ml RNase T1 for 1 hr at 37°C.  
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Half of the UV cross-linking reaction is incubated for 1 hr on ice with 20 µl of sheep anti-eIF3 antibody in 
binding buffer (20 mM Tris-HCl pH 7.5, 200 mM NaCl, 10 mg/ml BSA) in a final reaction volume of 500 µl, 
whereas 20 µl of preimmune serum is added to the other half of the UV cross-linking reaction.  
Next, 15 µl of pre-swollen protein A-coated Sepharose beads (Fluka) are added to either the 
immunoprecipitation reaction with anti-eIF3 or to the reaction with preimmune serum. Antibody-antigen 
complexes are allowed to bind to the protein A coated beads 15 min at 4°C. The antibody-antigen complexes 
bound to protein A beads are then recovered by centrifugation. The beads are washed two times for 10 min at 
4°C with wash buffer A and three times for 30 min at 4°C with wash buffer B (wash buffer A, 0.25 % Tween, 
0.25 % NP-40). After each wash the beads are transferred to a new eppendorf tube. The final wash is performed 
with PBS for 10 min at 4°C. Detergents are omitted from the final rinse as a precaution against the generation of 
abnormal SDS-PAGE migration patterns. 
Finally, the beads are resuspended in protein sample buffer containing 7 M urea to release the radio-labelled 
polypeptides. The protein A beads are removed by centrifugation and the solubilized radio-labelled proteins are 
analyzed by separation on a SDS-8 % polyacrylamide gel and visualized by autoradiography.  
 
2.2.9   Gel electrophoresis 
 
2.2.9.1   Agarose gel electrophoresis and recovery of DNA fragments from agarose gels 
 
To analyze or separate nucleic acid fragments, agarose gel electrophoresis is performed according to a standard 
protocol (Sambrook et al., 1989). Depending on the size of DNA fragments to be separated, 1 to 2 % agarose 
gels are prepared in 1× TAE buffer. Before loading the gel, the nucleic acid samples are mixed with 1/5 volume 
of FM-agarose gel loading buffer (75 % Glycerol, 0.1 mM EDTA, 0.1 % bromophenol blue, 0.1 % xylene 
cyanol FF). The electrophoresis is performed at ca. 2 to 5 Volts/cm, and stopped when the bromophenol blue 
tracking dye has migrated at least 2 cm from the wells. The gel is then soaked in ethidium bromide solution, a 
fluorescent intercalating dye, in a concentration of 0.5 µg/ml for 20-30 min. 
For analytical gels, the electrophoresis result is illuminated with ultraviolet light (λ = 254 nm) and photographed 
with a Polaroid MP-4 Land camera. For preparative gels, the band(s) of interest is located with ultraviolet light, 
cut out, and extracted with the GFX PCR DNA and Gel Band Purification Kit (Amersham) according to the 
description of the manufacturer. To control the efficiency of the elution, an aliquot of the recovered DNA is 
analyzed again on an agarose gel. 
When agarose gel electrophoresis is used to analyze the integrity of the full length non-radio-labelled in vitro 
transcribed RNAs, great care should be taken to avoid accidental contamination with RNases. The gel 
electrophoresis apparatus is cleaned carefully, autoclaved agarose and buffers are used.  
 
2.2.9.2   Denaturing polyacrylamide gel electrophoresis  
 
To analyze or separate ribonucleic acids, denaturing 6-12 % polyacrylamide gels are used. Electrophoresis is 
performed under denaturing conditions (containing 7 M urea). Autoclaved 1× TBE buffer is used as running 
buffer. First, pre-electrophoresis is performed for 15 min under normal electrophoresis conditions to flush out the 
impurities in the gel (and to create a higher temperature throughout the gel). Before loading, the ribonucleic acid 
samples are mixed with an equal volume of FA-gel loading buffer (80 % formamide, 0.1 mM EDTA, 0.1 % 
bromophenol blue, 0.1 % xylene cyanol FF) and denatured for 2 min at 70 °C. The gel is illuminated with UV 
light after staining with ethidium bromide.  
To determine the percent incorporation and integrity of in vitro synthesized radio-labelled RNAs, radio-labelled 
transcripts are mixed with an equal volume of FA-gel loading buffer and denatured for 3 min at 80°C, then 
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loaded to denaturing 6 % polyacrylamide gel with 7 M urea. Autoclaved 1× TBE is used as running buffer. The 
electrophoresis is performed at 30 mA for 8-9 min, the running is stopped when the bromophenol blue tracking 
dye has reached the middle of the gel. Radio-labelled RNAs are located by autoradiography. The gel is covered 
with plastic wrap and exposed directly to Kodak X-ray film for 3 to 5 min. 
 
2.2.9.3   SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
 
For the analytical and preparative separation of proteins under SDS-denaturing conditions, the discontinuous gel 
system is utilized (Laemmli, 1970). The gels are composed of 8 to 12 % poly-acrylamide separating gel and 6 % 
polyacrylamide stacking gel. Before loading, the protein samples are mixed with an equal volume of 4 × SDS gel 
loading buffer and denatured by heating for 5 min at 95°C. The electrophoresis is performed with a vertical gel 
chamber in 1×Tris-glycine buffer. After electrophoresis, the gel is fixed and stained immediately with 
Coomassie blue solution for 30 min, and then dried after destaining. 
For the analysis of radio-labelled proteins: after electrophoresis, the gel is fixed with destaining solution (5 % 
ethanol, 7.5 % acetic acid) for 15 min with gentle agitation. After destaining, the gel is covered with plastic 
wrap, placed on two moistened Whatman® blot papers, and then dried under vacuum on a gel-dryer. 
Autoradiography is subsequently performed. 
Stacking gel:     Separating gel: 
6.0 % Acrylamide/bisacrylamide (30:0.75)  8-12 %  Acrylamide/bisacrylamide (30:0.75) 
125.0  mM Tris-HCl, pH 6.8   375.0  mM Tris-HCl, pH 8.8 
 0.1 % (w/v) SDS    0.1 %  (w/v) SDS 
 0.1 %  (w/v) APS    0.1 %  (w/v) APS 
 0.1 %  (v/v) TEMED    0.1 %  (v/v) TEMED 
 
2.2.9.4   Coomassie brilliant blue staining 
 
Coomassie brilliant blue R-250 binds non-specifically to almost all proteins, which allows detection of 
essentially all protein bands in polyacrylamide gels. The gels to be stained and fixed are incubated for 30 min 
with gentle agitation in staining solution (0.12 % Coomassie brilliant blue R-250, 50 % ethanol, 10 % acetic 
acid). After staining, gels are destained several times with fresh destaining solution until a clear background 
appears. 
 
2.2.9.5   Autoradiography  
 
This is a technique used to visualize and quantitate radio-labelled RNA-protein complexes by direct exposure of 
the dried gel to Kodak X-ray film for 1 to 3 days at room temperature so as to generate sharper bands with lower 
background (direct autoradiography), or at -70°C using an intensifying screen to generate stronger bands 
(indirect autoradiography). Additionally, the wet gel is covered with plastic wrap and exposed directly to Kodak 
film for 5 to 15 min at room temperature to locate in vitro synthesized radio-labelled RNAs,. 
 
2.2.10   Cell culture methods 
 
2.2.10.1   Subculture protocol of adherent cell lines  
 
Cells are maintained in a 37°C, 5 % CO2 humidified incubator (Heraeus, Germany). Every 4-5 days (depending 
on the different type of cells), cells are first washed with 1× PBS, then trypsinized by 1× Trypsin-EDTA for 5-10 
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min at 37°C. The fresh DMEM is added to stop the reaction. The suspended cells are finally split and reseeded 
into new dishes or flasks. 
Preparation of working medium: 
450  ml   1× DMEM 
  50  ml   FBS 
    5  ml    Antibiotics (100× penicillin-streptomycin solution) 
The mixture is mixed well before using. 
 
2.2.10.2   Freezing protocol of mammalian cells 
 
The fresh freezing medium (6 ml D-MEM, 2 ml FBS, 2 ml high purity DMSO) should be made in advance. 
Cells grow until they have reached at least 80 % confluence for freezing preservation. The cells are prepared as 
described above. The cell suspension is pipetted into a sterilized centrifugation tube and centrifuged for 5 min at 
550 rpm at 4°C. The supernatant is discarded and the tube is placed on ice. 1 ml of ice-cold D-MEM/DMSO is 
added and leaving the tube on ice for 10 min. Cells are aliquoted in pre-cooled (4°C) freezing vials (1 ml of 
cells/vial) and immediately placed into a –70°C freezer overnight. The next day, the vials are transferred in a 
liquid nitrogen tank. 
 
2.2.10.3   Resuscitation of frozen cells 
 
A vial of frozen cells is thawed quickly in a 37°C water-bath. When the last ice has molten, the cells are pipetted 
immediately in a flask containing 5 ml of pre-warmed working DMEM. After 4-6 hours, the medium must be 
changed to remove dead cells. 
 
2.2.11   Transfection of nucleic acids into mammalian cell cultures 
 
2.2.11.1   Transfection with DNA (Lipofectamine® 2000 method) 
 
Cells are seeded in each well of a microtiter plate (6-, 12- or 24-well) in an appropriate growth medium 
containing serum and antibiotics at least 24 hr before transfection. The cells in each well should be up to at least 
70-80 % confluence for transfection. Circular plasmid DNA or PCR fragment DNA (1 µg) is diluted in 100 µl 
1× DMEM (without serum and antibiotics) in a microcentrifuge tube. 10 µl of Plus Reagent is added into the 
mixture, mixed by pipetting and incubated at room temperature for 15 min. 2 µl of Lipofectamine® Reagent is 
diluted into 100 µl 1× DMEM (without serum and antibiotics) in a second microcentrifuge tube and mixed by 
pipetting. The diluted Lipofectamine® Reagent is added into the tube containing pre-complexed DNA and Plus 
Reagent. This complex solution is mixed well and incubated for 15 min at room temperature. While complexes 
are forming, the medium in the wells is replaced with 0.5-1 ml 1× DMEM (without serum and antibiotics). The 
DNA-Plus-Lipofectamine® Reagent complexes (200 µl volume in total) are added into each well containing 
fresh medium. The complexes are mixed into the medium gently and incubated at 37°C, 5 % CO2 for 24-48 h for 
assay.  
 
Preparation of cell lysate: cells are harvested by addition of 1× Passive Lysis Buffer (Promega) after removal 
of the old medium and once wash with 1× PBS buffer in each well. The plate is placed on a shaker fro 15 min at 
room temperature until all cells were nearly detached. This raw cell suspension is transferred into a new 
microcentrifuge tube and spun at full speed by centrifugation. The supernatant is transferred to another new 
microcentrifuge tube and 15-20 µl is taken for assay on luminometer. 
 
2.2.11.2   Transfection with RNA 
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TransMessenger transfection reagent is designed to efficiently transfect eukaryotic cells with RNA. This reagent 
is based on a lipid formulation and is used in conjunction with a specific RNA-condensing reagent (Enhancer R) 
and an RNA-condensing buffer (Buffer EC-R). In the first step of TransMessenger-RNA complex formation, the 
RNA is condensed by interaction with Enhancer R in a defined buffer. In the second step, TransMessenger 
transfection reagent is added to the condensed RNA to produce TransMessenger-RNA complexes. The 
TransMessenger-RNA complexes are then mixed with serum-free medium and added directly to cells. 
For transfection of adherent cells using single-strand RNA in one well of a 24-well plate, the protocol is as 
follows: at least 24 hrs before transfection, 8-10 × 104 cells are seeded into each well of a 24-well plate in 0.5 ml 
appropriate growth medium containing serum and antibiotics. The cells are incubated at normal growth condition 
(generally at 37°C and 5 % CO2). On the day of transfection (cells should be 80-90 % confluent), 1.6 µl of 
Enhancer R is diluted in buffer EC-R. 0.8 µg of RNA is added and mixed by pipetting a few times. The final 
volume should be 100 µl (always mix Enhancer R with Buffer EC-R before addition of RNA) and incubated at 
room temperature for 5 min. 4 µl of TransMessenger transfection reagents is added to the RNA-Enhancer R 
mixture. The mixture is pipetted up and down a few times. The samples are incubated for 10 min at room 
temperature to allow transfection-complex formation. While complex formation takes place, the growth medium 
is gently aspirated from the plate, and the cells are carefully washed once with sterile PBS buffer using 1.5-2 
times the volume of medium used for cell seeding. 100 µl of growth medium without serum or antibiotics is 
added to the tube containing the transfection complexes. Mixing by pipetting up and down a few times, then the 
transfection complexes are immediately added drop-wise onto the wells (204 µl/well). The plate is gently swirled 
to ensure distribution of the transfection complexes. Cells are incubated with the transfection complexes for 3-4 
hrs under normal growth conditions. If needed, the complexes are removed from the cells, cells are washed once 
with PBS, then 0.5 ml fresh medium containing serum and antibiotics is added to the cells and incubated under 
normal growth conditions to allow for protein expression. Incubation time is determined by the assay and RNA 
used. 
 
Preparation of cell lysate: the same as that of DNA transfection (2.2.11.1) 
 
2.2.12   Ribonuclease protection assay (RPA) 
 
The ribonuclease protection assay is an extremely sensitive technique for the quantitation of specific RNAs in 
solution. The ribonuclease protection assay can be performed on total cellular RNA or poly(A)-selected mRNA 
as a target. The sensitivity of the ribonuclease protection assay derives from the use of a complementary in vitro 
transcript which is radio-labelled to high specific activity. The probe and target RNA are hybridized in solution, 
after which the mixture is diluted and treated with ribonuclease (RNase) to degrade all remaining single-stranded 
RNA. The hybridized portion of the probe will be protected from digestion and can, after removal of the RNase, 
be visualized via electrophoresis of the mixture on a denaturing polyacrylamide gel followed by 
autoradiography. Since the protected fragments are analyzed by high resolution polyacrylamide gel 
electrophoresis, the ribonuclease protection assay can be employed to accurately map mRNA features such as 
initiation and termination sites. If the probe is hybridized at a molar excess with respect to the target RNA, then 
the resulting signal will be directly proportional to the amount of complementary RNA in the sample. 
The purification protocol of all RNA solution during this assay was performed by using RNeasy kits from 
Qiagen Company. 
 
2.2.12.1   Synthesis of [α-32P]-labelled RNA probe and purification of the probe 
 
In order to perform the RPA, the [α-32P]-labelled anti-sense RNA probe is synthesized by T3 or T7 RNA 
polymerase in vitro transcription. Firstly, the anti-sense plasmid DNA is linearized by relevant restriction 
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enzyme and purified as mentioned before (Method 2.2.2.1). Then the linearized plasmid is transcribed according 
to the standard transcription protocol to generate the anti-sense probe. Then the following reagents are added to 
digest the DNA templates: 
RNA solution (~ 1 µg/µl)   adjusted to 90 µl  
RNase-free DNase I (10 U/µl)  1 µl 
RNase-free H2O    8 µl 
1 M MgCl2 (RNase-free)   1 µl    
__________________________________________________________ 
Final volume    100 µl 
 
The mixture is incubated at 37°C for 15 min. Then this RNA mixture is purified by RNeasy Kit (Qiagen) 
according to the manufacturer’s instruction. The probe is redissolved in a desired volume of RNase-free H2O and 
stored at -20°C or -40°C. 
 
2.2.12.2   Preparation of sample RNA 
 
About 0.8 µg of purified RNA sample is transfected into Huh-7 cells according to the supplier’s manual. After 
four hours of transfection, the cell lysate is prepared as quickly as possible from the transfected cells with PLB 
(Promega) procedure. After centrifugation at full speed for 1 min, the supernatant is transferred to a new 
microcentrifuge tube containing 1 % SDS and 10 µg of tRNA. Then, CaCl2 (RNase-free) is added to a final 
concentration of 1 mM, 30 µg of proteinase K are also added, and the sample mixture is incubate at 50°C for 1 
hr. After digestion, the lysate is extracted with phenol : chloroform and precipitated with ethanol. Finally, the re-
isolated RNA is dissolved in a certain volume of hybridization buffer and used for the next step or stored at -
20°C for future use. 
 
2.2.12.3   Hybridization and RNase digestion of probe and sample RNA 
 
About 30 µl of the purified RNA from 2.2.11.2 is taken into a new microcentrifuge tube containing 3-4 µl of 
probe RNA, mixed well and incubated for 5 min. at 85°C to denature RNAs. The sample is spun briefly and 
rapidly transferred to a 42°C water-bath to incubate overnight for hybridization (in order to obtain optimal 
hybridization, the hybridization time should be at least 14 hr). 
The fresh RNase digestion buffer containing 40 µg/ml RNase A is prepared before the hybridization procedure is 
finished. 300 µl of freshly-made RNase digestion buffer (10-fold volume of hybridization buffer used for last 
step) is added and incubated for 90 min. at 30°C. 16.5 µl of 10 % SDS is added (final is 0.5 %), and 
subsequently, 1 µl of 10 µg/µl tRNA (as carrier) , 11 µl of 30 mM CaCl2 as well as 100 µg of proteinase K are 
added. This mixture is incubated at 37°C for 30 min. to inactivate RNase A. Subsequently, the mixture is 
extracted with phenol : chloroform, precipitated with ethanol in the presence of NaCl (but not sodium acetate). 
The RNA pellet is washed three times with 80 % ethanol and dried at room temperature. 
  
2.2.12.4   Separation and detection of protected fragments 
 
After hybridization and RNase digestion, the precipitated sample is resuspended in 4 µl FA buffer and incubated 
for 5 min at 95°C to denature the RNA. The samples are loaded into wells of a denaturing polyacrylamide-TBE 
gel (gel percentage depending on the size of probe). Gels are run at about 30 mA constant current for 8-10 min. 
Then, the gel is fixed in fixer for 30-40 min., dried on a gel-drier for at least 1 hr. Finally, the dried gel is 
exposed to X-ray film. An appropriate time is determined for exposures until an optimal image is obtained. 
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3   Results 
 
3.1   Part I: The search for unknown cellular proteins which interact with   
        the Hepatitis C Virus 5´- and 3´-untranslated regions 
 
The main goal of this first part of the study was to investigate the interaction of proteins from extracts of liver-
derived cell lines with the HCV IRES RNA or the HCV IRES plus the 3´-UTR, aiming at the possible discovery 
of as yet unknown proteins which may regulate HCV translation in a tissue-specific manner. 
As described in the “Introduction” section, the initiation of translation occurs either by cap-dependent scanning 
or by direct binding of a ribosome to a specialized RNA element called an internal ribosome entry site (IRES) 
(Hellen & Sarnow, 2001). Although canonical translation initiation factors are involved in translation initiation 
directed by most IRES elements, in particular those of the picornaviruses which are distantly related to HCV, 
many other RNA-binding proteins have also been shown to play important roles. For instance, host cell proteins 
such as polypyrimidine tract-binding protein (PTB), the La autoantigen, poly(rC)-binding proteins (PCBP) and 
the protein encoded upstream of N-ras (Unr) bind directly to IRESes and enhance the translation of picornaviral 
mRNAs.  Also, translational initiation of hepatitis C virus (HCV) RNA is initiated by internal entry of ribosome 
at an IRES in the 5´-untranslated region (5´-UTR). Curiously, while most IRESes require only 5´-UTR 
sequences for full activity, the HCV IRES was shown to include a short stretch of protein-encoding sequences 
downstream of the initiating AUG (Reynolds et al., 1995; Lu & Wimmer, 1996), according to the fact that the 
AUG is embedded in an RNA secondary structure, the stem-loop IV which is part of the functional HCV internal 
ribosome entry site (see Fig. 6). However, other reports have suggested that the core-encoding sequence is not 
strictly essential for HCV IRES activity (Tsukiyama-Kohara et al., 1992; Wang et al., 1993; Rijnbrand et al., 
2001). Thus, the molecular basis of translational activation by the HCV core-encoding sequence is not yet 
completely understood. 
In the past ten years, except for the involvement of eIF3 (Buratti et al., 1998; Sizova et al., 1998), several other 
proteins such as La, PTB, PCBP, hnRNP C and L, and some ribosomal proteins are found to interact with the 
HCV IRES or with the 3´-UTR (Ali & Siddiqui, 1995, 1997; Ito & Lai, 1997; Tsuchihara et al., 1997; Hahm et 
al., 1998b; Chung & Kaplan, 1999; Fukushi et al., 1999; Gontarek et al., 1999; Luo, 1999; Spangberg et al., 
1999a; Fukushi et al., 2001; Otto et al., 2002), but some of them are not essential for 48S complex formation in 
vitro. Moreover, the proteasome subunit PSMA7 (Krüger et al., 2001), nucleolin (Izumi et al., 2001), the NS1-
associated protein 1 (NSAP1) (Kim et al., 2004) and some other proteins were also reported to bind HCV IRES 
RNA (Lu et al., 2004). However, none of these proteins could be linked to a possible tissue-specific stimulation 
of HCV translation. 
In this part of this study, the possible interaction of yet unknown cellular proteins with the HCV RNA was 
examined, either in the absence or in the presence, respectively, of 3´-UTR sequences, to search for proteins that 
bind synergistically in the presence of both the 5´-UTR and the 3´-UTR, and thus can be assumed to be involved 
in HCV RNA genome circularization and translation stimulation, and possibly confer tissue-specific translation 
regulation of HCV. 
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3.1.1   Optimization of protein binding to the HCV IRES RNA 
 
In this part of the study, the UV cross-linking assay (see Materials and Methods 2.2.6.1) was used as the major 
technique to search for new proteins, including cellular proteins or canonical translation initiation factors, which 
might be involved in the internal translation initiation of HCV RNA. 
One crucial feature of this method is that RNA-protein interactions can be detected in their natural conformation 
since no additional linker ligands which may disrupt the secondary structure of the RNA are introduced. 
Irradiation of radio-labelled RNA with UV light at 254 nm produces purine and pyrimidine free radicals. When a 
protein molecule is in close contact to the RNA, a covalent bond may be formed between a nucleotide free 
radical and a reactive amino acid of the protein, resulting in transfer of the radioactive label from RNA to the 
RNA-binding protein. The detection of a given protein in the UV cross-linking depends on several parameters 
like temperature, the time of incubation with the RNA, concentration of different mono-valent and divalent ions, 
buffer conditions as well as the type of the α-32P radio-labelled ribonucleotide used for internal labelling of the 
RNA molecule. The major disadvantage of this method is that not every protein that binds to the RNA may 
necessarily be cross-linked and detected. It has been shown that mainly 10 amino acids including cysteine, 
tyrosine, phenylalanine, histidine, arginine, lysine, serine, methionine, threonine and tryptophan can form a 
covalent bond with uracil or cytosine upon UV irradiation with different intensities (Smith, 1976). 
For this purpose, one HCV RNA template – the HCV IRES only – was obtained by linearization of the 
monocistronic HCV wild-type reporter plasmid with Aat II (Fig. 10A). Then in the first experiment, different UV 
cross-linking buffers were tested to find satisfying conditions for the binding of proteins to the [α-32P]-UTP 
labelled HCV IRES RNA in UV cross-linking reactions with cellular lysates (rabbit reticulocyte lysate, RRL, 
and cytoplasmic extract of Huh-7 cells, a hepatoma cell line). The result obtained with the reaction including 
double-distilled H2O only was almost the same as that obtained with the reaction including different buffers 
(data not shown). Accordingly, in all further experiments, no additional buffer was supplemented to the UV 
cross-linking reaction with the HCV IRES RNA except for the addition of potassium acetate or chloride to adjust 
the final potassium concentration to physiological conditions (~135 mM). 
In order to possibly improve the binding of proteins to the HCV IRES RNA, it was examined whether addition 
of various detergents or reducing agents such as dithiothreitol (DTT) would influence protein binding and UV 
cross-linking efficiency. Fig. 10B and C show a series of UV cross-linking assays performed with different 
concentrations of DMSO, glycerol, CHAPS, NP-40, Tween-20, Triton-X-100, DTT and β-mercaptoethanol in 
the reactions. The results show that increasing amounts of any detergent did not exhibit any stimulatory effect on 
the binding of the detected proteins to the [α-32P]-UTP labelled HCV IRES RNA (Fig. 10B). The binding of the 
proteins including p170, p116/110 to the HCV IRES did hardly change in all cases. According to these 
observations, no additional detergent was added to the reactions in all following UV cross-linking assays. 
Moreover, the influence of increasing amounts of DTT and β-mercaptoethanol on the binding of proteins to the 
labelled HCV IRES RNA was also examined (Fig. 10C). The result shows that both DTT and β-mercaptoethanol 
did also not exhibit any stimulatory effect on the cross-linking efficiency of any protein bound to the HCV IRES. 
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Fig. 10: Effects of some additives on the cross-linking results with [α-32P]-UTP labelled HCV IRES RNA 
in reticulocyte lysate. (A) Schematic diagram of the HCV wild-type (wt) construct and HCV IRES only RNA. 
The very beginning part of the core protein-encoding sequences is included in the "HCV IRES only" RNA (solid 
line). Aat II was used for generating the "HCV IRES only" RNA template. T7, T7 RNA polymerase promoter; 
UTR, untranslated region; C, partial core protein-encoding sequences; Ub, ubiquitin sequences; FLuc, Firefly 
luciferase reporter gene. (B, C) UV cross-linking was performed in 10 µl reaction volume with 4.4 µl of RRL 
and 0.06 pmol of HCV IRES RNA internally labelled with [α-32P]-UTP. Reaction mixtures were incubated for 
10 min at 30°C to allow the binding of proteins from the RRL to the HCV RNA in the presence of 135 mM 
potassium and then UV irradiated at 254 nm on ice for 30 min. Excess RNA was digested by incubation with 3 
mg/ml RNase A for 60 min at 37°C. Proteins were separated on SDS-8 % polyacrylamide gels and visualized by 
autoradiography. All detergents as well as DTT, β-mercaptoethanol (β-ME) and their concentrations are 
indicated above the gels. The molecular masses of 14C labelled proteins marker (M) are given in kDa and 
indicated at the left side of the gels. 
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Based on these observations, none of the tested reagents was used in the following UV cross-linking 
experiments.  
 
 
3.1.2   Analysis of the interaction of proteins from cellular lysates with the HCV IRES    
           and its deletion mutants 
 
According to the results obtained from the previous experiment, UV cross-linking assays with the HCV IRES 
and deletion mutants were performed. For this purpose, a series of deletion mutant plasmids was cloned from the 
basic monocistronic HCV wild-type construct as shown in Fig. 10A by PCR mutagenesis. All these deletions are 
shown in Fig. 11. 
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Fig. 11: Deletion mutations introduced into the HCV 5´-UTR sequence. The circled areas represent the 
deleted sequences. The big boxed area represents the large deletion of domain III within the 5´-UTR. The 
highlighted AUG represents the authentic start codon (modified from Honda et al., 1999). 
3   Results                                                                                              60                      
All these plasmids including the wild-type 5´-UTR and the deletion mutants were linearized with Aat II located 
in nucleotides downstream of the HCV core start codon AUG. The corresponding RNA molecules were in vitro 
transcribed by T7 RNA polymerase in the presence of [α-32P]-UTP. UV cross-linking assays with these RNA 
molecules were carried out under the optimized conditions described above. The results (Fig. 12) show that, 
unfortunately, no novel protein was detected with either RRL (Fig. 12A) or Huh-7 cytoplasmic extract (Fig. 
12B). Only subunits of eIF3 such as p170, p116/110 and p64 which bind to the HCV IRES wild-type were 
detected. However, with several deletion mutant RNAs proteins appear in addition to those obtained with the 
wild-type IRES, reflecting a situation in which the loss of specific binding of certain proteins (like eIF3) leaves 
RNA regions free for the binding of other proteins that would not bind to the wild-type IRES. 
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Fig. 12: Interaction of proteins from RRL (A) and Huh-7 lysate (B) with HCV IRES and its deletion 
mutants by UV cross-linking assay. The HCV RNA molecules were in vitro transcribed from the 
corresponding templates of the HCV IRES and the deletion mutants shown in Fig. 11. The reactions were 
performed as described in Fig. 10 with RRL and cytoplasmic lysate of Huh-7 cells. Proteins were separated on 
SDS-8 % polyacrylamide gels and visualized by autoradiography. The molecular masses of 14C labelled proteins 
marker (M) are given in kDa and the positions of the subunits of eIF3 (p170, p116/110 and p64) are indicated at 
the right side of the gel. wt, wild-type of HCV IRES; ∆1, ∆2, ∆3, ∆4 etc. represent the different mutants in which 
major domains or subdomains of the HCV 5´-UTR had been deleted. The protein sample UV cross-linked to 
each deletion mutant was run side by side with the wt reaction to allow a better comparison of the labelled 
protein patterns in (B). 
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The stem-loop 3, more accurately to say, the sub-domains 3a, 3b and 3c of the stem-loop 3, have been further 
confirmed in this experiment as the major binding site for eIF3 subunits (p170, p116/110). However, no new 
protein was found to bind to the HCV IRES RNA under these experimental conditions. 
Until now, very little is known about the components of the ribosome that contact the HCV IRES. On the one 
hand, many proteins with low molecular weight have been detected to be cross-linked to the HCV IRES as 
observed in Fig. 12. On the other hand, eukaryotic 40S ribosomal subunit consists of about 33 different low-
molecular weight proteins (called ribosomal protein small, “RpS”). Thus, it is a reasonable assumption that many 
small proteins found to bind to the HCV IRES are 40S ribosomal proteins. Previous experiments have shown 
that the small ribosomal subunit proteins S9 and S5 can bind to the HCV IRES (Fukushi et al., 1999; Fukushi et 
al., 2001). Another 7 small ribosomal subunit proteins have also been reported to be cross-linked to the HCV 
IRES. These are RpS2, RpS3, RpS6, RpS10, RpS15, RpS27 and RpS16 or RpS18 (Otto et al., 2002). 
 
                         
18S rRNA
97
66
45
low
MW 
proteins
30
M
A
B
28S rRNA
1 2 3 4 5 6 7
RRL
depleted 
RRL F-2 F-4 F-6
M RRL F-2 F-4 F-6 F-8 F-10 F-12 F-14 F-16
F-10 F-14
 
 
Fig. 13: Interaction of ribosomal proteins from RRL with [α-32P]-UTP labelled HCV IRES RNA by UV 
cross-linking assay. (A) Agarose gel for detection of 18S rRNA from different fractionates (F-2 to F-16) after 
sucrose gradient centrifugation of ribosomal 40S subunits. F-number, fraction numbers. All fractions were 
extracted by Phenol/chloroform and precipitated with ethanol prior to gel-loading. (B) UV cross-linking assays 
with different fraction lysates. Lane 1, normal RRL; Lane 2, RRL without ribosomes and eIF3; Lane 3-7, 
purified 40S ribosomal subunit from fraction numbers corresponding to (A) after sucrose gradient centrifugation. 
Assays were performed as described in Fig. 10. Proteins were separated on SDS-14 % polyacrylamide gels and 
visualized by autoradiography. The molecular masses of 14C labelled proteins marker (M) are given in kDa. The 
low molecular weight (MW) proteins related to 40S ribosomal subunit are indicated at the right side of the gel. 
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To confirm that the small proteins detected in Fig. 12 are mainly proteins of the small ribosomal subunit, 40S 
ribosomal subunits were isolated by sucrose gradient centrifugation from rabbit reticulocyte lysate according to a 
method described previously (Kieft et al., 2001). Although the peak of 40S ribosomal subunit in the gradient 
profile appeared to be not clear and sharp (data not shown), 18S rRNA, the only RNA inside the 40S ribosomal 
subunit, was readily detected in the bottom fractions recovered by fractionation of the gradient, which indicates 
that the 40S ribosomal subunits were sufficiently pure and at least did not contain any contaminating 60S 
subunits which would contain 28S rRNA (Fig. 13A). The result of the UV cross-linking assay with the purified 
40S subunits and HCV RNA (Fig. 13B) shows that indeed the low molecular weight proteins binding to the 
HCV IRES are proteins of the small ribosomal subunit. 
 
 
3.1.3   The HCV RNA constructs used for the protein-searching study 
 
Since no novel protein was found using the UV cross-linking assays with the HCV IRES only RNA, two 
additional RNA constructs were considered to be used in the further experiments. 
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Fig. 14: Schematic diagram of the HCV wide-type (wt) construct (A) and three corresponding RNAs (B). 
The very beginning part of the core protein-encoding sequences is included in the "HCV IRES only" RNA and 
the "HCV IRES + 3´-UTR" RNA. Aat II and Bam HI were used for generating the "HCV IRES only" RNA 
template and the other two RNA templates, respectively. The solid lines represent the RNA molecules and the 
horizontal dotted line represents the part deleted from the original HCV wt plasmid in the IRES + 3´-UTR 
combination construct. T7, T7 RNA polymerase promoter; UTR, untranslated region; C, partial core protein-
encoding sequences; Ub, ubiquitin sequences; FLuc, Firefly luciferase reporter gene.  
 
 
These two additional HCV RNAs are: (1) the combination of HCV IRES and 3´-UTR - firstly, a intermediate 
plasmid was generated by religation of the HCV wt construct after double-digestion with Bgl II and Eco NI 
followed by treatment with Klenow fragment; this intermediate plasmid was secondly double-digested with Aat 
II and Bgl II followed by Klenow fragment and religation. Then Bam HI was used to linearize this new plasmid 
to produce the corresponding template; (2) the HCV 3´-UTR only. This was produced in two steps: firstly, the 
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construct generated in (1) was double-digested with Bam HI and Bgl II; then the small fragment containing the 
HCV 3´-UTR was ligated into another vector derived from pM12 (see Appendix) double-digested with the same 
enzymes. The recovered Bam HI recognition sequence was then used to generate the linearized RNA template. 
The HCV RNAs were synthesized using T7 (for HCV IRES or IRES+3´-UTR) or SP6 (for HCV 3´-UTR only) 
RNA polymerase in the presence of [α-32P]-labelled ribonucleotides in vitro according to standard protocols.  
The idea of using the HCV IRES plus 3´-UTR combination RNA was to search for proteins that are possibly 
involved in HCV genome circularization; thus, such proteins could be assumed to bind strongly only in the 
presence of both the 5´- and the 3´-end of the genomic RNA. 
 
 
3.1.4 Choice of the optimal radioactive-labelling ribonucleotide for the detection of  
proteins binding to the HCV RNA 
 
The three HCV RNAs - IRES only, IRES plus 3´-UTR, and 3´-UTR only - were internally labelled with four 
different nucleotides; [α-32P]-ATP, -CTP, -GTP or -UTP, respectively. Rabbit reticulocyte lysate (RRL, 
purchased from Promega) which is competent for FMDV translation (Kühn et al., 1990) and also good for HCV 
RNA translation (data are shown later), as well as cytoplasmic lysate of human Huh-7 hepatoma cells were used 
as the source of IRES-binding proteins. UV cross-linking assays were then carried out using the radioactively-
labelled RNAs as described above and the two different lysates.  
Several proteins binding to the complete HCV IRES or the 3´-UTR were detected in the UV cross-linking assays 
with [α-32P]-ATP, -CTP, -GTP, and -UTP-labelled RNAs (Fig. 15). A strongly labelled protein band migrating at 
about 57 kDa in the presence of [α-32P]-CTP and -UTP, but only with the HCV IRES + 3´-UTR and the HCV 3´-
UTR only RNAs, is identical to polypyrimidine-tract binding protein (PTB) (Tsuchihara et al., 1997; Luo, 1999). 
Two other bands appeared between 220 and 97 kDa with different intensities. These two proteins are supposed 
to be the 170 kDa and 116 or 110 kDa subunits of eIF3 (Buratti et al., 1998; Sizova et al., 1998). Obviously, all 
these detectable bands appeared more evidently in cytoplasmic Huh-7 lysate (Fig. 15B) than in RRL (Fig. 15A). 
In addition, in Huh-7 lysate, many proteins migrating near 66 kDa were detected to be cross-linked to the HCV 
IRES only and IRES + 3´-UTR RNAs, but not to the HCV 3´-UTR only RNA. Many distinctly strong bands 
below 66 kDa were also observed when the HCV 3´-UTR RNA was internally labelled with [α-32P]-UTP. In 
RRL, only very faint bands below 66 kDa were found with some HCV RNAs, but again [α-32P]-UTP labelled 
RNAs generated a good binding pattern. 
Another polypeptide of about 66 kDa was also detected with [α-32P]-UTP labelled HCV RNAs especially in the 
Huh-7 lysate. This protein is supposed to be one of the subunits of eukaryotic translation initiation factor eIF3 
(Sizova et al., 1998). In addition, the UV cross-linking assay with [α-32P]-GTP labelled RNAs showed also 
strong labelling of proteins with the HCV IRES RNA in both RRL and Huh-7 lysate. Therefore, [α-32P]-UTP 
and -GTP labelled HCV RNAs were used for further detection of proteins in the UV cross-linking assay. 
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Fig. 15: Detection of proteins in RRL (A) and cytoplasmic extract of Huh-7 cells (B) using different HCV 
RNAs labelled with different nucleotides. The three HCV RNAs were in vitro transcribed from corresponding 
templates as shown in Fig. 14. UV cross-linking assays were carried out in 10 µl total volume with 4.4 µl of 
RRL or 4 µl of cytoplasmic extract of Huh-7 cells and 0.06 pmol of HCV RNAs internally labelled with either 
[α-32P]-ATP, -CTP, -GTP or -UTP as indicated. Reaction mixtures were incubated for 10 min at 30°C to allow 
the binding of proteins from the RRL or Huh-7 cytoplasmic lysate to the HCV RNAs in the presence of 135 mM 
potassium and then UV irradiated at 254 nm on ice for 30 min. Excess RNA was digested by incubation with 3 
mg/ml RNase A for 60 min at 37°C. Proteins were separated on SDS-8 % polyacrylamide gels and visualized by 
autoradiography. The molecular masses of 14C labelled proteins marker (M) are given in kDa and the positions of 
the subunits of eIF3 (p170 and p116/110) and PTB are indicated at the right side of the gels. 
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Fig. 16 shows a similar experiment using the three HCV RNAs labelled only with [α-32P]-UTP and -GTP 
performed in RRL and Huh-7 lysate. Again, very clear binding signals of the three proteins described above - 
p170, p116/110 and PTB - were observed in both lysates, but they appeared stronger with the cytoplasmic 
extract of Huh-7 (Fig. 16B) than with RRL (Fig. 16A). In the case of Huh-7 lysate, these three bands could be 
detected more evidently with [α-32P]-UTP labelled RNAs (Fig. 16, lanes 4-6 and 10-12) than with [α-32P]-GTP 
labelled RNAs (Fig. 16, lanes 1-3 and 7-9).  
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Fig. 16: UV cross-linking assay with [α-32P]-GTP and -UTP labeled HCV RNAs in RRL (A) and Huh 7 
lysate (B). The three HCV RNAs were in vitro transcribed from corresponding templates as shown in Fig. 14. 
UV cross-linking assays were performed as described in Fig. 10. Proteins were separated on SDS-8 % 
polyacrylamide gels and visualized by autoradiography. The molecular masses of 14C labelled proteins marker 
(M) are given in kDa and the positions of the subunits of eIF3 (p170 and p116/110) and PTB are indicated at the 
right side of the gels. 
 
 
According to these results, [α-32P]-UTP labelled HCV RNAs were finally chosen for all following UV cross-
linking experiments. 
 
 
3.1.5   Optimization of protein binding specificity 
 
In order to optimize the conditions for binding of proteins from RRL and Huh-7 lysate to the [α-32P]-UTP 
labelled HCV IRES, IRES plus 3´-UTR and 3´-UTR RNAs, the effects of various parameters on the efficiency 
of the UV cross-linking assay were examined. 
In order to reduce unspecific binding of proteins, transfer RNA (tRNA) was added as an unspecific competitor to 
the reactions. The results (Fig. 17) show that addition of tRNA resulted in efficient reduction of some unspecific 
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background (for example, the band marked with arrows in Fig. 17). However, too high concentrations of tRNA 
(2.5 µg/µl or 5 µg/µl) in the reactions even abolished binding of eIF3 subunits. Thus, a final concentration of 1 
µg/µl tRNA was used in all following experiments. 
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Fig. 17: UV cross-linking assays with HCV IRES only RNA (A), HCV IRES plus 3´-UTR RNA (B) and 
HCV 3´-UTR only RNA (C) in the absence or presence of tRNA in both RRL and Huh-7 lysate. The three 
HCV RNAs were in vitro transcribed from corresponding templates as shown in Fig. 14. The reactions were all 
performed as described in Fig. 10 under the same conditions in standard RRL and cytoplasmic lysate of Huh-7 
cells, respectively. The final amounts of tRNA added to the reactions are indicated above the gels. Proteins were 
separated on SDS-8 % polyacrylamide gels and visualized by autoradiography. The molecular masses of 14C 
labelled proteins marker (M) are given in kDa and the positions of the subunits of eIF3 (p170 and p116/110) and 
PTB are indicated. 
 
 
In the experiments described above, the binding signals obtained with all three different HCV RNAs were 
usually clearer with cytoplasmic extract of Huh-7 cells than with rabbit reticulocyte lysate, especially for PTB 
(Fig. 17B and C) and the subunits of eIF3 (Fig. 17A and B). Interestingly, it was unexpectedly observed that one 
of the subunits of eIF3 (p116/110) obviously also binds to the HCV 3´-UTR RNA (Fig. 17C). However, this 
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binding was not studied further at this time since this part of the study aimed at the detection of proteins that bind 
synergistically to both the 5´-UTR and the 3´-UTR. 
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Fig. 18: Comparison of different cellular lysates in UV cross-linking assay with three HCV IRES RNAs. 
The three HCV RNAs were in vitro transcribed from corresponding templates as shown in Fig. 14. The reactions 
were all performed as described in Fig. 10. Proteins were separated on a SDS-8 % polyacrylamide gel and 
visualized by autoradiography. The molecular masses of 14C labelled proteins marker (M) are given in kDa and 
the positions of the subunits of eIF3 (p170 and p116/110) and PTB are indicated. 
 
 
In addition to RRL and Huh-7 lysate, cytoplasmic lysate of HeLa cells was also tested with the three HCV RNAs 
since it had been reported that HCV IRES-directed translation is similarly efficient both in hepatocytic cells such 
as Hep G2 and Huh-7 and in non-hepatocytic cells such as HeLa cell (Tsukiyama-Kohara et al., 1992; Reynolds 
et al., 1995; Kamoshita et al., 1997). The result shown in Fig. 18 demonstrates that the protein binding patterns 
derived from the HeLa lysate were almost similar to that observed with RRL and Huh-7 lysate. However, the 
labelling intensities of those proteins binding to the HCV RNAs such as p170, p116/110 and PTB are clearly 
weaker in HeLa lysate, and even weaker than in RRL (e.g., the PTB band). 
Next, different preparations of cytoplasmic lysate of Huh-7 were also tested in order to confirm that the observed 
pattern of proteins is reproducible from batch to batch. The result shows that two different Huh-7 lysates 
prepared at different times generated almost the same labelling pattern in the UV cross-linking assay (Fig. 19), 
also regarding the binding signals of PTB and eIF3.  Thus, the procedure of Huh-7 lysate preparation was proven 
to be reproducible. Furthermore, the final potassium concentration in the reaction with Huh-7 lysate was tested 
as well (data not shown) and then always adjusted to ~135 mM which is consistent with the physiological 
conditions inside living cells.  
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Fig. 19: Comparison of different batches of Huh-7 lysate in the UV cross-linking assay with three HCV 
RNAs. The three HCV RNAs were in vitro transcribed from corresponding templates shown in Fig. 14. All 
reactions were performed as described in Fig. 15. Proteins were separated on a SDS-8 % polyacrylamide gel and 
visualized by autoradiography. The molecular masses of 14C labelled proteins marker (M) are given in kDa and 
the positions of the subunits of eIF3 (p170 and p116/110) and PTB are indicated. 
 
 
3.1.6   Detection of proteins in ammonium sulfate precipitation fractions 
 
In the cytoplasmic lysate of Huh-7 cells, many proteins were found to be cross-linked to the HCV RNA by UV 
irradiation. In order to investigate these binding proteins in more detail, ammonium sulfate precipitation was 
used to separate the proteins into different fractions. 
According to a Coomassie stain of the ammonium sulfate fractions analysed on a protein gel (Fig. 20A), most 
proteins are precipitated in the range of 20-80 % ammonium sulfate saturation, and the patterns of the individual 
fractions appear to be significantly different. Each fraction was then used for UV cross-linking assays with the 
three HCV RNAs. The result (Fig. 20B) shows that most proteins binding to the HCV RNAs are mainly present 
in the 20-40 % and 40-60 % ammonium sulfate fractions. Also, some proteins yielded very clear binding signals 
in other fractions. For example, PTB is present preferentially in the 20-40 % fraction, a little weaker in the 40-60 
% fraction and even much weaker in the 0-20 % fraction (Fig. 20B, lanes 5-6, 8-9, 11-12). Subunits of eIF3 
mainly binding to the HCV IRES are much more evident in the 20-40 % saturation fraction than in any other 
fraction (Fig. 20B, lanes 4, 7, 10, 13, 16). In addition, some new proteins binding to HCV RNAs (Fig. 20B, lanes 
12-17) or to the HCV 3´-UTR RNA (Fig. 20B, lane 18) were observed at 60-80 % and 80-100 % of ammonium 
sulfate saturation (marked with arrows), but they were not detected when complete Huh-7 lysate was used (Fig. 
20B, lanes 1-3). By the way, this experiment further confirmed that PTB does not bind to the HCV IRES in the 
UV cross-linking assay even though there are three polypyrimidine-rich tracts within the HCV IRES region (see 
Fig. 6 for reference and Fig. 20B, lanes 1, 4, 7, 10). 
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Fig. 20: Analysis of interaction of proteins from ammonium sulfate saturations with HCV RNAs in Huh-7 
cytoplasmic lysate. (A) Proteins present in Huh-7 cytoplasmic fractions after ammonium sulfate precipitation. 
Proteins were separated on a 10 % SDS-PAGE gel and stained with Coomassie brilliant blue. The molecular 
masses of marker proteins (M, Invitrogen) are indicated in kDa at the left side of the gel. (B) UV crosslink assay 
with [α-32P]-UTP labelled HCV RNAs and complete Huh-7 lysate or ammonium sulfate fractions. The three 
HCV RNAs used are shown in Fig. 14. Proteins were separated on a SDS-8 % PAGE gel and visualized by 
autoradiography. The molecular masses of 14C labelled proteins marker (M) are given in kDa, and the positions 
of the subunits of eIF3 (p170 and p116/110) and PTB are indicated. Some unknown binding proteins discussed 
in the text are indicated with arrows and question marks. 
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However, no new proteins could be detected to bind exclusively to the IRES plus 3´-UTR combination RNA but 
the IRES alone or the 3´-UTR alone, which could be assumed to be possibly involved in genome circularization 
and translation stimulation. 
 
 
3.1.7   Conclusions 
 
Unfortunately, except for some known cellular proteins (such as PTB and several subunits of eIF3) reported to 
bind to either the HCV 3´-UTR or the IRES RNA, no novel cellular protein which may bind to the HCV IRES 
RNA was detected, even in the presence of the 3´-UTR which might provide synergistically possible binding 
chance for proteins present in the cellular lysate like RRL and cytoplasmic extract of Huh-7 cells, under the 
binding systems presented here. Further attempts should concentrate on revising the HCV RNA construct used 
for this protein-seeking programme. In a later part of this study, re-designed RNA constructs were used, resulting 
in the discovery of a novel protein (see Results, Part IV). 
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3.2   Part II: Synergetic interaction of known cellular proteins – PTB,             
        hnRNP L and Unr – with the Hepatitis C Virus RNA 
 
The aim of the second part of this study was to analyze the interaction of a limited set of well-known trans-
acting cellular proteins with the HCV RNA including the IRES or the 3´-UTR or a combination of both IRES 
and 3´-UTR. 
As described in the first part of the Results section, several well-characterized cellular factors have already been 
reported to bind to the HCV RNA including the IRES or the 3´-UTR and to possibly affect the HCV IRES-
mediated translation. These factors include the human La autoantigen (Ali & Siddiqui, 1997; Isoyama et al., 
1999), PTB (Ali & Siddiqui, 1995; Tsuchihara et al., 1997; Luo, 1999), some ribosomal proteins (Fukushi et al., 
1999; Fukushi et al., 2001; Otto et al., 2002), poly(C)-binding proteins (PCBPs, Spangberg & Schwartz, 1999b), 
hnRNP L (Hahm et al., 1998b), eIF3 (Buratti et al., 1998; Sizova et al., 1998), NS1-associated protein 1 
(NSAP1, Kim et al., 2004), the proteasome subunit PSMA7 (Krüger et al., 2001), nucleolin (Izumi et al., 2001) 
and some other proteins including Unr (Lu et al., 2004). Among these, the interaction of PTB, which has been 
shown to play important roles in the translation of picornaviruses, with the HCV IRES and its exact role in HCV 
IRES-mediated translation are controversial (Ali & Siddiqui, 1995; Kaminski et al., 1995; Ito & Lai, 1999; 
Gosert et al., 2000; Tischendorf, 2004). This part will first focus on studying the interaction of PTB with the 
HCV RNA to examine whether PTB actually binds to the HCV IRES RNA or not. 
In addition, the possible influence of interactions between these RNA-binding proteins (such as PTB and hnRNP 
L, PTB and Unr, Unr and hnRNP L) on HCV IRES-dependent translation was investigated as well, since PTB 
and hnRNP L interact tightly (both of them belong to the hnRNPs family, (Hahm et al., 1998a), and PTB and 
Unr act synergistically in efficient Apaf-1 IRES function (Mitchell et al., 2001; Mitchell et al., 2003). 
  
 
3.2.1   Interaction of polypyrimidine tract-binding protein (PTB) with HCV RNAs 
 
3.2.1.1   Interaction of recombinant and cellular PTB with different HCV RNAs analyzed by UV  
              cross-linking assay 
 
In the HCV 5´-UTR, there are three pyrimidine-rich tract motifs which could, in principle, serve as binding sites 
for the polypyrimidine tract-binding protein (PTB). They are located at nucleotides 40 to 46 (Py-I), 120 to 130 
(Py-II), and 191 to 199 (Py-III). The Py-I and Py-III sequences are part of single-stranded regions, but Py-II 
sequences are partially base-paired with nucleotides 318 to 323 (Fig. 6 in Introduction section). Some conflicting 
observations have been reported on the interaction of PTB with the HCV IRES (Ali & Siddiqui, 1995; Kaminski 
et al., 1995; Beales et al., 2001). In order to analyze the binding of PTB to the HCV IRES, the interaction of 
recombinant PTB as well as cellular PTB with different HCV RNA constructs was investigated by the UV cross-
linking assay. These RNA constructs were generated from the corresponding monocistronic HCV plasmid 
construct shown in Fig. 14 in the first part of the Results section. 
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Two HCV RNAs were synthesized using T7 (HCV IRES only) or SP6 (HCV 3´-UTR only) RNA polymerase in 
the presence of [α-32P]-UTP. The radioactively labelled HCV IRES and 3´-UTR RNAs were incubated in a UV 
cross-linking reaction with purified recombinant His6-PTB at various protein concentrations without addition of 
any other protein. tRNA was added simultaneously to the reaction mixtures as a competitor to eliminate possible 
unspecific binding. 
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Fig. 21: Interaction of recombinant PTB with the HCV IRES and 3´-UTR RNAs in the absence of cellular 
lysate. UV cross-linking assays were performed in 10 µl volumes in the presence of 1 µg/µl tRNA and analyzed 
on an 8 % SDS-PAGE. The amount of recombinant PTB (rec. PTB) added to the reactions is indicated on the top 
of the gel. The molecular masses of 14C labelled proteins marker (M) are given in kDa. The position of rec. PTB 
(59 kDa) is indicated at the right side of the gel. 
 
 
The reaction mixtures were subsequently UV-irradiated on ice for 30 min, and then digested with RNase A prior 
to analysis by SDS-PAGE and autoradiography. Only very weak PTB bands were found to be cross-linked to the 
HCV 5´-UTR RNA, whereas the HCV 3´-UTR which is known to be bound effectively by PTB (Tsuchihara et 
al., 1997) showed very strong PTB binding (Fig. 21). In conclusion, the recombinant PTB does obviously not 
interact with the HCV 5´-UTR. 
The PTB binding experiment described above was carried out with a PTB protein expressed in E. coli. To 
analyze the possible interaction of PTB from cell lysate with the HCV IRES and 3´-UTR RNAs, rabbit 
reticulocyte lysate (RRL) purchased from Promega and Huh-7 S10 cytoplasmic lysate prepared from cultured 
Huh-7 hepatoma cells were used. Two or three closely migrating proteins with an average molecular mass of 57 
kDa were observed as major bands in the HCV 3´-UTR RNAs, but these proteins were not found with the HCV 
IRES RNA (Fig. 22). These two or three bands in the range of 57 kDa may represent isomers of PTB as reported 
by other groups (Garçia-Blanco et al., 1989; Bothwell et al., 1991; Patton et al., 1991). 
In conclusion, the cellular 57 kDa PTB protein interacts directly with the HCV 3´-UTR, but not with the HCV 
IRES. Even though PTB is required for the internal translation directed by some picornavirus IRESes such as the 
FMDV IRES and the EMCV IRES (Hellen et al., 1993; Witherell et al., 1993; Niepmann et al., 1997), the results 
shown here indicate that PTB does not bind the HCV IRES. This finding is in accordance with a previous report 
by another group which shows that PTB is not required for translation directed by the HCV IRES in a reporter 
construct which does not contain the HCV 3´-UTR (Kaminski et al., 1995).  
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Fig. 22: Interaction of the endogenous PTB contained in RRL and Huh-7 lysate with the HCV IRES and 
3´-UTR RNAs. UV cross-linking assays were performed in 10 µl volumes with [α-32P]-UTP labelled HCV 
RNAs. Proteins are analyzed by 8 % SDS-PAGE and visualized by autoradiography. The molecular masses of 
14C labelled proteins marker (M) are given in kDa, and the position of cellular PTB (cell. PTB) is indicated at the 
right side of the gel. 
 
 
3.2.1.2   Effect of PTB on HCV translation in reticulocyte lysate 
 
The results of the PTB binding experiments presented above have shown that neither recombinant PTB nor 
cellular PTB can be effectively UV cross-linked to the HCV IRES RNA, which means that translation initiation 
of the HCV RNA does not require PTB. 
It has been shown that the HCV RNA genome possesses a unique highly conserved region at the 3´-end of the 
genome. The 3´-UTR of HCV consists of three elements: a 30- to 40-nucleotide (nt) variable region, followed by 
a 20- to 200-nt poly-(U/C) stretch and, at the very 3´-end, a highly conserved 98-nt sequence termed the 3´X 
region (Tanaka et al., 1995; Tanaka et al., 1996). Tsuchihara and co-workers have reported that PTB can 
specifically bind to the HCV 3´-UTR (Tsuchihara et al., 1997). These authors suggested that a 3´UTR-PTB 
interaction is involved in the specific initiation of HCV genome replication. However, they did not show if PTB-
binding is functional or not. It will be shown in the third part of the Results section that translation of HCV can 
be stimulated by the HCV 3´-UTR. Therefore, the following experiments were carried out to investigate whether 
there is a functional role of PTB in HCV translation through the interaction with the 3´-UTR. 
For this purpose, two different monocistronic reporter RNAs were used (Fig. 23). They both contain the entire 
HCV 5´-UTR sequence plus partial core protein-encoding sequences, a ubiquitin sequence and the entire Firefly 
luciferase (FLuc) reporter gene, either ending exactly at the 3´-end of the FLuc coding sequence, or additionally 
including the complete HCV 3´-UTR. The upstream part of the core protein-encoding sequence was included 
since the 5´-region of the core protein-encoding sequence was required for efficient internal initiation of HCV 
(Reynolds et al., 1995; Rijnbrand et al., 1995). 
The two monocistronic reporter RNAs were in vitro-transcribed from PCR-generated templates. In vitro-
translation experiments using these RNAs were then performed in rabbit reticulocyte lysate (RRL) in the 
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presence of 130 mM potassium chloride, which is close to the physiological potassium concentration of 140 
mM. The efficiency of translation was then analyzed by measuring Firefly luciferase (FLuc) activity. 
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Fig. 23: Schematic representation of the HCV plasmids, PCR templates for transcription and reporter 
RNAs. T7, T7 RNA polymerase promoter; UTR, untranslated region; C, partial core protein-encoding 
sequences; Ub, ubiquitin sequences; FLuc, Firefly luciferase reporter gene. 
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Fig. 24: Effect of the presence of the HCV 3´-UTR on HCV IRES-mediated translation in rabbit 
reticulocyte lysate. Firefly luciferase (FLuc) activities from various amounts of RNA expressed by in vitro-
translation performed in standard rabbit reticulocyte lysates (RRL). The columns and bars represent the means 
and standard deviations of at least three independent experiments. 
 
 
The results demonstrate that the activity of the Firefly luciferase translated from different transcripts in 
reticulocyte lysate at different amount of RNA did not show any difference, irrespective if the 3´UTR was 
included or not (Fig. 24). 
In addition, a possible role of PTB in the HCV IRES-driven translation was further investigated by using an in 
vitro translation system described previously, the PTB-depleted RRL (Niepmann, 1996; Niepmann et al., 1997). 
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The endogenous PTB was removed from normal RRL using RNA (EMCV IRES domain 1)-affinity beads (see 
Materials and Methods). The amount of PTB remaining in the lysate was monitored by a UV cross-link assay 
using radioactively labelled FMDV IRES RNA (Fig. 25). After treatment with the RNA-affinity beads, the 
amount of PTB in RRL was largely, but not completely, reduced. Some proteins seemed not to be affected 
dramatically, whereas others were influenced seriously (Fig. 25, lane 2). For instance, eIF4G was still present in 
PTB-depleted RRL, but the labelling intensity of eIF4B appeared much weaker in depleted RRL than in normal 
RRL. Nevertheless, it was shown that PTB can stimulate binding of eIF4G to the FMDV IRES when added to 
this PTB-depleted reticulocyte lysate (Song et al., 2005), which proved that this PTB-depleted lysate is suitable 
for testing a possible influence of PTB on HCV translation. 
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Fig. 25: Comparison of PTB-depleted and normal RRLs by UV cross-linking assay with radioactively 
labelled FMDV IRES RNA. UV cross-linking assays were performed in 10 µl volumes in normal RRL (lane 1) 
or PTB-depleted RRL (lane 2), respectively. Proteins were analyzed on 8 % SDS-PAGE and visualized by 
autoradiography. The molecular masses of 14C labelled proteins marker (M) are given in kDa. The position of 
cellular PTB (cell. PTB, 57 kDa) is indicated on the right side of the gel. eIF4G, eukaryotic initiation factor 4G; 
eIF4B, eukaryotic initiation factor 4B. 
 
 
                                       
 
Fig. 26: The wild-type PTB protein and its deletion mutants used for the translation stimulation assay. 
Mutants are shown with amino acid numbers flanking the deletions (Song et al., 2005). The small N-terminal 
box represents the His6-tag.  
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To examine if the PTB-depleted lysate functionally responds to the addition of recombinant PTB, test 
experiments (Fig. 27) were performed with the foot-and-mouth disease virus (FMDV) IRES and PTB as well 
with domain deletion mutants of PTB (see Fig. 26).  
PTB has four RNA-recognition motifs (RRM) or ribonucleoprotein (RNP) domains (Gil et al., 1991; Kenan et 
al., 1991; Patton et al., 1991). PTB ∆I was even more active than wild-type PTB in the stimulation of IRES 
activity. Thus, PTB domain I is not required for FMDV translation stimulation. With PTB ∆II, a slightly lower 
efficiency of FMDV translation stimulation was observed. At the highest concentration of 240 nM, still 85 % 
stimulation was achieved. 
 
                                                
 
Fig. 27: Test of the PTB-depleted lysate: stimulation of FMDV IRES dependent translation by wild-type 
PTB and PTB deletion mutants. The dotted line indicates the basal translation efficiency of 40.6 % obtained 
with PTB-depleted RRL in the absence of supplemented PTB. To the PTB-depleted RRL, either wild-type PTB 
(wt) or the corresponding mutants PTB∆I, ∆II, ∆I,II, ∆III or ∆IV (see Fig. 26), respectively, were added before 
translation. The X-axis indicates the final concentrations of added PTB protein in the reaction. Readings show 
the efficiency of translation of the IRES dependent luciferase gene (pM12 RNA), standardized by setting the 
reaction with 100 ng wild-type PTB as 100%. All curves originate from the same value at about 40% stimulation 
(lines not shown due to the logarithmic scale on the X-axis). 
 
 
A stimulation of IRES-driven translation was also obtained with PTB ∆I,II. In contrast, PTB ∆III caused only a 
very slight increase in translation efficiency, whereas no stimulation was detected with PTB ∆IV (Song et al., 
2005). In conclusion, stimulation of FMDV IRES-driven translation can be achieved with a PTB protein that 
only contains the two RNA-binding domains III and IV, and the PTB-depleted RRL can be regarded as a test 
system suitable for the analysis of the role of PTB in in vitro-translation reactions. 
This PTB-depleted RRL was then used to analyze the effect of added purified recombinant His6-PTB on the 
HCV translation. The results show that the HCV IRES-directed translation could not be stimulated by addition of 
exogenous PTB to the PTB-depleted RRL (Fig. 28). However, Firefly luciferase expression was considerably 
reduced in the PTB-depleted RRL compared with normal RRL, indicating that some other factors required for 
HCV IRES-mediated translation might have been depleted together with PTB during the depletion procedure.  
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Fig. 28: Effect of PTB on HCV translation performed in vitro in PTB-depleted RRL. The amounts of 
recombinant PTB (rec. PTB) added in the reactions are indicated. Firefly luciferase (FLuc) activities of the 
translational products from HCV RNAs were measured in PTB-depleted RRL with increasing amount of 
recombinant PTB. The columns and bars represent the means and standard deviations of duplicate experiments. 
 
 
Taken together with the results above, it is concluded that PTB, although specifically binding to the HCV 3´-
UTR, has no detectable effect on the efficiency of translation of the HCV RNA in this in vitro-translation 
system.  
 
 
3.2.2   Interaction of heterogeneous nuclear ribonucleoprotein L (hnRNP L) with  
           HCV RNAs 
 
Heterogeneous nuclear ribonucleoproteins (hnRNPs) are abundant nucleoplasmic pre-mRNA-binding proteins 
which play important roles in the biogenesis of mRNA (Dreyfuss et al., 1993). hnRNPs are, by definition, 
nuclear proteins that interact with heterogeneous nuclear RNAs (hnRNAs). Several functions have been 
suggested for hnRNPs. They mostly relate to RNA functions such as pre-mRNA processing, mRNA 
translocation from the nucleus to the cytoplasm, and translation (Dreyfuss et al., 1993). The last two functions 
are attributed to a group of hnRNPs that shuttle between the nucleus and the cytoplasm. Several hnRNPs were 
reported to play roles in translation. PTB (hnRNP I) was shown to enhance IRES-dependent translation of 
encephalomyocarditis virus (EMCV) and foot-and-mouth disease virus (FMDV) mRNAs (Kaminski et al., 1995; 
Niepmann, 1996). hnRNP E2, which is also known as PCBP2, was required for the efficient translation of 
poliovirus RNA in HeLa cells (Blyn et al., 1997). On the other hand, hnRNP K and E1 inhibit translation of 
erythroid 15-lipoxygenase mRNA by binding to the 3´-UTR of the mRNA (Ostareck et al., 1997). Therefore, it 
would not be surprising to discover other hnRNPs which may be involved in the process of translation. 
hnRNP L was reported to be localized mainly in the nucleus (Pinol Roma et al., 1989). Interestingly, hnRNP L 
was found in the cytoplasm as well as in the nucleus when transcription of cellular mRNA was blocked by 
poliovirus infection or treatment with actinomycin D (Hahm et al., 1998b). These findings suggest that hnRNP L 
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may shuttle between the nucleus and the cytoplasm in a transcription-sensitive manner similar to that of some 
other hnRNP proteins, for example, hnRNP A1, E, and I (Michael et al., 1995). Therefore, hnRNP L may 
facilitate translation of some mRNAs while it stays in the cytoplasm. The following experiments were launched 
on the basis of the evidence that this 68 kDa hnRNP L protein can specifically interact with the 3´ border of the 
HCV IRES including part of the core protein-encoding sequence (Hahm et al., 1998b). 
 
 
3.2.2.1   Detection of the interaction of hnRNP L with different HCV RNAs by shifts and UV  
              cross-linking assay 
 
In the following experiments, the electrophoretic mobility shift assay (EMSA), or band shift, and the standard 
UV cross-link assay were used to detect the binding of hnRNP L or other recombinant proteins to the HCV 
RNAs. The EMSA is based on the observation that protein-RNA complexes migrate through polyacrylamide 
gels more slowly than free RNA fragments.  
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Fig. 29: Schematic diagram of differences between shift and UV cross-linking assays. EMSA, 
electrophoretic mobility shift assay; R•P, non-covlant RNA-protein complex; R-P, covalently fixed RNA-protein 
complex. 
 
 
Both the electrophoretic mobility shift assay (EMSA) and the UV cross-link assay detect direct interactions 
between native protein and native RNA, but each assay has particular advantages and disadvantages. In the shift 
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assay, the protein-RNA interaction is monitored approximately quantitatively and allows a rough estimation of 
dissociation constants (Kd). However, successful detection requires that the interaction of a given protein 
molecule with a given RNA molecule is stable enough to withstand both the incubation step and the gel-
electrophoresis. In contrast, in the UV-crosslink assay even very short-lived binding events are captured by UV-
induced covalent bonds between protein and RNA. However, only 5 to 10 % of the interactions are covalently 
fixed by the UV-light, while all other interactions are disrupted when loading the samples to a denaturing protein 
gel. 
Thus, the major difference between these two methods, as shown in Fig. 28, is that both long- and short-lived 
RNA-protein complexes can be detected after UV irradiation, whereas only long-lived RNA-protein complexes 
can be detected in the EMSA. Based on this difference, different binding results were often obtained using the 
different methods, even if the binding reactions were exactly the same. 
hnRNP L can specifically bind to sequences at the 3´-border of the HCV IRES (Hahm et al., 1998b). However, it 
remains unclear how this binding may be influenced by the presence of the 3´-UTR. In order to answer this 
question, low amounts of recombinant GST-fused hnRNP L (kindly provided by Prof. A. Bindereif, Giessen) 
were used in the shift assay with the three HCV RNA constructs shown in Fig. 14. The result shown in Fig. 30A 
demonstrates that GST-hnRNP L interacts directly with the HCV IRES RNA but not with the HCV 3´-UTR 
RNA. 
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Fig. 30: Interaction of GST-fused hnRNP L with HCV RNAs analyzed by EMSA. (A) Interaction of GST-
hnRNP L with transcripts that had not been gel-purified. The solid bars on the right side mark the authentic 
RNAs of the desired length, and the dotted bars represent the short transcripts prematurely terminating within the 
poly-(U/C) stretch in the HCV 3´-UTR. (B) Interaction of GST-hnRNP L with gel-purified HCV transcripts. The 
HCV RNAs used in the assay are shown in Fig. 14. Shifts were performed using [α-32P]-UTP labelled HCV 
RNAs. Samples were analyzed on 4 % non-denaturing polyacrylamide-TBE gels and visualized by 
autoradiography. The amounts of hnRNP L added to the reactions are indicated on the top of the gels. The 
positions of free RNA and RNA-protein complexes are indicated. 
 
 
It should be noted that the small RNA fragments observed below the authentic HCV IRES plus 3´UTR and the 
3´-UTR RNA fragments (dotted bars in Fig. 30A) resulted from incomplete transcription through the long poly-
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(U/C) stretch within the 3´-UTR during in vitro transcription. Therefore, the EMSA experiment was repeated 
with gel-purified transcripts, with essentially the same result (Fig. 30B). 
In the experiment shown above, hnRNP L is shown to bind clearly to the HCV IRES in a binding system without 
any other protein. Then, it was reasonable to investigate if this binding was still detectable when the cellular 
lysates such as RRL and cytoplasmic extract of Huh-7 were used in the binding assay, and if this binding of 
hnRNP L to the HCV IRES might play a role in in vitro-translation assay. hnRNP L was reported to be localized 
mainly in the nucleus (Pinol Roma et al., 1989). To make sure that recombinant GST-hnRNP L protein 
supplemented to cellular extracts such as reticulocyte lysate or Huh-7 cell extract for functional assays would 
result in a considerable increase in the hnRNP L concentration in these reactions, the presence of the hnRNP L in 
these extracts was tested by western-blotting using anti-hnRNP L antibody (kindly provided by Prof. A. 
Bindereif, Giessen).  
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Fig. 31: Detection of endogenous hnRNP L in RRL and cytoplasmic extract of Huh-7 cells. HeLa nuclear 
extract was used as a positive control. PTB-depleted RRL was also tested. 
 
 
The result demonstrates that there is no detectable hnRNP L in either RRL or Huh-7 S10 lysate (Fig. 31, lanes 2-
4), whereas hnRNP L can be detected in HeLa nuclear extract in considerable amounts (lane 1). 
Then, UV cross-link assays were carried out using the same three HCV RNA molecules together with the 
recombinant GST-fused hnRNP L. The results shown in Fig. 32 clearly demonstrate that hnRNP L can 
specifically bind to the HCV IRES in the absence of lysate (Fig. 32, lanes 2 and 6). However, this binding was 
competed when GST-hnRNP L protein was mixed with either RRL or Huh-7 lysate (Fig. 31, lanes 3, 4, 7 and 8). 
In addition, the HCV 3´ -UTR was confirmed not to bind hnRNP L in the UV cross-linking assay (Fig. 31, lane 
10). This result is in accordance with the results of the shift assays shown in Fig. 30. 
Taken together, these results indicate that hnRNP L weakly interacts with HCV IRES RNA, but not with the 
HCV 3´-UTR. 
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Fig. 32: Interaction of GST-fused hnRNP L with HCV RNAs analyzed by UV cross-linking assays. The 
reactions were performed with [α-32P]-UTP labelled HCV RNAs in the presence of 1 pmol of GST (lanes 1, 5 
and 9) or GST-hnRNP L (lanes 2, 6 and 10), with GST-hnRNP L-supplemented RRL (lanes 3, 7 and 11) or with 
GST-hnRNP L-supplemented Huh-7 lysate (lanes 4, 8 and 12). The amount of GST-hnRNP L added to both 
lysates was 1 pmol. The HCV RNAs used in this assay are shown in Fig. 14. Proteins were separated by 12 % 
SDS-PAGE and visualized by autoradiography. The position of GST-hnRNP L (~94 kDa) is indicated with an 
arrow at the right side of the gel. The molecular masses of 14C labelled proteins marker (M) are given in kDa. 
 
 
3.2.2.2   Effect of recombinant hnRNP L on HCV translation 
 
In the western blot described above, no endogenous hnRNP L was detected in the reticulocyte lysate, rendering 
the lysate possibly suitable as an in vitro test system for the detection of a possible function of added 
recombinant hnRNP L on HCV translation. Using the monocistronic HCV RNA constructs with or without an 
exact end of the HCV 3´-UTR (Fig. 23), in vitro translations were carried out at a physiological potassium 
concentration (~130 mM) in normal RRL.  
The results show that the HCV IRES-directed translation is not sufficiently enhanced in both RRL and PTB-
depleted RRL in the presence of hnRNP L, irrespective if the 3´-UTR is present or not (Fig. 33). Addition of 0.1 
pmol (equivalent to ~10 nM) of GST-hnRNP L caused a slight stimulation of Firefly luciferase expression, 
increasing about 20 % in normal RRL and 31 % in PTB-depleted RRL only when the HCV RNAs containing the 
3´-UTR were used (Fig. 33A and B). However, the observation that the translation efficiencies decreased at high 
amounts of hnRNP L in both cases implicates that the role of hnRNP L in the HCV IRES-directed translation 
might be somehow dose-dependent. 
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Fig. 33: Effect of hnRNP L on HCV translation in normal RRL (A) and PTB-depleted RRL (B). Firefly 
luciferase (FLuc) activities were determined after 60 min. incubation of the reporter RNAs (Fig. 23) at 30°C 
together with the amounts of recombinant hnRNP L indicated at the bottom of the graphs. The columns and bars 
represent the means and standard deviations of duplicate experiments. 
 
 
Since PTB is present in normal RRL and hnRNP L interacts with PTB (Hahm et al., 1998a), possible changes in 
translation activity might be induced by the interactions among HCV RNA, hnRNP L and PTB (the 
corresponding explanation will be considered in the Discussion section). 
 
 
3.2.3   Interaction of the protein encoded upstream of N-ras (Unr) with HCV RNAs 
 
The Unr gene (upstream of N-ras) was identified as a transcription unit located immediately upstream of the N-
ras gene in the genome of several mammalian species: guinea pig (Doniger & DiPaolo, 1988), rat (Jeffers et al., 
1990), mouse and human (Nicolaiew et al., 1991). Unr is ubiquitously expressed and codes for an 85 kDa 
protein. It is an essential gene: the homozygous knockout is lethal in mice at the stage of embryo development at 
day 10, which implies that Unr is not essential for general cell viability and cell division, but must be essential 
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for certain stages in differentiation (Boussadia et al., 1997). It has a broad tissue and cell-type distribution (Lopez 
Fernandez et al., 1995) and is largely cytoplasmic (Jacquemin Sablon et al., 1994). There are two known 
isoforms differing by the inclusion or exclusion of the optional exon 5 (Boussadia et al., 1993) with a 10 : 1 ratio 
in abundance of the smaller versus the larger isoform. Unr is a member of the cold-shock family of single-
stranded nucleic acid-binding proteins (Doniger et al., 1992). However, it is exceptional amongst this family in 
that it has five copies of the cold-shock domain (CSD), each of which has an unusual amino acid sequence 
signature motif, FFH, at its RNA-binding surface, whereas all other members of the family have FVH at this 
position (Doniger et al., 1992). The occurrence of this unusual motif in all five CSDs implies that Unr arose by 
repeated duplication of a protein that originally had just one domain. 
Unr has been identified as one of two proteins which bind to the human rhinovirus-2 (HRV-2) 5´-UTR and 
stimulate translation from HRV-2 IRES, the second protein is PTB (Hunt & Jackson, 1999b). All five cold-shock 
domains of Unr have been reported to be required for stimulation of human rhinovirus RNA translation (Brown 
& Jackson, 2004). 
 
 
3.2.3.1   Interaction of recombinant Unr with different HCV RNAs by gel shift assay and UV  
              cross-linking assay 
 
It has been shown that Unr can be UV cross-linked to the human rhinovirus (HRV) IRES RNA (Hunt et al., 
1999a). To determine whether Unr interacts directly with the three HCV RNAs shown in Fig. 14, EMSA and UV 
cross-linking assays using [α-32P]-UTP labelled RNAs and purified recombinant His-Unr protein (kindly 
provided by Dr. H. Jacquemin-Sablon, Bordeaux) were carried out. 
Initially, only HCV IRES RNA was used for the UV cross-linking assay in normal RRL. However, no binding of 
Unr to the HCV IRES was detected, even in the absence of tRNA which may function as a competitor to reduce 
unspecific binding (Fig. 34A). Then, the other two RNAs were taken into account for the following experiments. 
First, high concentrations of [α-32P]-UTP labelled HCV RNAs (about 0.12-0.14 pmol) were used for the shift 
assay under the standard conditions reported for the EMSA (Konarska & Sharp, 1986). However, no shifted 
bands were detected with all three different RNAs (data not shown). Only when lower concentrations of RNAs 
(about 6-7 nmol) were used in the shift assay, protein-RNA complexes were found with the HCV 3´-UTR RNA 
at the concentration of 10 nM Unr. With the other two RNAs (IRES and IRES plus 3´-UTR), RNA-protein 
complexes could be detected only at a high concentration of Unr (100 nM) (Fig. 34B). These results indicate 
that: (1) Unr may not interact directly with the HCV IRES; (2) Unr binds to the HCV 3´-UTR; and (3) the 
presence of the HCV IRES somehow inhibits the binding of Unr to the 3´UTR. 
In contrast, in the UV cross-linking assay, Unr interacts with all three HCV RNAs (Fig. 35A) in the absence of 
any other protein. All binding signals were still detectable even in the presence of tRNA, but became 
significantly weaker, especially in the case of HCV IRES RNA (Fig. 35A). However, in the presence of other 
proteins derived from Huh-7 lysate, the binding of Unr to the HCV RNAs was not detectable any more (Fig. 
35B). 
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Fig. 34: Binding of recombinant Unr to the HCV RNAs. (A) UV cross-linking assay with HCV IRES RNA 
with [α-32P]-UTP labelled HCV IRES RNA in RRL. The final concentrations of Unr added in each reaction are 
indicated on the top of the gel. The samples were analyzed by 8 % SDS-PAGE and autoradiography. The 
molecular masses of 14C labelled proteins marker (M) are given in kDa. The expected position of Unr (~94 kDa) 
is marked with an arrow. (B) Binding of Unr to the gel-purified HCV RNAs in the shift assay. No tRNA and no 
heparin were used in this assay. Samples were analyzed on 4 % nondenaturing polyacrylamide gels and 
visualized by autoradiography. The white arrows represent free RNAs, and black arrows represent RNA-protein 
complexes. 
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Fig. 35: Binding of Unr to [α-32P]-UTP labelled HCV RNAs analyzed by the UV cross-linking assay. (A) 
Assays performed in the absence or presence of tRNA without any other protein. The amount of recombinant 
Unr (rec. Unr) added to each reaction was 1.3 pmol (equivalent to ~130 nM). The final concentration of tRNA in 
the reaction is 1 µg/µl. The position of rec. Unr (~94 kDa) is indicated. (B) Assays performed in Huh-7 lysate in 
the absence or presence of rec. Unr, in the presence of 1 µg/µl tRNA. Samples were separated by 8 % SDS-
PAGE and visualized by autoradiography. The molecular masses of 14C labelled proteins marker (M) are given 
in kDa. The expected position of Unr is indicated. 
 
3   Results                                                                                              85                      
In conclusion, Unr binds only weakly to the HCV 3´-UTR, and its binding can be competed by other proteins in 
the cell lysate.  
 
 
3.2.3.2   Effect of recombinant Unr on HCV translation 
 
To address the question whether Unr plays a functional role in the translation of HCV RNAs with or without the 
3´-UTR region (Fig. 23), in vitro-translation assays were performed with the HCV RNAs in normal RRL (Fig. 
36). 
The results show that addition of recombinant Unr protein to the reticulocyte lysate leads to a decrease in 
translation efficiency. Moreover, these data imply that the translation level of HCV RNA could be relieved to a 
certain extent by the presence of the HCV 3´-UTR. Similar results were also found in PTB-depleted RRL (data 
not shown). 
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Fig. 36: Effect of recombinant Unr on HCV translation in normal RRL. The amounts of increasing 
recombinant Unr (Rec. Unr) added to the reactions are indicated at the bottom of the graph. Relative Firefly 
luciferase (Rel. FLuc) activities in the lysates were measured after assay. The Fluc values expressed from HCV 
RNA with or without 3´-UTR are set to 100 %. The bars represent standard deviations of three independent 
experiments. 
 
 
Taken together, these data suggest that the recombinant Unr protein used here inhibits the translation efficiency 
of the HCV RNA. The reasons for this observation are not known yet. However, it can be speculated that the 
status of the Unr protein preparation may play a role, since the recombinant Unr protein had been purified from 
E.coli under denaturing conditions and was renatured after purification. Thus, it is not known that which portion 
of the protein is in the authentic native conformation and if misfolded proteins inhibit the translation reaction. 
 
 
3.2.4   Interaction of PTB, hnRNP L and Unr with HCV RNAs 
 
The results presented above show that the interactions of different cellular proteins individually with HCV RNAs 
are quite different: PTB and Unr bind clearly to the HCV 3´-UTR but not to the HCV IRES RNA alone, whereas 
hnRNP L binds to the HCV IRES only. With respect to the HCV IRES-mediated translation, the roles they play 
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are different. PTB and Unr both exhibit down-regulatory effects with different degrees on HCV translation, 
whereas hnRNP L shows a slightly stimulating effect at a certain concentration. It is known that PTB and hnRNP 
L interact with each other, and they are possibly involved in functions like pre-mRNA processing and mRNA 
translocation from the nucleus to the cytoplasm (Dreyfuss et al., 1993; Hahm et al., 1998a). Moreover, the 
presence of both Unr and PTB is required for the formation of an RNA structure in Apaf-1 IRES that has the 
correct conformation for binding of the 40S ribosomal subunit to initiate translation efficiently (Mitchell et al., 
2003). Therefore, it was interesting to investigate if these trans-acting factors interact with one another and 
whether they may act synergistically in the translation of the HCV RNA, which is the main goal of the following 
part of the work. 
  
 
3.2.4.1   Interaction of PTB, hnRNP L and Unr in concert with the HCV RNAs 
 
3.2.4.1.1   PTB and hnRNP L 
 
The results in the previous section show that PTB can bind specifically to the HCV 3´-UTR irrespective if 
cellular proteins are present or not (Fig. 21 and 22), and hnRNP L clearly binds to the HCV IRES (Fig. 30 and 
32). In order to check a possible interaction of PTB and hnRNP L in concert with the HCV RNA in the shift 
assay, the following experiment was designed. The HCV IRES plus 3´-UTR RNA labelled with [α-32P]-UTP 
was selected for the shift assays and incubated with increasing amounts of GST-hnRNP L in the absence or 
presence of a constant amount of recombinant PTB.  
The result shown in Fig. 37 demonstrates unambiguously that PTB and hnRNP L not only bind independently of 
each other to the HCV IRES plus 3´-UTR RNA (Fig. 37, lanes 2, 6 and 7), but they also bind together to the 
same HCV RNA as seen by the position of the higher shifted bands marked with arrows (Fig. 37, lanes 3-5).  
Then, UV cross-linking assays were performed with the three HCV RNAs in the presence of both PTB and 
hnRNP L. Interestingly, it was found that PTB binding to the HCV RNAs is clearly strengthened by the presence 
of hnRNP L. With increasing amounts of hnRNP L, binding of PTB to the RNA was gradually increased, 
especially in the case of the RNAs including 3´-UTR portion (Fig. 38, lanes 5-12). 
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Fig. 37: Binding of PTB and hnRNP L to the HCV IRES plus 3´-UTR RNA in a supershift assay. The final 
concentration of tRNA added to each shift reaction was 1 µg/µl. All samples were analyzed on a 4 % 
nondenaturing polyacrylamide gel and visualized by autoradiography. The final amounts of hnRNP L added to 
the reactions are indicated on the top of the gel. The position of the free RNA and of RNA-protein complexes are 
indicated on the right side of the gel.  
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In contrast, when the hnRNP L concentration was kept constant and PTB added in variable amounts, no 
corresponding stimulation of hnRNP L binding by increasing amounts of PTB was detected (data not shown). 
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Fig. 38: Stimulation of PTB binding to the HCV RNAs by hnRNP L analyzed by the UV cross-linking 
assay. Three HCV RNAs labelled with [α-32P]-UTP were used (see Fig. 10). Assays were performed in the 
presence of 1 µg/µl tRNA without any other protein. The amounts of GST-hnRNP L added to the reactions are 
indicated on the top. The final concentration of PTB added to each reaction is 1 pmol (equivalent to a final 
concentration of ~100 nM). All samples were separated by an 8 % SDS-PAGE and visualized by 
autoradiography. The molecular masses of 14C labelled proteins marker (M) are given in kDa. The positions of 
PTB and GST-hnRNP L are indicated on the right side of the gel. 
 
 
At the same time, two unexpected observations were obtained in this assay. One is that the HCV 3´-UTR, shown 
previously not to interact with hnRNP L, is bound by hnRNP L in the presence of PTB. The other finding is that 
PTB can bind to the HCV IRES RNA in the presence of hnRNP L, although the labelling intensity is very weak. 
These observations are quite contrary to the results of the former experiments when PTB or hnRNP L were 
examined individually with corresponding HCV RNAs. Presumably, these binding signals are due to possible 
protein-protein interactions between PTB and hnRNP L in combination with the HCV RNA. However, the 
mechanism behind this observation remains unclear.  
Next, UV cross-linking assays were performed under the same condition with all PTB deletion mutants (Fig. 26) 
present in constant amounts and variable amounts of hnRNP L, but this time, only the HCV IRES plus 3´-UTR 
RNA was used. The results shown in Fig. 39 not only confirm that hnRNP L stimulates the binding of PTB to 
the HCV RNA (see Fig. 38), but also verify that PTB ∆I,II strongly interacts with the HCV IRES plus 3´-UTR 
RNA. In contrast, neither PTB ∆III (46.5 kDa) nor ∆IV (47.6 kDa) protein can bind to the HCV IRES plus 3´-
UTR RNA in the UV cross-linkING assays (lanes 9-16). These observations show that not only in the interaction 
of PTB with the FMDV IRES, but also in the interaction with the HCV RNA, the PTB domains III and IV are 
much more important than the domain I and II. 
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Fig. 39: hnRNP L stimulates the binding of PTB wild-type (A) and PTB domain deletion mutants ∆I and 
∆II (B), PTB ∆I,II (C), PTB ∆III and ∆IV (D) to the HCV RNA analyzed in the UV cross-linking assay. Only 
HCV IRES plus 3´-UTR RNA labelled with [α-32P]-UTP shown in Fig. 14 was used. Assays were performed in 
the presence of 1 µg/µl tRNA without any other protein. The amounts of GST-hnRNP L added to the reactions 
are indicated on the top of the gels. The final concentration of PTB and its mutants present in each reaction is 1 
pmol (equivalent to a final concentration of ~100 nM). All samples were separated on 12 % SDS-PAGE and 
visualized by autoradiography. The molecular masses of 14C labelled proteins marker (M) are given in kDa. The 
positions of GST-hnRNP L, PTB wild-type (wt) and deletion mutants (except PTB ∆III and ∆IV) are also 
indicated. 
 
 
3.2.4.1.2   Unr and hnRNP L 
 
Next, Unr was included in the same experiment as described above. Using the three HCV RNAs, UV cross-link 
assays were carried out with a constant amount of recombinant GST-hnRNP L and variable amounts of 
recombinant Unr, but no other protein present. Unfortunately, no effect of Unr on the binding of hnRNP L to the 
HCV IRES was observed since there is no interaction of Unr with the HCV IRES RNA. However, the binding of 
hnRNP L to the HCV IRES including 3´-UTR RNA unexpectedly declines with increasing amounts of Unr 
added to the reactions (Fig. 40, lanes 5-8). The same effect was observed with the HCV 3´-UTR RNA (Fig. 40, 
lanes 9-12).  
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Fig. 40: Binding of hnRNP L to the three HCV RNAs in the presence of Unr analyzed by the UV cross-
linking assay. The three HCV RNA constructs labelled with [α-32P]-UTP were shown in Fig. 14. Assays were 
performed in the presence of a final concentration of 1 µg/µl tRNA without any other protein. The amounts of 
recombinant His-Unr added to the reactions are indicated on the top of the gel. The final amount of GST-hnRNP 
L presented in each reaction is 1 pmol (equivalent to a final concentration of ~100 nM). All samples were 
separated on 8 % SDS-PAGE and visualized by autoradiography. The molecular masses of 14C labelled proteins 
marker (M) are given in kDa. The position of GST-hnRNP L is indicated. 
 
Thus, Unr appears to compete with the binding of hnRNP L, in contrast to PTB which stimulates the binding of 
hnRNP L (see above).  
 
 
3.2.4.1.3   PTB and Unr 
 
In the experiments described above, PTB has been shown to bind to the HCV 3´-UTR (Fig. 21 and 22), and Unr 
also binds to the HCV RNA containing the 3´-UTR portion (Fig. 34B and 35A). It has been demonstrated that 
Unr and PTB are able to act in synergy to stimulate Rhinovirus IRES function in RRL (Hunt et al., 1999a). In 
order to examine the interaction of PTB and Unr together with the HCV RNA, the following experiment was 
designed. UV cross-linking assays were performed using the HCV 3´-UTR RNA as well as the HCV IRES plus 
3´UTR RNA labelled with [α-32P]-UTP in normal RRL supplemented with increasing amounts of recombinant 
His-Unr protein since Unr and PTB proteins do not interact with HCV IRES only. 
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Fig. 41: Binding of PTB to HCV RNAs in the presence of Unr in normal RRL (A) and PTB-depleted RRL 
(B) analyzed by the UV cross-linking assay. Assays were performed in the presence of final amount of 1 
µg/µl. The amounts of recombinant His-Unr added to the reactions are indicated on the top of the gels. The final 
amount of recombinant PTB (rec. PTB) added to the PTB-depleted RRL (B) is 0.3 pmol (equivalent to a final 
concentration of 30 nM). All samples were separated on 8 % SDS-PAGE and visualized by autoradiography. 
The molecular masses of 14C labelled proteins marker (M) are given in kDa. The positions of endogenous PTB 
(end. PTB) and rec. PTB are also indicated. 
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From the UV cross-linking results (Fig. 41A), it is obvious that the binding of PTB to the HCV RNAs in normal 
RRL is not enhanced but slightly inhibited by the presence of Unr. A similar inhibitory effect is also detected in 
PTB-depleted RRL supplemented with recombinant PTB (Fig. 41B). Again, no Unr band was found to bind to 
HCV RNAs in both cases, confirming that cellular proteins can easily compete for Unr binding. 
Taken together, these results suggest that Unr compete binding of PTB to the HCV RNA containing the 3´-UTR. 
It can be only speculated if a certain fraction of the recombinant Unr protein (which was purified under 
denaturing conditions and then renatured) which is not in a native state may exert these inhibitory effects. 
 
 
3.2.4.1.4   PTB, hnRNP L and Unr 
 
The results described above demonstrate the interaction of any two of three proteins with the HCV RNAs in the 
absence or presence of any lysate by different methods, either shift or UV cross-linking assays. As a last step, the 
interactions of all these three proteins together with the HCV RNA were examined. Considering the binding of 
these three proteins to the HCV RNA, only the HCV IRES plus 3´-UTR RNA was used for this experiment. In 
order to rule out any interference with other cellular proteins, this assay was carried out without any lysate.  
When PTB and Unr were present in constant amounts in the reactions, the binding of PTB to the HCV RNA was 
stimulated by increasing amounts of hnRNP L, which is in accordance with the results obtained in Fig. 38. 
Similar results are also detected when hnRNP L and Unr are constant parameters and the PTB concentration was 
varied (Fig. 42, lanes 5-8), indicating that PTB can slightly stimulate binding of hnRNP L to the HCV RNA. In 
contrast, the binding of hnRNP L and PTB to the HCV IRES + 3´-UTR RNA is inhibited by increasing amounts 
of Unr (Fig. 42, lanes 9-12), further confirming that the Unr protein used here acts as a competitor of PTB or 
hnRNP L binding to the HCV RNA. 
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Fig. 42: Interaction of PTB, hnRNP L and Unr with HCV IRES plus 3´-UTR RNA analyzed by UV cross-
linking assays. The UV cross-link assays were carried out with the HCV IRES plus 3´-UTR RNA labelled with 
[α-32P]-UTP in the presence of a final amount of 1 µg/µl tRNA without any other proteins. The amount of each 
protein added to the reactions is indicated on the top of the gel. The final amounts of the two proteins present in 
constant amounts in the reactions are 1 pmol each (equivalent to a final concentration of ~100 nM). All samples 
were separated on 8 % SDS-PAGE and visualized by autoradiography. The molecular masses of 14C labelled 
proteins marker (M) are given in kDa. The positions of recombinant GST-hnRNP L and PTB wt are indicated. 
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Taken together, PTB and hnRNP L may play a synergistic role in binding to the HCV RNA including the IRES. 
In contrast, a possible role of Unr remains unclear from these in vitro-binding assays with the recombinant 
proteins, mainly due to uncertainties regarding the native state of the Unr preparation used. 
 
 
3.2.4.2   Effects of PTB, hnRNP L and Unr on the HCV translation 
 
To address the question whether PTB, hnRNP L and Unr play a synergistic role in the translation of HCV RNA, 
combination of each two of the proteins were chosen in a series of in vitro-translation assays which were carried 
out with two HCV RNA constructs in either normal RRL or PTB-depleted RRL.  
First, PTB and hnRNP L were used together to analyze their functional role in HCV translation with HCV RNA 
constructs with or without 3´-UTR as shown in Fig. 23. In order to use an extract with low concentration of PTB, 
PTB-depleted RRL was used and supplemented with a constant low amount of recombinant PTB. To this 
reaction, hnRNP L was added in increasing amounts (Fig. 43). However, no significant influence of hnRNP L on 
HCV translation could be observed. 
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Fig. 43: Effect of hnRNP L and PTB together on HCV translation in PTB-depleted RRL. The amounts of 
GST-hnRNP L added to each reaction are indicated at the bottom of the graph. Recombinant His6-PTB was 
present in a constant amount of 0.5 pmol (equivalent to the final concentration of 50 nM) in each reaction. 
Firefly luciferase (FLuc) activities expressed from the two HCV RNAs were determined. The columns and bars 
represent the means and standard deviations of duplicate experiments. 
 
 
Taken together with the results of the experiments above, HCV translation is not significantly affected by PTB 
and hnRNP L, individually or together, in in vitro assays. 
Next, PTB and Unr were examined together in in vitro-translation assays. As mentioned above, the recombinant 
Unr protein inhibits the translation efficiency of HCV RNA, but this effect could be relieved to a certain extent 
by the presence of the HCV 3´UTR region in normal RRL (Fig. 36). Using the same HCV RNAs with or without 
3´-UTR, in vitro-translation reactions were carried out with different amounts of recombinant PTB and Unr 
proteins in PTB-depleted RRL. However, HCV translation efficiencies did not change significantly in the 
presence increasing amounts of PTB (Fig. 44A). This observation is consistent with that obtained from the 
former in vitro-translation assays when recombinant PTB was added to the PTB-depleted RRL (Fig. 28). 
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Correspondingly, HCV translation was inhibited when increasing amounts of the recombinant Unr protein were 
added to the PTB-depleted RRL supplemented with exogenous His6-PTB (Fig. 44B), which is consistent with 
the result of Fig. 36. Similarly, the same inhibitory effect was also found when increasing amounts of the 
recombinant Unr were added to the PTB-depleted RRL without exogenous PTB supplemented (data not shown). 
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Fig. 44: Effect of PTB and Unr on HCV translation in PTB-depleted RRL. (A) Effect of PTB in the 
presence of Unr on HCV translation in PTB-depleted RRL. (B) Effect of Unr in the presence of PTB on HCV 
translation in PTB-depleted RRL. The amounts of PTB and Unr added to each reaction are indicated at the 
bottom of the graphs. Relative Firefly luciferase (Rel. FLuc) activities in the reactions were measured after 60 
minutes incubation of the reporter RNAs with the indicated recombinant PTB and Unr proteins at 30°C. The 
FLuc values obtained from HCV RNA with and without 3´-UTR in the absence of PTB are set to 100 %. The 
bars represent standard deviations of three independent experiments. 
 
                     
3.2.5   Conclusions 
 
PTB binds efficiently to the HCV 3´-UTR but only extremely weakly to the HCV IRES. In contrast, hnRNP L 
binds to the HCV IRES only. Together, these two proteins mutually promote their binding to the HCV RNA. 
However, in the in vitro-translation with reticulocyte lysate, only a very slightly positive effect of hnRNP L on 
HCV translation was observed. 
The recombinant Unr protein used in this work binds to the HCV 3´-UTR, but no significant effect of Unr on 
HCV translation could be observed in in vitro-translation in reticulocyte lysate. 
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3.3   Part III: The Hepatitis C Virus RNA 3´-untranslated region strongly   
        enhances translation directed by its internal ribosomal entry site 
 
The main aim of this third part of the study was to investigate the functional influence of the HCV 3´-
untranslated region (3´-UTR) on HCV translation directed by its internal ribosome entry site. 
 
 
3.3.1 The reporter construct used to analyze the possible influence of the HCV 3´-UTR 
on translation 
 
Several conflicting results have been reported previously on the effect of the HCV 3´-UTR on the IRES-directed 
translation. Some studies reported a stimulatory role of the viral 3´-X (Ito et al., 1998; Ito & Lai, 1999; Michel et 
al., 2001), whereas others reported either no detectable or even an inhibitory role of the 3´-end sequences (Fang 
& Moyer, 2000; Murakami et al., 2001; McCaffrey et al., 2002). The reasons for these discrepancies are not 
directly evident. Some of researchers discussed that different concentrations of translation factors in the 
employed translation assay systems, different intracellular mRNA concentrations, and/or mis-folding of in vitro-
generated RNAs could contribute to the discrepancies (Kong & Sarnow, 2002). However, it was noted that (i) 
some of these studies concentrated only on a possible role of the HCV 3´-X region but not of the entire viral 3´-
UTR, and (ii) the HCV RNA molecules used in most studies did not have precise 3´ termini. It is hypothesized 
that these experimental variations may have caused the discrepancies between the results obtained in different 
studies.  
 
                
5´-UTR 3´-UTRFLucc
T7
CMV Ub
reporter RNA  HCV+3´-UTR (wt)
reporter RNA  HCV+∆3´-UTR
precise 3´-end  
 
Fig. 45: Schematic representation of the HCV plasmid and reporter RNAs (indicated with arrow lines). 
CMV, Cytomegalovirus immediate early promoter; T7, T7 RNA polymerase promoter; UTR, untranslated 
region; C, partial core protein-encoding sequences; Ub, ubiquitin sequences; FLuc, Firefly luciferase reporter 
gene. The precise 3´-ends are also indicated.  
 
 
In an attempt to clarify the role of the HCV 3´-UTR on HCV IRES activity, different reporter constructs were 
compared and two different monocistronic reporter mRNAs containing the entire HCV 5´-UTR sequence plus 
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partial core protein-encoding sequences and the entire Firefly luciferase (FLuc) reporter gene, either ending 
exactly at the 3´-end of the FLuc coding sequence, or additionally including the complete HCV 3´-UTR were 
designed for the following in vitro-translation experiments (Fig. 45). The important point for this monocistronic 
RNA constructs is that each of them has an exact end at its 3´-terminus, either with or without 3´-UTR, 
respectively. 
  
 
3.3.2 Optimization of in vitro translation conditions 
 
The templates for in vitro-transcription of the reporter RNAs were generated by PCR to obtain run-off transcripts 
with the precise 3´-ends (see Fig. 45). At the very beginning, the effect of different amounts of RNA on in vitro-
translation reactions was analyzed. Fig. 46 shows the Firefly luciferase (FLuc) activities directed by the HCV 
IRES expressed in rabbit reticulocyte lysate (RRL) from different amounts of RNA. A high expression level was 
obtained at 200 ng of the HCV reporter RNA used in the reaction. Interestingly, it was found that increasing 
amounts of RNA (e.g., 800 ng) did not produce higher expression levels, but led to lower FLuc expression. 
Therefore, 200 ng HCV RNA was selected for all following in vitro translation assays since the amount of 200 
ng per reaction appears to represent the upper limit of the dynamic range of expression of FLuc. 
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Fig. 46: In vitro translation directed by the HCV IRES at different RNA amounts. Amounts of RNA were 
incubated in 10 µl in vitro translation reaction including 4.4 µl RRL. The columns and bars represent the means 
and standard deviations of four independent experiments, respectively. FLuc, Firefly luciferase reporter gene. 
 
 
In order to analyze the changes in HCV translation at different concentrations of potassium and magnesium, 200 
ng of the monocistronic mRNA shown in Fig. 45 were used in this experiment. The concentration of potassium 
present in the cells is usually about 140 mM. Considering that the endogenous concentration of potassium 
acetate (KAc) is 113 mM (added by the supplier) in normal rabbit reticulocyte lysate, different concentrations of 
potassium were adjusted by addition of exogenous potassium in the assays. The monocistronic HCV reporter 
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RNA was in vitro-translated in RRL and FLuc activity was measured. The result showed that the highest FLuc 
activity was detected near the physiological concentration of potassium, whereas the FLuc expression dropped at 
further increased potassium concentrations, indicating that too high salt concentrations may somehow inhibit 
expression of the FLuc reporter gene (Fig. 47A). Based on this result, the physiological concentration of 
potassium (~150 mM) was selected for all following in vitro-translation assays. 
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Fig. 47: In vitro translation directed by the HCV IRES at different salt concentrations. (A) HCV IRES-
dependent translation in the presence of different potassium concentrations (endogenous and added). Translation 
reactions with monocistronic RNA were performed at 30°C in rabbit reticulocyte lysate. (B) HCV IRES-
dependent translation in the presence of different magnesium concentrations (endogenous and added). The 
columns and error bars represent the means and standard deviations of two independent translations, 
respectively. FLuc, Firefly luciferase reporter gene.  
 
 
In addition, the effect of different concentrations of magnesium (which is about 0.5 mM inside mammalian 
cells), on the translation driven by the HCV IRES was then examined in the presence of the physiological 
concentration of potassium (the RRL contains 0.712 mM magnesium added by the supplier). The result shown in 
Fig. 47B indicates that the highest translation level directed by the HCV IRES in RRL was achieved at low 
concentrations of magnesium since the highest expression of FLuc was detected at 0.24 mM. The FLuc activity 
decreases sharply when the concentration of magnesium is ≥ 1 mM in the reaction. This observation means that 
the concentration of 0.7 mM magnesium contained in the endogenous reticulocyte lysate is sufficient to allow 
the efficient translation driven by the HCV IRES in RRL when 3-4 µl of RRL are used in a 10 µl reaction, 
resulting in a final magnesium concentration of about 0.25-0.3 mM. 
Based on these observations, the concentrations of both potassium and magnesium were fixed at 140 mM, which 
is close to the physiological condition, and 0.24 mM, respectively, for all following in vitro translation 
experiments. 
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3.3.3 Effect of the HCV 3´-UTR on IRES-mediated translation in rabbit reticulocyte  
lysate 
 
Using the monocistronic HCV constructs shown in Fig. 45, the templates for in vitro-transcription of the reporter 
RNAs were generated by PCR to obtain run-off transcripts with precise 3´-ends. These RNAs were in vitro-
translated in rabbit reticulocyte lysate (RRL) at a final potassium concentration of 135 mM which is close to 
physiological conditions. The translation products of these RNAs were examined by measuring FLuc activity 
(Fig. 48A) and by analyzing Fluc protein amounts by SDS-PAGE and autoradiography (Fig. 48B). However, no 
significant difference in translation efficiency was detected between these two reporter RNAs, even when using 
different amounts of RNA to rule out a possible saturation effect in the system. These results indicate that the 
HCV 3´-UTR has no obvious effect on its IRES-dependent translation in rabbit reticulocyte lysate. 
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Fig. 48: Functional analysis of the HCV 3´-UTR by in vitro translation. (A) Firefly luciferase (FLuc) 
activities from various amounts of RNA expressed in RRL at a physiological potassium concentration (~135 mM 
KCl). In vitro-translation reactions were performed using 4.4 µl standard rabbit reticulocyte lysate (RRL) in a 
volume of 10 µl. The columns and bars represent the means and standard deviations of at least three independent 
experiments. (B) In vitro-translation products of various amounts of RNA separated by 12 % SDS-PAGE and 
visualized by autoradiography. Firefly luciferase (FLuc) protein (62 kDa) is indicated on the right. M, 14C-
labelled marker proteins. Molecular masses of marker proteins are indicated in kDa. 
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3.3.4 Influence of reporter construct design and transfection protocol details on the 
detection of translation enhancement by the 3´-UTR 
 
Hepatitis C Virus infects specifically human liver cells. Therefore it is an obvious approach to use transfection of 
human hepatoma cell lines to examine a possible effect of the HCV 3´-UTR on translation. However, the results 
obtained in several studies using transfection of hepatoma cell lines with reporter constructs including the HCV 
5´-UTR and the 3´-UTR are controversial (Ito et al., 1998; Friebe & Bartenschlager, 2002; Kong & Sarnow, 
2002; McCaffrey et al., 2002; Imbert et al., 2003; Yi & Lemon, 2003a). Most of these studies used transfection 
and transient expression of complete circular reporter plasmids or of linearized plasmids. Only in one study, 
reporter RNAs were transfected into cultured Huh-7 cells, but no enhancement effect of transfection by the HCV 
3´-UTR was detected (Friebe & Bartenschlager, 2002). In an attempt to eliminate experimental parameters that 
hamper a possible enhancing action of the 3´-UTR on HCV IRES-dependent translation, we used a series of 
reporter constructs and performed different transfection assays. 
For this purpose, two types of HCV plasmid DNAs (one with the entire 3´-UTR [named pHCV+3´-UTR], the 
other without the 3´-UTR [named pHCV+∆3´-UTR], see Fig. 45 for reference) were transfected into Huh-7 
cells. At 40 hrs after transfection, FLuc activities expressed in the cells were determined. However, the 
translation efficiency obtained with pHCV+3´-UTR was not significantly different from that of pHCV+∆3´-UTR 
(Fig. 49A). Also in a time-course experiment (Fig. 49B), no difference in expression of the FLuc from both 
plasmids was observed. 
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Fig. 49: Effects of the HCV plasmid constructs on HCV translation in vivo. (A) HCV plasmids were 
transfected into Huh-7 cells. Relative Firefly luciferase (Rel. FLuc) activities in the lysates were measured at ~40 
hrs after transfection. The Fluc activity of the plasmid without 3´-UTR is artificially set to 100 %. (B) Effects of 
HCV plasmids on translation efficiency at different time points after Huh-7 cells were transfected respectively. 
Cells were harvested at different times and Firefly luciferase (FLuc) activities were measured. The columns and 
bars represent the means and standard deviations of at least three independent experiments, respectively. 
 
 
To analyze if the presence of an exact 3´-end of the HCV 3´-UTR sequence is required to allow a possible 
enhancing effect of the 3´-UTR on translation, two types of PCR fragments from the above plasmids were 
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generated. These PCR fragments include the cytomegalovirus (CMV) promoter and either terminate at the 
Firefly luciferase stop codon, or additionally include the HCV 3´-UTR (Fig. 50A). With these PCR fragments, a 
slight difference in FLuc expression was observed (Fig. 50B). 
When the FLuc activities were measured at different time points after transfection of the PCR fragments into 
Huh-7 cells, significant differences could be observed (Fig. 50C). Obviously, at early time points after 
transfection, the FLuc expression from the PCR fragment including the HCV 3´-UTR was up to three-fold higher 
than that from the PCR fragment without 3´-UTR (Fig. 50C), while this relative difference decreased with 
increased time after transfection. Thus, assaying reporter gene activity in a time course after transfection may be 
important for the outcome of experiments testing a possibly enhancing effect of 3´-UTR on HCV IRES-directed 
translation. 
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Fig. 50: Effects of the HCV PCR fragments on HCV translation in vivo. (A) Schematic representation of the 
HCV PCR fragments (indicated with lines) with cytomegalovirus (CMV) immediate early promoter upstream of 
T7 promoter. CMV, Cytomegalovirus immediate early promoter; T7, T7 RNA polymerase promoter; UTR, 
untranslated region; C, partial core protein-encoding sequences; Ub, ubiquitin sequences; FLuc, Firefly 
luciferase reporter gene. (B) HCV PCR fragments were transfected into Huh-7 cells. Relative Firefly luciferase 
(Rel. FLuc) activities in the lysates were measured at ~40 hrs after transfection. The Fluc activity of plasmid 
without 3´-UTR is artificially set to 100 %. (C) Effects of HCV PCR fragments on translation efficiency at 
different time points after transfection of Huh-7 cells. Cells were harvested at different times and Firefly 
luciferase (FLuc) activities were measured. The columns and bars represent the means and standard deviations of 
at least three independent experiments, respectively.  
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In contrast with the above DNA transfection experiments, a strong stimulating effect of the HCV 3´-UTR on 
translation was found when in vitro-transcribed RNAs (see Fig. 45) were transfected into Huh-7 cells (Fig. 51). 
The translation efficiency of the in vitro-transcribed RNA which contains the 3´-UTR (HCV+3´-UTR) was 10 to 
20 times higher than that of RNA without 3´-UTR (HCV +∆3´-UTR). It is important to note that the RNA with 
3´-UTR has a precise 3´-end similar to the authentic HCV genome since the RNAs were generated from PCR 
fragments (Fig. 50A) exactly ending at a position corresponding to the 3´-terminus of genomic HCV RNA. The 
differences found here are by far larger than those found in previous reports (Ito et al., 1998; Michel et al., 2000) 
and also those detected in PCR fragment transfection experiments described above (Fig. 50B and C). Thus, the 
HCV 3´-UTR can strongly enhance translation directed by the HCV IRES when monocistronic reporter RNA 
with a 3´-end precisely corresponding to the HCV RNA 3´-end is used.  
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Fig. 51: Translation efficiency of the HCV RNAs transcribed from the corresponding PCR fragments (see 
Fig. 50A) at different time points after transfection of Huh-7 cells. Cells were harvested at the indicated time 
points after transfection and Firefly luciferase (FLuc) activities were measured. The columns and bars represent 
the means and standard deviations of at least four independent experiments, respectively.  
 
 
3.3.5 Expression differences are not due to differences in RNA stability or transfection    
efficiency 
 
The stem-loop 1 (SL 1) in the 3´-X region forms a stable secondary RNA structure (see Fig. 9, Introduction) that 
could be argued to protect the 3´-end of the reporter RNA against degradation by exonucleases after transfection, 
whereas the reporter RNA without HCV 3´-UTR might be degraded more easily. To rule out the possibility that 
the differences in translation efficiency are due to differences in RNA stability, a specific Fluc anti-sense RNA 
probe which could hybridize with a 3´ portion of the Firefly luciferase-coding sequence in both RNAs was 
generated (Fig. 52A), and the integrity of the reporter RNAs was tested in an RNase protection assay after re-
isolation from the transfected cells. The results showed that with both transfected reporter RNAs, fragments of 
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the expected length are detected (Fig. 52B), indicating that the 3´-region of the FLuc-encoding sequence was not 
degraded in both cases. Thus, the differences in translation efficiency are not due to differences in RNA stability. 
  
                               
A
5´-UTR 3´-UTRFLucc
T7
CMV Ub
reporter RNA  HCV+3´-UTR (wt)
reporter RNA  HCV+∆3´-UTR
antisense FLuc probe
B
probe
FLuc
GAPDH  
protected
GAPDH probe
FLuc GAPDH
-3´
-U
TR
+3
´-U
TR
-3´
-U
TR
+3
´-U
TR
 
 
Fig. 52: RNase protection assay. (A) Organization of the anti-sense FLuc RNA probe for the RNase ptotection 
assay. (B) RNA stability control. Cytoplasmic RNA from Huh-7 cells transfected with RNA "HCV - ∆3´-UTR" 
or RNA "HCV+3´-UTR" was harvested 4 hrs after transfection, purified and analyzed by RNase protection assay 
using [α-32P]-UTP labelled antisense FLuc RNA probe. As a control, glyceraldehyde-3-phosphate-
dehydrogenase (GAPDH) mRNA antisense RNA probe was used. CMV, Cytomegalovirus immediate early 
promoter; T7, T7 RNA polymerase promoter; UTR, untranslated region; C, partial core protein-encoding 
sequences; Ub, ubiquitin sequences; FLuc, Firefly luciferase reporter gene; wt, wild-type. 
 
 
To further rule out the possibility that the differences in FLuc expression are due to variations in transfection 
efficiency, the HCV reporter RNAs were co-transfected together with another reporter RNA construct containing 
the Renilla luciferase gene. For this purpose, Renilla luciferase reporter RNA was capped and polyadenylated to 
allow its efficient translation in eukaryotic cells. Fig. 53 shows how efficiently the processed Renilla luciferase 
RNA was expressed in Huh-7 cells compared with the expression level of unprocessed Renilla luciferase 
reporter RNA. 
Then, this modified Renilla luciferase reporter RNA was co-transfected together with the HCV reporter RNAs 
into Huh-7 cells in different amounts. Again, the HCV IRES-directed FLuc expression was much more efficient 
in the presence of the HCV 3´-UTR (Fig. 54A), while the co-transfected Renilla reporter RNA was expressed 
with similar efficiency in both cases (Fig. 54B). Moreover, the translation stimulation effect by the HCV 3´-UTR 
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was almost similar after transfection of different amounts of reporter RNA, ruling out any possible saturation 
effect in the assay. 
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Fig. 53: Comparison of expression levels of different types of Renilla luciferase RNA in Huh-7 cells. RLuc, 
Renilla luciferase reporter gene; unmodified RNA, RNA molecule transcribed directly from the corresponding 
template without modification; capped and polyadenylated RNA, transcribed RNA was processed by capping at 
the 5´-end and poly (A)-tailing at the 3´-end; empty, only assay tube. 
 
 
 
   
0
10
20
30
40
50
0.8/0 0.7/0.1 0.6/0.2 0.4/0.4
Fi
re
fly
Lu
c.
 a
ct
iv
ity
(x
10
00
)
RNA amount (µg FLuc/µg RLuc)
- 3´-UTR
+ 3´-UTR
HCV reporter RNA (Firefly luc)
A
0
50
100
150
200
250
0.8/0 0.7/0.1 0.6/0.2 0.4/0.4
R
en
ill
a
Lu
c.
 a
ct
iv
ity
(x
10
00
)
RNA amount (µg FLuc/µg RLuc)
- 3´-UTR
+ 3´-UTR
Co-transfected control RNA (Renilla luc)
B
 
 
Fig. 54: Co-transfection controls. HCV plus or minus 3´-UTR reporter RNAs (see Fig. 45) were co-transfected 
together with different amounts of Renilla luciferase RNA into Huh-7 cells. Cells were harvested 4 hrs after 
transfection. Firefly luciferase (A) and Renilla luciferase (B) activities were determined according to the 
manufacturer’s instructions. 
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3.3.6 Additional nucleotides at the 3´ end of 3´-UTR disable stimulation 
 
From the above results, it was concluded that three parameters have impact on the outcome of experiments 
testing the translation enhancement by the HCV 3´-UTR:  
(i) the nature of the 3´-end of the reporter construct plays a role since a PCR fragment providing an exact end of 
the 3´-UTR resulted in translation stimulation (Fig. 50B and C) whereas transfection of circular plasmid DNA 
did not (Fig. 49A and B); (ii) the nature of nucleic acid transfected is important since the translation stimulation 
by the 3´-UTR was more remarkably evident when RNA rather than DNA was used (Fig. 50C); (iii) the time 
course of measuring reporter gene activity reveals that the stimulatory action of the 3´-UTR is more evident at 
shorter times after transfection (Fig. 50B and C). 
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Fig. 55: Additional nucleotides at the 3´ terminal end impair translation enhancement by the 3´UTR. (A) 
Different RNAs with or without the HCV 3´-UTR followed by 321 nucleotides derived from the plasmid vector 
sequence, or ending exactly at the FLuc stop codon or the HCV 3´-UTR, respectively. T7, T7 promoter; UTR, 
untranslated region; C, partial core protein-encoding sequences; Ub, ubiquitin sequences; FLuc, Firefly 
luciferase reporter gene; 321 nts, additional sequences from plasmid vector. The columns and bars represent the 
means and standard deviations of at least three independent transfections, respectively. (B) Activities of Firefly 
luciferase (FLuc) in Huh-7 cell lysates harvested 4 hrs after transfection with the reporter RNAs shown in (A). 
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To further test if the efficient translation stimulation indeed requires a precise 3´ end of the HCV 3´-UTR, two 
additional reporter construct templates with artificially extended 3´-ends including 321 nucleotides of unrelated 
vector sequences were generated by PCR (Fig. 55A). When the corresponding RNAs with artificially extended 
3´-ends were compared with the RNA possessing an authentic end of the HCV 3´-UTR, only the RNA with an 
authentic 3´-UTR terminus gave rise to translation enhancement (Fig. 55B). This observation confirms that a 
precise 3´-end of the HCV 3´-UTR (corresponding to that of authentic viral RNA genome) is required for 
efficient translation enhancement. 
 
 
3.3.7 The HCV 3´-UTR enhances IRES-dependent translation preferentially in human  
liver-derived cell lines 
 
The above results demonstrated that the HCV 3´-UTR can remarkably enhance its IRES-mediated translation in 
a human liver cell-based translation system but not in a non-liver system such as rabbit reticulocyte lysate, 
consistent with the fact that HCV preferentially infects liver cells. Nevertheless, it has been reported that the 
HCV IRES is also active in non-liver-derived cells (Wang et al., 1993; Reynolds et al., 1995; Kamoshita et al., 
1997). Therefore, it was further analyzed whether this stimulatory effect of the 3´-UTR is only restricted to 
human hepatoma cells such as Huh-7 and Hep G2 cells, or whether also non-hepatoma cells such as HeLa and 
BHK cells allow translation stimulation by the 3´-UTR.  
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Fig. 56: Effects of the 3´-UTR of on HCV translation in different cell lines. Firefly luciferase (FLuc) 
activities were determined 4 hrs after transfection with HCV plus or minus 3´-UTR RNAs. The columns and 
bars represent the means and standard deviations of at least three independent experiments, respectively. The 
ratios shown above the columns represent the FLuc activitiy from the reporter RNA without 3´-UTR relative to 
the Fluc activity from the reporter RNA with 3´-UTR in different cell lines.  
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For this purpose, two reporter RNAs, HCV+∆3´-UTR and HCV+3´-UTR (see Fig. 45), were transfected into 
four different cell lines: Huh-7, Hep G2, HeLa and BHK cells, and Firefly luciferase activities were determined 
at different time points after transfection. The result shows that the differences in translation efficiency caused by 
the presence of the 3´-UTR is only two- to four-fold in BHK and HeLa cells but 17- to 25-fold in Hep G2 and 
Huh-7 cells (Fig. 56). These data indicate that the HCV 3´-UTR preferentially enhances HCV IRES-dependent 
translation in a cellular environment derived from human liver cells. 
 
 
3.3.8 Effects of deletions in the 3´-UTR on HCV IRES-mediated translation 
 
To identify the contribution of the three elements of the 3´-UTR, the variable region (VR), the poly (U/C)-tract 
and the 3´-X region with its three stem-loops, to translation stimulation, a series of deletion mutants in the 3´-
UTR sequence was generated (Fig. 57A). The FLuc activities expressed from the corresponding reporter RNAs 
after transfection into Huh-7 cells were measured over a time range of 2 to 12 hrs post-transfection (data not 
shown). Since no time specific differences were evident from these data (compare with Fig. 51), the values 
determined at 4 hrs after transfection are shown here (Fig. 57B). 
First, it was tested if efficient reporter translation requires additional sequences downstream of the luciferase 
gene stop codon. A random sequence of 15 nucleotides was added directly downstream of the luciferase stop 
codon (HCV+RD15, Fig. 57A). After transfection into Huh-7 cells, both RNAs, the HCV-∆3´-UTR RNA and 
the HCV+RD15 RNA, were translated with almost similar efficiencies (Fig. 57B), indicating that the luciferase 
gene can be correctly translated from the RNA ending exactly at the luciferase stop codon. 
Deletion of any of the three sequence elements of the HCV 3´-UTR, the variable region, the poly(U/C)-tract or 
the 3´-X region (RNAs HCV-∆3´VR, -UC and -X, respectively), had serious impact on translation efficiencies 
(which range from 7 % to 11 % of wild-type efficiency). Surprisingly, a combination deletion of the variable 
region and the pyrimidine tract (HCV-∆3´VUC RNA) resulted in more efficient translation compared with the 
single deletions. From these observations, we can only speculate that these sequences might bear not only 
determinants that enhance translation but also determinants that negatively regulate translation. This idea is 
supported by the finding that a combination deletion of the poly(U/C)-tract and the 3´-X region (HCV-∆3´-UCX 
RNA) also translated slightly more efficiently than the corresponding single deletions. Since the stem-loops 
within the 3´-X region appear to contribute positively to translation efficiency (see below), we assume that such 
negatively regulating determinants may be confined to the sequences upstream of the X-region. 
When the three predicted stem-loop structures of the 3´-X region were deleted (Fig. 57A), analysis of these 
RNAs revealed that the involvement of these stem-loops in translation stimulation gradually decreases from 3´ to 
5´ (Fig. 57B). Deletion of SL1 allowed only 30 % residual translation activity, whereas deletion of SL2 resulted 
in 53 % and deletion of SL3 even in 86 % activity. 
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Fig. 57: Effects of deletion mutants within the 3´-UTR on translation efficiency of the HCV RNA. (A) The 
HCV 3´-UTR and its deletion mutants. The general structure of the reporter construct is shown at the bottom, 
with the 3´-UTR deletion mutant RNAs and the predicted RNA stem-loop structures of the 3´-X on the top. The 
HCV 3´-UTR was fused exactly to the luciferase coding sequence. HCV + RD15 includes an artificial sequence 
of 15 random nucleotides (open bar) immediately downstream of the Firefly luciferase (FLuc) coding sequence. 
SL, stem-loop; wt, wild-type. The Fluc antisense probe used for the RNA stability control (Fig. 58) is shown at 
the bottom. (B) Firefly luciferase (FLuc) activities expressed in Huh-7 cells were measured 4 hrs after 
transfection with all deletion mutants introduced within the HCV 3´-UTR RNAs. Relative Firefly luciferase 
(Rel. FLuc) activities are indicated on the right side of each horizontal column. The FLuc activitiy of HCV+3´-
UTR (wt) is artificially set to 100 %. The columns and bars represent the means and standard deviations of two 
independent experiments.  
 
 
With combination deletions of the three stem-loops of the 3´-X region an interesting result was obtained. When 
SL1 was deleted in combination with SL2, the translation efficiency was 18 %. This value is close to the product 
of the translation efficiencies of both single elements (0.30 × 0.53 = 0.16). Similarly, deletion of SL1 together 
with SL3 resulted in 23 % activity which is again close to the product of translation efficiencies of both single 
elements (0.30 × 0.86 = 0.26). These results suggest that the combination of stem-loop 1 together with the other 
stem-loops contribute to translation stimulation synergistically. With a combination deletion of SL2 and SL3, the 
translation efficiency was 65 %, which is only roughly in the range of the product of translation efficiency of 
both single elements (0.86 × 0.53 = 0.46). 
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According to the different deletions, the predicted secondary structures of the 3´-ends are different among the 
different RNA variants used in the experiments described above. Only some of these reporter RNAs have very 
stable RNA secondary structures at the 3´-end which may protect the different RNAs from degradation by 
exonucleases after transfection. 
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Fig. 58: RNA stability control. Cytoplasmic RNA from Huh-7 cells transfected with the RNAs used in Fig. 
57B was harvested 4 hrs after transfection, purified and analyzed by ribonuclease protection assay using the [α-
32P]-UTP labelled antisense FLuc RNA probe (see Figs. 57A and 52B). As a control, the same cytoplasmic RNA 
samples were also analyzed using a glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) mRNA antisense 
RNA probe (lower panel). In lanes 1 and 16, 5% of the undigested antisense RNA probes were loaded. 
 
 
To rule out the possibility that the differences in translation efficiency are due to differences in RNA stability, 
we tested the integrity of the 3´-portion of the Firefly luciferase-coding sequence by RNase protection assay 
(Fig. 22). The result show that all transfected reporter RNAs appear with the expected length (note: the anti-
sense probe includes also 29 nucleotides of 3´-UTR sequence) and with similar signal intensity, indicating that 
differences in RNA stability do not account for the differences in translation efficiency. 
 
 
3.3.9 Conclusions 
 
The HCV 3´-UTR stimulates translation of a reporter RNA with the HCV IRES at the 5´-end in human 
hepatoma cell lines. This stimulation requires an exact 3´-end of the 3´-UTR, as well as the use of a 
monocistronic reporter RNA and activity measurement at short times after transfection. 
The variable region, the poly(U/UC)-tract and the 3´-terminal stem-loop 1 of the 3´-X region contribute 
significantly to the translation enhancement, whereas the stem-loops 2 and 3 of the 3´-X region are less 
important for this effect. 
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3.4 Part IV: An unknown protein of about 210 kDa binds to the HCV 
RNA only in the presence of both 5´-UTR and 3´-UTR 
 
In the previous experiments of this work, no new binding protein was detected by the UV cross-linking assay to 
interact with the HCV IRES RNA molecules irrespective if the 3´-UTR is present or not. Some extra protein 
bands were observed only when the HCV 3´-UTR RNA is included, but these bands were found to interact with 
the 3´-UTR alone as well (Figs. 16, 18 and 19). Also, some proteins interacting only with HCV IRES deletion 
mutants or detected more evidently with the deletion mutants than with the HCV wild-type IRES were observed 
(Fig. 12). Taken the above results together, the presence of the HCV 3´-UTR obviously did not augment the 
binding of protein(s) to the HCV IRES. 
However, this conclusion seems to be inconsistent with the fact that the 3´-UTR of HCV is not only responsible 
for the replication of viral RNA, but is also involved in the stimulation of IRES-directed translation as shown in 
the third part of the Results section. From the finding that the 3´-UTR stimulates translation, it must be assumed 
that some factor(s) are involved in an RNA 5´-3´-end interaction so that the translation initiation could be 
positively regulated by the 3´-UTR. Moreover, the translation stimulation by the HCV 3´-UTR has been reported 
by other groups (Ito et al., 1998; Michel et al., 2001; McCaffrey et al., 2002), although the degree of stimulation 
is much lower in those studies than that observed in this work. These arguments gave rise to a reconsideration of 
the experimental design of the HCV RNA constructs used for the search for new proteins, finally resulting in the 
discovery of a novel yet unknown protein that binds to the HCV RNA. 
 
 
3.4.1   Redesigning the HCV RNA constructs used for the protein search 
 
Take into account the above considerations, two inconsistent features were realized in the design of the HCV 
RNAs used before in the UV cross-linking experiments. The plasmid used for the transfection studies, HCV+3´-
UTR (wt), has an in-frame Firefly luciferase reporter gene sequence between 5´- and 3´-UTR (Fig. 23), whereas 
the HCV IRES plus 3´-UTR plasmid used for the UV cross-linking assays, subcloned from the above plasmid by 
deleting the ubiquitin sequences and the Firefly luciferase-coding sequence from the HCV+3´-UTR wt plasmid, 
has an artificial stretch of sequence between 5´- and 3´-UTR which does not constitute a functional open reading 
frame (ORF), even if short, but was out-of-frame (due to the restriction sites used for the deletion) (Fig. 14). 
Another feature is the 3´-end of the 3´-UTR. The former out-of-frame HCV IRES plus 3´-UTR RNA generated 
from the corresponding plasmid did not have a precise 3´-end (Fig. 14). It could be assumed that always no 
difference was observed in the previous UV cross-linking assays with both HCV IRES only RNA and HCV 
IRES plus 3´-UTR RNA (Figs. 15-19) just because of two different reasons: either that additional nucleotides 
downstream of the 3´-UTR may influence the protein binding to the authentic 3´-UTR sequences, or the 
ribosomes would not correctly terminate at the authentic stop codon but translate through the variable region and 
disable protein binding. 
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In order to allow a decision  between these two hypotheses, a new plasmid with an artificial in-frame sequence 
(96 nucleotides) between the HCV 5´- and 3´-UTR was generated from the HCV + 3´-UTR (wt) construct (Fig. 
14A) by double-digestion with Aat II and Eco NI followed by treatment with Klenow fragment and religation. 
From this plasmid, a PCR fragment with a precise 3´-terminus of the 3´-UTR was generated from which the 
RNA was then transcribed. Thus, this in-frame RNA also has an exact 3´-end. In contrast, the formerly 
constructed out-of-frame plasmid was made as described in the first part of the Results section (3.1.3), resulting 
in four additional nucleotides added into the artificial linker between the 5´- and the 3´-UTR due to two 
subsequent cloning steps including fill-in and removal processes. Therefore, the total number of nucleotides 
between the 5´- and the 3´-UTR was changed to 100. Fig. 59 shows the difference between the in-frame and out-
of-frame HCV RNA constructs. 
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Fig. 59: Schematic diagram of the in-frame and out-of-frame HCV RNA constructs. The very upstream part 
of the core protein-encoding sequences is present in all HCV RNA constructs. Bam HI was used for generating 
the "HCV 3´-UTR only" RNA template and out-of-frame RNA plus 3´-UTR RNA templates, respectively. Aat II 
and Eco NI were used for generating the in-frame HCV IRES plus 3´-UTR clone vector. The in-frame RNAs 
were all transcribed from the corresponding PCR fragments (indicated with thin lines). T7, T7 RNA polymerase 
promoter; UTR, untranslated region; C, partial core protein-encoding sequences; Ub, ubiquitin sequences; FLuc, 
Firefly luciferase reporter gene. The solid thick lines represent the HCV RNA molecules and the horizontal 
dotted lines represent the parts deleted from the original plasmid. The small white box in the out-of-frame RNA 
construct represents the four additional nucleotides demolishing the open-reading-frame. 
 
 
3.4.2 Detection of an unknown protein binding to the HCV RNA with a precise end of 
the 3´-UTR 
 
Then, two [α-32P]-UTP labelled in-frame RNAs (Fig. 59) were in vitro-transcribed from the corresponding PCR-
generated templates. Using these two new RNAs, UV cross-linking assays were performed in Huh-7 extract, 
together with the two RNAs used before (compare Fig. 14). Surprisingly, a clearly visible protein band appears 
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at about 210 kDa in the lane with the in-frame HCV IRES plus 3´UTR RNA (Fig. 60, lane 2), whereas no band 
is observed at the corresponding position in any other lane, in particular also not in the lane with the out-of-
frame RNA (Fig. 60, lane 1). 
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Fig. 60: Interaction of proteins from Huh-7 lysate with HCV RNAs analyzed by the UV cross-linking 
assay. Four HCV RNAs (see Figs. 14 and 59) were used in 10 µl UV cross-linking reactions including 3 µl 
cytoplasmic Huh-7 lysate. Proteins were separated on 8 % SDS-PAGE and visualized by autoradiography. The 
molecular masses of 14C labelled proteins marker (M) are given in kDa. An unknown new protein band is 
indicated with an arrow and a question mark on the right side of the gel. 
 
 
In order to further allow a decision whether the exact 3´-end or reading frame is the decisive parameter for 
binding of the 210 kDa protein, the out-of-frame HCV IRES plus 3´-UTR RNA was in vitro transcribed from the 
PCR-generated template with the exact end of the 3´-UTR (Fig. 61A). UV cross-linking assays were performed 
in Huh-7 cytoplasmic extract using this [α-32P]-UTP labelled RNA together with another RNA shown in Fig. 
61A. Unexpectedly, this about 210 kDa protein band appears in both lanes with the HCV RNAs containing an 
exact end of the 3´-UTR (Fig. 61B, lanes 2 and 3), whereas no band is observed at the corresponding position in 
the lane of HCV RNA with an artificial extension of the 3´-UTR due to the linearization of the template by 
restriction enzyme (Fig. 61B, lane 1). Thus, the existence of a correct 3´-UTR appears to be required for the 
binding of this 210 kDa protein, irrespective if the sequence between IRES and 3´-UTR is an open-reading-
frame or not (Fig. 61B, lanes 2 and 3). No other study has ever reported about a protein of about 210 kDa 
interacting with the HCV RNA so far. In addition, the eIF3 subunits - p170, p116 and p110 - seem to serve as an 
internal control for the protein-binding assay. Interestingly, the other two proteins migrating by far more slowly 
than 220 kDa were also observed to bind to the RNAs with an exact end of the 3´-UTR (Fig. 61B, lanes 2 and 3). 
However, their binding will need further confirmation. 
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Fig. 61: A precise end of the 3´-UTR is important for the detection of the 210 kDa protein in the UV cross-
linking assay. (A) Schematic diagram of the HCV RNAs with or without precise end of the 3´-UTR. The very 
upstream part of the core protein-encoding sequences is present in all HCV RNA constructs. Bam HI was used 
for generating the HCV RNA template without an authentic 3´-UTR. The RNAs with an exact end of the 3´-
UTR were all transcribed from the corresponding PCR fragments (indicated with thin lines). T7, T7 RNA 
polymerase promoter; UTR, untranslated region; C, partial core protein-encoding sequences; Ub, ubiquitin 
sequences; FLuc, Firefly luciferase reporter gene. The solid thick lines represent the HCV RNA molecules and 
the horizontal dotted lines represent the parts deleted from the original plasmid. The small white box in the out-
of-frame RNA construct represents four additional nucleotides demolishing open-reading-frame. (B) Three HCV 
RNAs shown in (A) were used in 10 µl UV cross-linking reactions including 3 µl Huh-7 lysate, respectively. 
Proteins were separated on 6 % SDS-PAGE and visualized by autoradiography. The molecular masses of 14C 
labelled proteins marker (M) are given in kDa and the positions of the subunits of eIF3 (p170, p116 and p110) 
are indicated. An unknown new protein band is indicated with an arrow on the right side of the gel, as well as 
two additional bands of more than 220 kDa with dotted arrows. 
 
 
Since the position of this new unknown protein binding to the in-frame HCV RNA is about 210 kDa, it could 
have been possible that the new protein detected is identical to eukaryotic initiation factor 4G (eIF4G) which 
binds to the foot-and-mouth disease virus (FMDV) IRES. eIF4G may act as a multipurpose adaptor connecting 
the RNA with the ribosome (Hentze, 1997). For example, eIF4G can provide a scaffold for the interaction of 
eIF4F complexes with poly(A) binding protein (PABP) on most eukaryotic cellular mRNAs during the process 
of translation initiation (Tarun & Sachs, 1996), and eIF4G has been described to bind to the subdomain 4 of the 
FMDV IRES initiating cap-independent translation (Saleh et al., 2001). 
In order to rule out that this new protein is identical with eIF4G, two kinds of FMDV RNAs, FMDV IRES wild 
type (wt) and 4M mutant (Bassili et al., 2004) RNA were included in the next UV cross-linking assay. Binding 
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of eIF4G to FMDV IRES can be abolished by one of the mutants of the FMDV IRES, called FMDV 4M, which 
was subcloned in our lab (Bassili et al., 2004). In addition, due to the size of this unknown protein, a low 
percentage acrylamide gel was used in the experiment. 
The results show that this protein is most probably not eIF4G since eIF4G interacting with the FMDV wt RNA, 
although faint in RRL (arrow in Fig. 62, lane 2), migrates faster than the new protein binding to the HCV IRES 
plus 3´-UTR RNA (Fig. 62, lanes 2 and 3). 
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Fig. 62: Interaction of proteins from both RRL and Huh-7 lysate with HCV RNAs analyzed by the UV 
cross-linking assay. Assays were performed using three HCV RNAs (Fig. 60) in both RRL and Huh-7 lysate. 
Proteins were separated on 6 % SDS-PAGE and visualized by autoradiography. FMDV, foot-and-mouth disease 
virus; wt, wild-type; 4M, a mutant of the FMDV IRES which abolishes the binding of eIF4G to the FMDV IRES 
(Bassili et al., 2004). eIF4G binding to the FMDV wt IRES is indicated with a small arrow (lane 2). The 
molecular masses of 14C labelled proteins marker (M) are given in kDa and the positions of the subunits of eIF3 
(p170, p116/110) are indicated. The unknown new protein band is indicated with an arrow on the right side of 
the gel. 
 
 
Moreover, this unknown protein could be cross-linked to the HCV IRES plus an exact end of the 3´-UTR RNA 
in both RRL and Huh-7 cell lysate. Obviously, it does not bind to the other two types of HCV RNA - HCV IRES 
only and HCV IRES plus a non-authentic 3´-UTR RNA - in both RRL and Huh-7 lysate (Fig. 62, lanes 4-7). 
This observation clearly indicates that the unknown protein can interact with the HCV RNA only when the RNA 
has an exact 3´-end of the 3´-UTR. The reason why negative results were always obtained in all previous 
experiments of the protein search may be also partially explained by this idea. 
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3.4.3   The unknown protein interacts with the variable region of the HCV 3´-UTR  
 
The fact that this unknown protein only binds to the RNA containing the IRES plus the authentic 3´-UTR raises 
the question whether there is a synergistic interaction between the HCV 5´- and 3´-UTR in the presence of this 
protein during the translation initiation. In order to examine this promising hypothesis, a series of experiments 
must be considered. The first step is to find out which part in the 3´-UTR region is providing the binding site of 
this protein. For this purpose, a series of plasmids that meets the demands of the aspect mentioned above was 
cloned. 
First of all, to identify how the three elements of the 3´-UTR, the variable region (VR), the poly (U/C)-tract and 
the 3´ X-region, individually or in concert, affect the binding of this unknown protein, a series of deletion 
mutants in the 3´-UTR sequence was generated in the short in-frame construct (96-nucleotide ORF). These 
mutants included individual deletions of any of the three sequence elements of the HCV 3´-UTR, the variable 
region, the poly(U/C)-tract or the 3´ X-region (RNAs HCV-∆VR, -∆UC and -∆X, respectively), as well as 
combination deletions of these elements (Fig. 63). 
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Fig. 63: Schematic diagram of the HCV RNA construct and its deletion mutants. The HCV IRES plus 3´-
UTR plasmid was modified from that shown in Fig. 59. The PCR fragment is indicated with a line. The arrow 
line represents the final HCV RNA molecule. T7, T7 RNA polymerase promoter; Py, polypyrimidine-rich tract; 
UTR, untranslated region; SL, stem-loop.  
 
 
From these HCV deletion mutant constructs as shown in Fig. 63, the templates for in vitro-transcription of the 
HCV RNAs were generated by PCR to obtain the corresponding [α-32P]-UTP labelled transcripts with precise 
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3´-ends. These RNAs were subsequently used in UV cross-linking assays with Huh-7 cytoplasmic lysate. The 
result shows that the 210 kDa protein appears to bind not only to the HCV IRES plus an authentic 3´-UTR RNA 
but also to some deletion mutants of the HCV 3´-UTR (Fig. 64). However, the binding of this protein appeared 
not to be easy to understand. For example, the binding signal vanished in the absence of 3´ X-region (Fig. 64, 
lane 8), whereas it was still there when the poly-(U/C) stretch of the 3´-UTR was deleted (Fig. 64, lane 7). 
Interestingly, the 210 kDa protein signal also vanished but another new protein which is migrating slightly 
slowlier than the protein of interest appeared in the absence of the variable region (Fig. 64, lane 6). Based on the 
above observations, the variable region plus the 3´-X region of 3´-UTR should be responsible for the binding of 
this protein. However, the protein was again detected even stronger in the absence of both 3´-X and poly-(U/C) 
stretch (Fig. 64, lane 11). In contrast, the ∆VRX-mutant also appears to bind the protein (Fig. 64, lane 10), an 
observation which is completely inconsistent with the results obtained with the other RNAs. 
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Fig. 64: Effects of deletions within the HCV RNAs containing exact 3´-ends on the binding of the unknown 
210 kDa protein in Huh-7 lysate. Proteins were separated on a 6 % SDS-PAGE gel after UV cross-linking with 
HCV and FMDV RNAs and visualized by autoradiography. The HCV RNA molecules were in vitro transcribed 
from the templates shown in Fig. 63. The unknown new protein band is marked with a horizontal arrow on the 
right side of the gel. Other new proteins binding to the mutants are indicated with slanted arrows in the gel. 
FMDV, foot-and-mouth disease virus; wt, wild-type; 4M, one of the mutants of FMDV IRES which can abolish 
the binding of eIF4G to the FMDV IRES (Bassili et al., 2004). The molecular masses of 14C labelled proteins 
marker (M) are given in kDa and the positions of the subunits of eIF3 (p170, p116 and p110) are indicated on the 
right side of the gel. 
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In addition, the positions of the new proteins migrating in different lanes showed small differences so that it was 
hard to judge what the actual reason for the conflicting observations was. In order to further analyze the 
protein(s) in question and to possibly resolve the observed discrepancy, some mutants were selected (∆VR, 
∆VRX, ∆UC, ∆UCX), a new order of the samples was arranged on the gel, and the gels were run extremely long 
to allow a maximal separation of the proteins to possibly identify differences in their migration (Fig. 65). 
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Fig. 65: Effects of deletions within the in-frame HCV RNAs on the binding of the unknown protein 
analyzed by the UV cross-linking assay in both RRL (A) and Huh-7 lysate (B). The HCV RNA molecules 
were in vitro-transcribed from the templates shown in Fig. 63. The unknown novel protein band of interest is 
indicated with arrow c. Three other proteins are marked with arrow d (largest protein) and e (larger protein) 
and f (smaller protein). Proteins were separated on a 6 % SDS-PAGE gel and visualized by autoradiography. 
auth. 3´-UTR, authentic end of the 3´-UTR. The molecular masses of 14C labelled proteins marker (M) are given 
in kDa and the position of the p170 subunit of eIF3 is indicated on the right side of the gels. 
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The results with the high resolution gel shown in Fig. 65 indicate that the proteins binding to the ∆UCX and 
∆UC mutants are all below 220 kDa, and their migrating positions are exactly the same as that of the target 
protein binding to the HCV wild-type RNA (band c in Fig. 65). Additionally, two other proteins interacting 
with two different HCV mutants but not with the wild-type RNA are also found. One protein binding to the ∆VR 
mutant RNA is obviously larger than 220 kDa (band e in Fig. 65), whereas the other protein binding to the 
∆VRX mutant RNA (band f in Fig. 65) is migrating only very slightly faster than the unknown protein bound 
to the HCV wild-type RNA (band c in Fig. 65). Thus, the 210 kDa protein binds to the variable region of the 
3´-UTR. This protein can be always detected in both RRL and Huh-7 lysate (Figs. 62 and 65), indicating that 
RRL (which is available in large amounts) can be used in purification steps towards identification of this protein. 
Moreover, another protein which migrates even much more slowly than 220 kDa appears with the wild-type 3´-
UTR (Fig. 65, band d). This protein does not appear with any of the deletion mutant RNAs, indicating that it 
may be involved, in addition to the new 210 kDa protein, in a protein complex that binds to the HCV 3´-UTR 
only when the 3´-end of the viral RNA is authentic (reference to Figs. 61, 64 and 65). 
It is still unclear how these new proteins bind to the HCV IRES plus 3´-UTR RNA. Deletion mutants introduced 
into the HCV 5´-UTR and a series of 5´-UTR deletions in combination with the 3´-UTR or its mutants can be 
subsequently used to further answer the following questions:  
(1) Is also the 5´-UTR involved in binding of these proteins?  
(2) Are these proteins involved in the translation activity mediated by the HCV IRES? 
(3) Are these proteins possibly involved in a switch between HCV translation and viral RNA replication? 
(4) Are these proteins specific to cell types that share common biochemical features with human liver cells, e.g., 
also fast growing cells like rapidly dividing reticulocytes; in other words, are these proteins possibly involved in 
the regulation of lipid metabolism which is required for membrane lipid synthesis in liver cells as well as in 
quickly growing cells? 
 
 
3.4.4   Conclusions 
 
A protein of about 210 kDa as well as another high molecular mass protein apparently binds to the 3´-UTR of 
HCV. Binding of the 210 kDa protein requires the variable region of the 3´-UTR as well as a precise end of the 
3´-UTR. In addition, binding of these proteins can be detected with Huh-7 hepatoma cell extract as well as with 
rabbit reticulocyte lysate. 
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4   Discussion 
 
In this study, the role of the 5´- and 3´-untranslated region of the RNA genome of Hepatitis C Virus on HCV 
translation as well as the interaction of cellular RNA-binding proteins with the viral RNA were investigated. 
In the first part of the discussion, the interaction of some selected well-known RNA-binding proteins with the 
HCV IRES and the 3´-UTR as well as the search for new proteins binding to the IRES is discussed. In the 
second part, the functional role of the HCV 3´-UTR in translation stimulation is discussed in comparison with 
several other conflicting reports. Finally, the discovery of a novel, yet unknown protein binding to the HCV 3´-
UTR and its possible involvement in the HCV life cycle is discussed. 
 
 
4.1   Interaction of cellular proteins with the HCV RNA untranslated  
        regions and their effects 
 
Since Hepatitis C Virus was discovered in the late 1980s, many studies have focused on mapping structural 
elements which can function as target sites for RNA-protein interactions. Several kinds of trans-acting cellular 
factors which interact with the HCV IRES, core protein sequences or the 3´-UTR and which possibly affect 
IRES-mediated translation activity have already been found up to now. As detailed in the introduction, these 
factors include the 52 kDa human La autoantigen,  the 57 kDa polypyrimidine tract-binding protein (PTB), some 
ribosomal proteins, poly(rC)-binding proteins 1 and 2 (PCBPs), heterogeneous nuclear ribonucleoprotein L 
(hnRNP L), eukaryotic translation initiation factor eIF3 and NS1-associated protein 1 (NSAP1). Among these 
factors, the interaction of PTB with the HCV IRES and the exact role of it in HCV IRES-mediated translation 
are controversial, whereas hnRNP L had been previously reported to interact only with sequences at the 
beginning of the HCV polyprotein, not with the end of the viral genome, while the interaction of Unr with HCV 
RNA had not yet been investigated at all. 
 
4.1.1 PTB 
 
For the picornaviruses, it has been clearly reported that PTB binds to the internal ribosome entry site in several  
viruses, such as poliovirus (PV) (Hellen et al., 1993; Hellen et al., 1994), human rhinovirus (HRV) (Borman et 
al., 1993), encephalomyocarditis virus (EMCV) (Borovjagin et al., 1994), foot-and-mouth disease virus (FMDV) 
(Niepmann, 1996) and hepatitis A virus (HAV) (Chang et al., 1993), and is involved in the cap-independent 
protein translation facilitated by the IRES elements. 
In this study, the possible binding of PTB to the HCV RNA, either the 5´-UTR or the 3´-UTR alone, or the two 
regions in combination has been investigated. The results presented here show that PTB does not bind to the 
HCV 5´-UTR region, and is also not functionally required for internal initiation of translation when the IRES is 
used in the absence of the 3´-UTR. 
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A conserved feature found in all 5´-UTRs of picornavirus RNAs is the presence of a pyrimidine tract followed 
by an AUG triplet, the so-called Yn-Xm-AUG motif (Beck et al., 1983; Wimmer & Nomoto, 1993). Extensive 
studies on the pyrimidine tract by deletions and point mutations have demonstrated that this motif is essential for 
picornavirus IRES function, and the pyrimidine tract must be properly spaced from the AUG triplet for maximal 
efficiency of translation (Jang & Wimmer, 1990; Kühn et al., 1990; Meerovitch et al., 1991; Pilipenko et al., 
1992). As mentioned before, the HCV 5´-UTR contains three independent pyrimidine-rich motifs (see Fig. 66B): 
site I is located from nucleotide (nt) 40 to 46 (Py-I); site II includes a helical structure encompassing nt 120 to 
130 (base-paired partially with nt 318 and 323 located in the vicinity of initiator AUG) (Py-II), and site III 
resides in nt 191 to 199 in the apical loop of the biggest domain III (Py-III). Additional features around all three 
polypyrimidine-rich tracts include a stem-loop and a single-stranded region followed by a second stem-loop. 
However, their exact structural and sequence features do not match the requirements which were found for PTB 
binding with the EMCV IRES (Witherell et al., 1993; Kolupaeva et al., 1996). Witherell and co-workers 
suggested, on the basis of their detailed examination of the sites for PTB binding, that a common feature for 
strong PTB binding includes a helix–ss(single-stranded) RNA–helix motif which contains small U-rich single-
stranded bulges or loops linking two helices (Witherell et al., 1993; Witherell & Wimmer, 1994). In the HCV 
IRES, however, these structural requirements are not fulfilled, a reason why PTB does not bind to the HCV 
IRES. In contrast, the oligopyrimidine tracts in the HCV IRES have other functions. 
Functional studies have shown that deletion of the Py-I may strikingly reduce the functional activity of the HCV 
IRES (Wang et al., 1993), and an anti-sense oligonucleotide directly against the Py-I sequence blocked HCV 
RNA translation (Wakita & Wands, 1994). These observations support the functional importance of this 5´ 
upstream region. In fact, this region has been later verified as the exact 5´-border of the HCV IRES (Honda et 
al., 1999). The second pyrimidine tract (Py-II) contains a highly-ordered secondary and tertiary structure. Further 
biochemical and genetic analysis supports evidence for a pseudoknot structure in this region. Disruption of this 
helical interaction resulted in a dramatic reduction in translation initiation. Compensatory mutants maintaining 
the base substitutions in this pyrimidine tract and restoring the helical structure regained efficient translation 
(Wang et al., 1995a), arguing for a more structural role of this sequence. The third pyrimidine-rich motif, Py-III, 
located in the apical loop of the largest domain III, is somehow characteristic of the pyrimidine-rich sequence 
motif Yn-Xm-AUG. However, this feature did not coincide with binding of PTB to the HCV IRES in this work, 
which is consistent with some other observations (Kaminski et al., 1995; Ito & Lai, 1999), but opposite to 
another report (Ali & Siddiqui, 1995). Accordingly, mutations in this Py-III tract and the relevant downstream 
AUG do not result in a decrease in translation efficiency (Wang et al., 1994). Most likely, the apical loop of the 
stem-loop III is involved in binding of eIF3 and thus is not available for binding of PTB. 
Fig. 66 is an attempt to explain as far as possible why PTB does not bind to the HCV IRES even though there are 
three pyrimidine-rich motifs within the HCV 5´-UTR. According to the structure of the sequence-specific RNA-
binding domains III and IV of PTB (Yuan et al., 2002), the ideal structure of the RNA to be bound should 
contain a small apical loop rather than a larger, more flexible structure (Nagai et al., 1995a; Nagai et al., 1995b). 
The typical motif for PTB-binding is UCUU located in the apical loop of the RNA secondary structure, like in 
the stem-loops 2 and 4 of FMDV (Fig. 66D) and in the stem-loop 3 within the HCV 3´-UTR (Fig. 66C). These 
three stem-loops all have a small loop: the number of bases is ≤ 7. Moreover, the base Uracil is predominant in 
these loops. In contrast, the three polypyrimidine-tracts in the HCV 5´-UTR do not meet these structural 
requirements. In Py-I and Py-II, the sequences are too long single-stranded regions, and they contain too many 
Cytosines. Py-III has a typical UCUU sequence in single-strand apical loop (Fig. 66B), but the loop is too large 
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compared with the other PTB-binding loops of both the FMDV and the 3´-UTR. Presumably, a tight small loop 
structure is required for the accurate recognition by PTB so that the loop of the RRM domain (Fig. 66A) can 
properly protrude into the RNA loop, facilitating recognition of bases in the loop by the conserved 
ribonucleoprotein (RNP) motif amino acid residues in the four- or five-strand β-barrel surface of the RRM 
domains (Nagai et al., 1995a; Nagai et al., 1995b). 
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Fig. 66: Proposed structural requirements for the binding of PTB to the viral RNAs. (A) The structure of 
the PTB domains III and IV (Yuan et al., 2002). The conserved ribonucleoprotein (RNP) β-strand motifs and α-
helices are coloured purple and light green, respectively. The loops between the two middle β-strand sheets are 
supposed to hook into the apical loop of the RNA. (B) The locations of the three pyrimidine-tracts within the 
HCV 5´-UTR. (C) The binding sites for PTB in the HCV 3´-UTR. (D) The binding sites for PTB within the 
FMDV IRES. 
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Although two reports on interaction of PTB with the HCV IRES have produced positive results by either UV 
cross-linking assay (Ali & Siddiqui, 1995) or electron microscopy with gold-labelled PTB (Beales et al., 2001), 
several attempts in this work to show binding of PTB to the HCV IRES in different lysates failed, even though 
various deletion mutants of the 5´-UTR were used (Fig. 12). Initially it was suspected that the failure of detection 
of PTB binding to the HCV IRES might be just due to a failure in label transfer from RNA to protein. However, 
negative results were still obtained when different radioactive nucleotides were used for labelling the HCV IRES 
RNA (Figs. 15 and 16). Thus, it can be concluded that PTB does not directly interact with the HCV IRES of the 
genotype 1b used in this study. 
In addition, potential PTB binding sites have been discovered in the HCV core gene (Ito & Lai, 1999), in the 
poly (U/C) stretch of the 3´-UTR (Luo, 1999), and in the stem-loops 2 and 3 within the 3´ X-region (Ito & Lai, 
1997; Tsuchihara et al., 1997). Among these, the region located in the 3´-end of the core-encoding sequence was 
found to down-regulate HCV translation by PTB binding (Ito & Lai, 1999). Several conflicting studies 
demonstrated either stimulating (Ali & Siddiqui, 1995; Anwar et al., 2000; Gosert et al., 2000) or inhibitory 
(Murakami et al., 2001; Tischendorf, 2004) effects of PTB on HCV IRES-dependent translation in vitro or in 
vivo, leaving a possible role of PTB in HCV IRES-dependent translation still controversial. In this work, PTB 
has been unambiguously shown to bind specifically to the HCV 3´-UTR by the RNA gel shift assay and by the 
UV cross-linking assay, and in another Ph.D. thesis work in our lab, it was shown that PTB stimulates HCV 
translation in the presence of the 3´-UTR (E. Tzima, Ph.D. thesis, 2005, Giessen University).  
 
4.1.2 hnRNP L protein 
 
In 1989, an unusual heterogeneous nuclear ribonucleoprotein, named L (hnRNP L), was found (Pinol Roma et 
al., 1989). UV cross-linking assays in intact HeLa cells showed that hnRNP L is an hnRNA-binding protein. It 
was shown that hnRNP L binds a cis-acting RNA sequence in the pre-mRNA derived from the herpes simplex 
virus thymidine kinase (HSV-TK) gene, and this RNA-protein interaction enabled proper RNA processing and 
accumulation of intron-independent pre-mRNAs (Liu & Mertz, 1995). Later, two cytoplasmic functions of 
hnRNP L were characterized. One study found that hnRNP L binds to the 3´ border region of the HCV IRES, 
and the binding of hnRNP L to HCV IRES might correlate with the translational efficiency of the HCV RNAs 
(Hahm et al., 1998b). A stretch of HCV core protein-encoding sequence of at least 33 nucleotides is required for 
efficient binding of hnRNP L and perhaps for translation activity (Hahm et al., 1998b), consistent with the 
observation that the 3´ boundary of the HCV IRES reaches into the core protein-encoding region (Reynolds et al., 
1995). These additional sequences contain many CA-repeat sequences which have been shown to be specific 
binding sites for hnRNP L (Hui et al., 2003). However, no direct evidence had been further provided for a 
possible role of hnRNP L in HCV translation. 
In another study, hnRNP L was shown to interact with PTB, an interaction which can be speculated to play a 
functional role in pre-mRNA splicing and mRNA transport (Hahm et al., 1998a). The interaction of PTB with 
hnRNP L was first identified by yeast-two-hybrid screening and then confirmed by biological methods. The 
binding of PTB to hnRNP L was found to be a direct protein-protein interaction in the yeast cell, and the N-
terminal half of PTB (Amino Acid 1-329, domain I-II) and most of the hnRNP L protein (AA 141-558, domain 
II-IV) are involved in the interaction between PTB and hnRNP L (Hahm et al., 1998a). This result implicates 
that the domain I and II of PTB should be mainly responsible for this protein-protein interaction. 
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In this work, hnRNP L was found to interact with the HCV IRES but not with the 3´-UTR by RNA gel shifts and 
UV cross-linking assays (Figs. 30 and 32). At the same time, it was confirmed that hnRNP L is not localized in 
the cytoplasm but mainly in the nucleoplasm (Fig. 31), rendering cytoplasmic cell extracts suitable for 
supplementation with recombinant hnRNP L to yield a functional reconstitution system.  
Furthermore, it was found that binding of PTB to the HCV IRES plus 3´-UTR RNA or to the 3´-UTR RNA was 
enhanced by the presence of hnRNP L (Fig. 38), and increasing amounts of hnRNP L resulted in a further 
increase in PTB binding. Surprisingly, the HCV 3´-UTR, which is supposed to contain no binding site for 
hnRNP L alone, was also clearly shown to be bound by hnRNP L in the presence of PTB (Fig. 38, lanes 10-12). 
Correspondingly, a similar effect was also observed with the HCV IRES only RNA. Only in the presence of 
hnRNP L, PTB binds to the IRES (Fig. 38, lanes 2-4). These results imply that there is a synergistic interaction 
of PTB and hnRNP L with the HCV RNA when both proteins are present. 
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Fig. 67: Hypothetical model of interaction of hnRNP L with PTB in binding to the HCV combination RNA. 
The typical binding site UCUU for PTB located in stem-loop (SL) 3 of the 3´-X tail is indicated (see also Fig. 
66). hnRNP L binds to the HCV core protein-encoding sequences upstream of nucleotide 402. The roman 
numbers in the PTB protein indicate its four domains. The authentic start and stop codons (AUG and UGA) are 
also indicated. The interaction of hnRNP L with PTB may stabilize the binding of PTB to the 3´-UTR. VR, 
variable region of the 3´-UTR. 
 
 
To better understand which domain of PTB is responsible for a possible interaction of hnRNP L with PTB 
during their interactions with the HCV RNA, all deletion mutants of PTB (shown in Fig. 26) were included in 
the assay together with hnRNP L. The results shown in Fig. 39 not only confirm the stimulating effect, but also 
show different roles of different PTB RRM domains in the interaction with the RNA. Deletion of PTB domain I, 
II, or I and II together does not affect the strong binding of PTB to the HCV RNA because of the presence of 
domain III and IV (Figs. 39, lanes 5-16). These results are consistent with the binding of PTB domains to the 
IRES of FMDV (Song et al., 2005). However, this result obviously is not consistent with the former observation 
that domains I and II together are required for the interaction of PTB with hnRNP L (Hahm et al., 1998a). This 
discrepancy may have the reason that the presence of RNA-protein interactions may facilitate the protein-protein 
4   Discussion                                                                                              121                      
 
 
interaction. Therefore, this mutual interaction may stabilize and strengthen the interaction of PTB with the 3´-
UTR as illustrated in Fig. 67. Moreover, a PTB-hnRNP L complex may have an RNA-binding specificity 
different from PTB and/or hnRNP L alone. Nevertheless, the results shown here unambiguously demonstrate 
that hnRNP L stimulates the binding of PTB to the HCV RNA, suggesting that a PTB-hnRNP L interaction may 
be somehow involved in HCV translation initiation. Further experiment will be necessary to investigate in more 
detail the interaction of hnRNP L and PTB with the HCV RNA in vitro.  
After analyzing the role of PTB and hnRNP L in vitro, they were tested together in the HCV IRES-directed 
translation system using two HCV RNAs with or without 3´-UTR. It was shown that HCV translation efficiency 
was evidently not affected in the presence of hnRNP L, irrespective if the 3´-UTR was present or not, in either 
RRL or PTB-depleted RRL (Fig. 33). Under the same experimental conditions, increasing amounts of 
recombinant PTB were added to the PTB-depleted RRL, but HCV translation efficiency was not altered by the 
presence of both PTB and hnRNP L (Fig. 43). The FLuc expression from the HCV RNA with 3´-UTR is only 
slightly higher (maximal ~ 70 %) than that from the HCV RNA minus 3´-UTR in the presence of hnRNP L 
added. However, this minor difference is also detected only in the absence of hnRNP L. Thus, HCV translation 
is not significantly affected by PTB and hnRNP L, individually or together, in the in vitro assay used here. 
However, in in vivo experiments using transfection of reporter and effector RNAs into Huh-7 cells, it was shown 
that PTB and hnRNP L act together, resulting in a slight stimulation of HCV IRES-directed translation in the 
presence of the 3´-UTR (E. Tzima, Ph.D. thesis, 2005, Giessen University). 
 
4.1.3 Unr protein 
 
The Unr gene (upstream of N-ras) is defined as a transcription unit encoding a protein with five copies of the 
cold-shock domain (CSD), located immediately upstream of the N-ras gene in several mammalian genomes 
(Doniger & DiPaolo, 1988; Jeffers et al., 1990; Nicolaiew et al., 1991). Unr has been identified as one of two 
proteins (the other being PTB) which binds to the human rhinovirus-2 (HRV-2) 5´-UTR and stimulates 
rhinovirus translation (Hunt et al., 1999a). All five cold-shock domains of Unr have been reported to be required 
for stimulation of human rhinovirus translation (Brown & Jackson, 2004). 
Several of the genes whose protein products are associated with apoptosis contain IRESes, including XIAP 
(Holcik et al., 1999), DAP5 (Henis-Korenblit et al., 2000), c-myc (Stoneley et al., 1998; Stoneley et al., 2000) 
and Apaf-1 (Coldwell et al., 2000), and can therefore be translated in a cap-independent manner. A former report 
demonstrates that both Unr and PTB stimulate internal ribosome entry on the Apaf-1 IRES in vitro (Mitchell et 
al., 2001). Moreover, in cell lines that lack these proteins or have reduced levels of them, internal ribosome entry 
mediated by the Apaf-1 IRES can be stimulated by co-transfection of plasmids encoding these factors. 
To address the question whether Unr interacts directly with the HCV RNA, electrophoretic mobility shifting 
assays and UV cross-linking assays were carried out using purified recombinant His-Unr protein. The shift 
experiments show that Unr does not bind to HCV IRES at all, but binds well to the HCV 3´-UTR, with a Kd 
value in the range of 30 nM (Fig. 34B). On the contrary, Unr was detected to bind to the HCV IRES in the 
absence of other proteins in the UV cross-linking assay (Fig. 35A). Even though tRNA was present in the 
reaction, the binding signals were clearly detected. In reticulocyte lysate, however, binding of Unr could not be 
detected. It can only be speculated that Unr binding is easily competed by other proteins. By mass spectrometry-
based peptide sequencing, another group has found that as many as 26 proteins can bind to the HCV IRES RNA 
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but not to a reversed-complementary sequence RNA (Lu et al., 2004). Among these proteins, Unr and Unr-
interacting protein (UNRIP) were identified. However, these researchers did not explore functional implications 
of this binding for translation. 
In in vitro-translation assays, Unr showed down-regulatory effect on HCV IRES-dependent translation in both 
normal RRL and PTB-depleted RRL supplemented with recombinant PTB (Figs. 36 and 44B). However, it must 
be assumed that this inhibitory effect may be due to the fact that this Unr protein was prepared under denaturing 
conditions from E. coli cells, and it is not known which portion of the protein is in an authentic native state and if 
remaining denatured protein may unspecifically inhibit translation. Thus, unfortunately, no valid conclusion can 
be drawn from these in vitro experiments using recombinant Unr protein. 
However, promising observations were obtained by our cooperation partner in France. Mouse embryonic stem 
(ES) cells and Unr knock-out ES cells were transfected using two HCV plasmid constructs, either with or 
without 3´-UTR, respectively (Fig. 45). Their result shows that the FLuc expression levels from the HCV 
plasmid without 3´-UTR changed only slightly upon Unr knout-out ES cells. However, a larger difference was 
detected when the HCV plasmid with 3´-UTR was used for the transfection (Table 7). In the presence of the 3´-
UTR the FLuc translated activity obtained with the HCV IRES in Unr -/- ES cells is lower (< 50 %) compared 
with that in Unr +/+ ES cells. Thus, the presence of Unr makes a difference when the HCV 3´-UTR is present.  
 
 
 
 
 
Table 7: Expression levels of HCV reporter constructs with or without 3´-UTR in ES-cells in vivo. The 
values of Firefly luciferase activities are set to 100 % in normal ES cells. Unr -/-, Unr knock-out embryonic stem 
(ES) cells; Unr +/+, normal ES cells (Results from Dr. Hélène Jacquemin-Sablon, Bordeaux, France). 
 
 
Taken together, purified recombinant Unr protein seems not suitable for functional in vitro studies, and more cell 
transfection-based experimental approaches may be used to elucidate a possible function. Indeed, transfection 
studies (E. Tzima, Ph.D. thesis, 2005, Giessen University) support evidence that Unr and PTB may 
synergistically stimulate HCV translation in the presence of the 3´-UTR to a certain extent, a finding that would 
be consistent with the Unr knock-out ES cell experiments mentioned above. 
 
 
4.2   The HCV 3´-UTR strongly enhances the IRES-dependent translation 
 
At least four distinct elements have been suggested to regulate HCV RNA translation:  
Firstly, the sequences of the HCV IRES within the 5´-UTR are required for translation. Indeed, some mutations 
resulted in dramatic changes in IRES activity (Wang et al., 1994; Kamoshita et al., 1997; Collier et al., 1998; 
Honda et al., 1999; Laporte et al., 2000; Lerat et al., 2000). Actually, it would be better to say that the secondary 
and tertiary structures are as important as some primary sequences within the 5´-UTR region for IRES activity. 
ES cells unr +/+ unr -/- 
HCV-- 3´UTR 100 % 85 % 
HCV-+3´UTR 100 % 49 % 
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Secondly, in vitro studies from several groups suggested that cellular proteins (such as PTB, hnRNP L and La) 
can slightly stimulate HCV translation (Ali & Siddiqui, 1997; Hahm et al., 1998b; Ito & Lai, 1999; Anwar et al., 
2000). One group reported a slight stimulation by PTB in vivo system (Gosert et al., 2000). However, it is shown 
in this work that PTB and hnRNP L do not have positive effect on HCV IRES-directed translation in vitro, and 
PTB does not even bind to the HCV IRES at all. 
Thirdly, HCV proteins have been described to affect HCV IRES efficiency. Because of its particularity of 
promoting persistent infection, HCV has been suggested to possess a self-modulating mechanism to maintain a 
low level of replication. Therefore, it can be assumed that viral protein(s) might modulate a balance between the 
three key steps of the viral life cycle: translation, replication, and packaging. Some of these proteins have been 
proposed to influence HCV IRES activity, such as the core protein and several non-structural proteins. However, 
the results are rather inconsistent. For example, HCV core protein (HCV-C) was reported to either inhibit or 
stimulate translation (Shimoike et al., 1999; Zhang et al., 2002; Boni et al., 2005); the non-structural proteins 
NS4A and NS4B were shown to decrease HCV IRES translation (Kato et al., 2002), whereas others reported a 
stimulatory effect of translation by NS4B and NS5A (He et al., 2003). 
Finally, the 3´-X region of the HCV genome has been shown to enhance IRES-dependent translation weakly (Ito 
et al., 1998; Michel et al., 2001), although the mechanism for this enhancement has not been elicited yet and 
remains controversial. From the results presented in this thesis, it must be concluded that the entire 3´-UTR, but 
not only 3´-X region, is involved in HCV IRES-dependent translation. 
Most eukaryotic cellular mRNAs and many viral mRNAs have a cap structure at the 5´ terminus and a poly(A) 
tail at the 3´-end which play essential roles in the regulation of translation, either individually or in concert 
(Hentze, 1997; Sachs et al., 1997). Each of them works by associating with specific RNA-binding proteins, and 
together they function synergistically to stimulate translation. The translation initiation factor eIF4F binds to the 
5´-terminal cap structure of cellular mRNA through its subunit eIF4E, and the poly(A) binding protein (PABP) 
facilitates mRNA 5´-3´ end interaction by binding both to the mRNA poly(A)-tail and to the eIF4G subunit of 
eIF4F (Tarun & Sachs, 1996). This concept of RNA 5´-3´ end interaction for translation stimulation could be 
also applied to the HCV RNA genome, even in the absence of the terminal cap and poly(A) structures. Such an 
interaction of the terminal HCV genome structures, possibly facilitated by yet unknown viral and/or cellular 
proteins, could play a role in a switch from HCV translation to minus-strand RNA synthesis during the viral life 
cycle, similar to the switch that has been reported for poliovirus (Gamarnik & Andino, 1998). 
As a first step towards testing this hypothesis, it is necessary to explore if the HCV 3´-UTR affects IRES-
directed translation at all. Up to present, several groups have investigated a possible modulating effect of the 
HCV 3´-UTR on translation directed by the HCV IRES either in vitro, in cell culture or in vivo in transfected 
livers of mice (Table 8). In some studies, a positive influence of 3´-UTR sequences (sometimes comprising only 
the 3´-X region) was shown (Ito et al., 1998; Ito & Lai, 1999; Michel et al., 2001; McCaffrey et al., 2002) 
whereas others showed that the HCV 3´-UTR has no stimulatory influence on HCV IRES-directed translation 
(Fang & Moyer, 2000; Friebe & Bartenschlager, 2002; Kong & Sarnow, 2002; Imbert et al., 2003; Yi & Lemon, 
2003a). One study even reported an inhibitory effect of the 3´-UTR (Murakami et al., 2001). 
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Table 8: Previous reports on a possible role of the HCV 3´-UTR in IRES-dependent translation. In the 
table, 0 stands for no influence of 3´-UTR on translation; “--” represents down-regulation of translation by 3´-
UTR; RRL, rabbit reticulocyte lysate; non-liver, non-liver cell line. 
 
 
In an attempt to clarify this confusing situation, it was shown here that reporter construct design is an important 
parameter in experiments testing 3´-UTR function. By employing transfection of monocistronic reporter RNAs 
with precise 3´-ends into a human liver-derived cell line, it is shown in this study that all three sequence 
elements of the HCV 3´-UTR, the variable region, the poly(U/C)-tract and the highly conserved 3´-X region, 
contribute to efficient translation activity. In particular, efficient translation stimulation depends strictly on a 
precise 3´-terminus of the HCV 3´-UTR (Fig. 51). The presence of additional nucleotides at the 3´-end of the 
HCV 3´-UTR disables its translation enhancer function (Fig. 55). This fact may be a reason why many of the 
previous studies did not detect translation stimulation by the 3´-UTR since they used either circular plasmid 
DNA or plasmids linearized not exactly at the HCV 3´-end (Fang & Moyer, 2000; Kong & Sarnow, 2002; 
McCaffrey et al., 2002; Imbert et al., 2003). Moreover, nuclear processing such as capping, splicing and 
polyadenylation of cellular polymerase II transcripts may have profound effects on their biological activity, 
consistent with our observation that translation stimulation by the 3´-UTR is much stronger when RNA rather 
than DNA is used for transfection (Figs. 49-51). The requirement for a precise 3´-end of reporter constructs is 
also strikingly obvious from the observation of the group of S. Lemon that an in vitro-transcribed replicon RNA 
with additional nucleotides at the 3´-terminus regained the original HCV 3´-end by the loss of these additional 
nucleotides after transfection into cells and replication passages (Yi & Lemon, 2003a). The second study using 
precise reporter RNA ends (Friebe & Bartenschlager, 2002) showed that mutations in the 3´-UTR affect 
replication but not translation. However, these researchers generated a precise 3´-end of the replicon template 
DNA by introducing a mutation in the 3´-terminal stem-loop sequence to generate a Sca I recognition sequence, 
and we do not know if this mutation may hamper a possible stimulatory effect on translation in the replicon 
reporter construct used, even if these exchanges maintain stem-loop structure and have been observed in a 
natural HCV 3b isolate (Yamada et al., 1996). According to the observations that have been previously reported 
(Fang & Moyer, 2000; Friebe & Bartenschlager, 2002; Yi & Lemon, 2003a) and also here, no evidence was 
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found that deletions within the 3´-UTR accelerate the degradation of synthetic HCV RNA transcripts by 
exoribonucleases after transfection (Fig. 58). Thus, the negative impact of deletions within this segment of the 
viral RNA is likely to result from the loss of an essential RNA signal that participates in translation. 
Another common feature of those previous studies reporting a positive enhancement of HCV translation by the 
3´-UTR (Ito et al., 1998; Ito & Lai, 1999; Michel et al., 2001; McCaffrey et al., 2002) is that they used 
monocistronic reporter constructs. In contrast, those studies which did not observe translation stimulation (Friebe 
& Bartenschlager, 2002; Yi & Lemon, 2003a) used dicistronic reporter constructs employing an additional 
(picornavirus) IRES element to drive translation of HCV nonstructural proteins. It is known from experiments in 
our lab (Bassili et al., 2004; C. Jünemann, unpublished results) that a second IRES element in a reporter 
construct can influence the activity of the first reporter gene in cis and by that conceal a modulating effect of the 
3´-UTR. In addition, the time at which reporter gene activity is measured may be a relevant parameter. It was 
found that transfection of PCR fragments resulted in a significant difference (up to 3-fold) early after 
transfection (8 to 12 hrs), whereas the differences were reduced after longer times. In some other studies (Kong 
& Sarnow, 2002; Imbert et al., 2003), cells were harvested after longer times, which may be another reason to 
miss significant differences in expression. 
Another important aspect of the involvement of the 3´-UTR in translation stimulation is that it may confer at 
least a certain degree of tissue specificity. HCV replicates preferentially in human hepatocytes (Lauer & Walker, 
2001), and the viral infection often results in chronic diseases such as liver cirrhosis and hepatocellular 
carcinoma, suggesting that the liver cell may provide factors particularly supporting HCV translation and/or 
RNA replication. A cell-specific advantage for HCV replication in liver cells could be conferred by trans-acting 
proteins binding to the 3´-UTR, subsequently resulting in translation enhancement mediated by an RNA 3´-5´-
end interaction in cis. Even though a certain degree of translation stimulation by the 3´-UTR was reported also in 
non-liver-derived systems like rabbit reticulocyte lysate (Ito et al., 1998; Ito & Lai, 1999; Michel et al., 2001) 
and HeLa cells (McCaffrey et al., 2002), it was observed in this study that the translation enhancing effect of the 
3´-UTR is much stronger in Huh-7 or Hep G2 cells than in HeLa or BHK cells. Thus, it can be assumed that as 
yet unknown proteins present in human liver-derived cells in higher amounts than in non-human liver-derived 
cells may be involved in an HCV RNA 3´-5´-end interaction. This notion is consistent with the finding that HCV 
can replicate in HeLa cells only with very low efficiency, while efficient replication in selected HeLa cell clones 
requires adaptive mutations in the non-structural protein coding region (Zhu et al., 2003). Therefore, it is of 
considerable importance to explore the role of possible liver cell-specific factors in HCV translation. 
Based on the observation that PTB stimulates translation of several picornaviruses (Borman et al., 1993; 
Kaminski et al., 1995; Niepmann et al., 1997), it was speculated if PTB is also involved in the regulation of HCV 
translation. However, the results with the HCV IRES were controversial (Ali & Siddiqui, 1995; Kaminski et al., 
1995; Ito & Lai, 1999; Tischendorf, 2004). Furthermore, studies exploring a possible role of the HCV 3´-UTR in 
HCV translation revealed that PTB binds to the poly(U/C)-tract within the 3´-UTR (Tsuchihara et al., 1997; 
Chung & Kaplan, 1999; Gontarek et al., 1999; Ito & Lai, 1999; Luo, 1999). However, no clear evidence for a 
stimulation of 3´-UTR-mediated HCV translation by PTB was found, although Gosert and co-workers (Gosert et 
al., 2000) reported the stimulatory effect of PTB on HCV translation in vivo. PTB is also present in many non-
liver tissues like reticulocytes and HeLa cells (Borman et al., 1993; Kaminski et al., 1995), suggesting that the 
mere presence of PTB is not sufficient to explain tissue-specific expression of HCV. 
The cis-acting signals in the 3´-UTR were found to be involved in translation regulation partially coincide with 
the signals required for RNA replication (i.e., the initiation of viral minus-strand synthesis) (Yanagi et al., 1999; 
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Kolykhalov et al., 2000; Friebe & Bartenschlager, 2002; Yi & Lemon, 2003a, 2003b). All three elements, the 
variable region, the poly(U/C)-tract and the 3´-X region appear to contribute to both processes, replication and 
translation stimulation. Oh et al. have shown that the 3´-UTR is required for specific recognition of genome-
length RNA by a purified NS5B RNA dependent RNA polymerase in vitro. Furthermore, the de novo synthesis 
of genome-length, negative-strand RNA in this in vitro system was associated with the binding of NS5B to 
sequences within the 3´ X-region, the poly(U/UC) tract, and the NS5B-coding sequence (Oh et al., 1999; Oh et 
al., 2000). However, modifications affecting the variable region have less serious effects on replication 
efficiency (Yanagi et al., 1999; Friebe & Bartenschlager, 2002; Yi & Lemon, 2003a). Moderate modifications of 
pyrimidine-tract length are tolerated to a certain extent, but at least a certain minimal length of the poly(U/C)-
tract is absolutely required for RNA synthesis. Of the three highly conserved stem-loop structures of the 3´-X 
region, the stem-loop 2 moderately contributes to translation enhancement, while the stem loop 3 contributes 
only very slightly. In contrast, for replication (i.e., RNA minus-strand synthesis), both stem-loop 2 and 3 are 
essential. Also the most 3´-terminal stem-loop 1 is required for RNA synthesis (Friebe & Bartenschlager, 2002; 
Yi & Lemon, 2003a, 2003b), matching the obvious requirement for a contact of the viral RNA replication 
machinery with the very 3´-end of the viral RNA genome which is the template for synthesis of the negative 
strand replicative intermediates.  
Furthermore, the 5´-proximal domains I and II of the 5´-UTR have been shown to be essential for replication 
while sequences lying further downstream within the 5´-UTR and comprising domain III may help to facilitate 
replication but are not absolutely required (Friebe & Bartenschlager, 2002; Kim et al., 2002). These results 
suggest an interesting symmetry in the 5´and 3´ terminal RNA signals for both translation and replication. Such a 
notion is strengthened by the suggestion that the 3´-ends of the negative- and positive-strand RNAs may share 
common structural features (Schuster et al., 2002). 
In many studies on replication, the read-out for monitoring HCV replication after transfection of modified 
replicon RNAs into cells is the amount of newly synthesized RNA minus strands (or the indirect measurement of 
their biological activity). Accordingly, this read-out usually also includes the initial translation of the transfected 
replicon RNA. For future studies, it may be interesting to investigate both aspects in monocistronic reporter 
systems, using separate read-outs to dissect the effects of mutations in the 3´-UTR on translation and on RNA 
minus strand synthesis. Nevertheless, the finding in this study that the 3´- terminal stem-loop 1 is an important 
determinant for translation enhancement points to the idea that this stem-loop may be involved in the regulation 
of a switch from translation of the viral RNA genome to RNA minus strand synthesis like it was shown for 
poliovirus (Gamarnik & Andino, 1998). This process may require long-range RNA-RNA interactions and even 
genome circularization, involving RNA sequences and/or secondary structures not only in the 3´-UTR but also in 
the NS5B coding region and in the 5´-UTR as well as viral proteins like the NS5A and NS5B polymerase 
moieties (Luo, 1999; Friebe & Bartenschlager, 2002; Lee et al., 2004; Thurner et al., 2004; You et al., 2004; 
Friebe et al., 2005). 
Very recently, a novel RNA element in the 3´ terminal coding sequence of NS5B that is essential for the viral 
RNA replication was discovered (Lee et al., 2004; You et al., 2004; Friebe et al., 2005). By using computer-
based secondary structure prediction and enzymatic and chemical probing, these groups identified the very same 
RNA element in the NS5B coding region. Moreover, they also found that only the stem-loops (SLs) in close 
proximity to the 3´-end of the ORF are essential for RNA replication. The location at the 3´-end of the ORF 
could facilitate the binding of newly synthesized NS5B in order to initiate negative-strand RNA synthesis which 
may then interfere with translation. Friebe et al. found that the sequences in NS5BSL3.2, the second loop from 
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the 3´-end of the viral ORF are critical for viral RNA replication. More importantly, they have discovered that 
there is a nucleotide sequence complementarity between the stem-loop of 5BSL3.2 and the loop region of stem-
loop 2 within the extremely conserved 98-nt X tail, the very 3´-end region of HCV RNA genome. Mismatches 
introduced into the loops inhibited RNA replication, which could be rescued when complementarity was restored 
(Friebe et al., 2005). This special interaction stabilizing an RNA conformation within the 3´ terminal region of 
the viral genome was named a "kissing-loop" structure. Based on their observations, the authors assumed that 
this kissing-loop interaction could be mediated by viral or host cellular proteins. Some proteins have been 
reported to bind to the 3´-UTR, including PTB which binds to SL2 and SL3 in the X-tail and to the poly(U/UC) 
tract (Tsuchihara et al., 1997; Luo, 1999), autoantigen La (Spangberg et al., 1999a), and several ribosomal 
proteins (Wood et al., 2001). However, the role of these proteins for HCV RNA replication or possibly 
translation has not been studied. Although they did not analyze in detail the effects of the mutations in 
NS5BSL3.2 on RNA translation, they found that even altered 5BSL3.2 sequences that disturbed the RNA 
structure still allowed expression of a functional NS5B, while the insertion of the intact version of 5BSL3.2 into 
the variable region rescued RNA replication. Consistently also, You and co-workers (You et al., 2004) reported 
no significant differences in the expression of viral proteins from the wild-type and NS5BSL3.2 mutants in vitro. 
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Fig. 68: HCV translation is enhanced by the 3´-UTR. Most likely, viral and/or cellular proteins which remain 
to be determined are involvement in translation stimulation. 
 
 
In the closely related bovine viral diarrhoea virus (BVDV), the sequence and secondary structures of the RNA 
signals in the 3´-UTR are quite different from that in the HCV 3´-UTR. The two conserved stem-loops of BVDV 
that are located most 3´-terminal are required for RNA minus-strand synthesis (Yu et al., 1999). Cellular proteins 
binding to the 3´-UTR of the closely related pestivirus BVDV were identified and shown to be required for RNA 
replication (Isken et al., 2003). These proteins belong to a class of nuclear factors that appear to bring about a 
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circular conformation of BVDV genome via interactions with the 3´- and the 5´-UTR. In contrast, the upstream 
variable region binds nuclear factors associated with RNA (NFAR) and may be involved in a switch between 
translation and replication (Isken et al., 2003; Isken et al., 2004). 
Extending this idea to the situation with HCV, it will be interesting to determine whether the NFAR proteins are 
involved in such a switch through interaction with the kissing-loop in the HCV genome. Consequently, several 
questions arise: (i) are factors such as the NFAR group proteins involved in HCV translation enhancement by 
mediating long-range interactions between the 3´- and the 5´-UTR; (ii) are there synergistic interactions of 
NFAR proteins with other proteins binding to the 3´-UTR or with NSAP1 binding near the 5´-UTR (Kim et al., 
2004); and (iii) are there factors in human liver-derived cells that confer at least a certain degree of tissue 
specificity to HCV translation by interacting preferentially with the 3´-UTR rather with the 5´-UTR? (Fig. 68). 
At last, previous reports that have described the 3´-UTR enhancement of HCV translation have generally used 
short reporter constructs that do not contain the significant RNA structure present with the core or NS5B coding 
regions. Thus, it is questionable if this stimulatory effect obtained in vitro reflects the authentic situation. To 
demonstrate that the findings shown here are biologically relevant, it should be shown that translation of the 
HCV genome-length RNA is similarly affected by the presence or absence of the 3´-UTR sequences. Thus, the 
long-standing debate on this issue may be eventually settled after such studies are done. For that reason, the 
corresponding work will be continued using the HCV full-length genome of genotype 1b, in collaboration with 
the research group of Prof. R. Bartenschlager, University of Heidelberg.  
 
 
4.3   Regulation of HCV translation by a novel, as yet unknown 210 kDa protein? 
 
In an approach using the HCV RNA construct containing both 5´-UTR and the 3´-UTR with a precise end, a 
novel protein of about 210 kDa (p210) as well as an additional high molecular weight band were detected by the 
UV cross-linking assay. In contrast, no band was found with HCV RNA containing a non-precise end of the 3´-
UTR in both cytoplasmic extract of Huh-7 cells and reticulocyte lysate (Figs. 60, 61B and 62). By comparing the 
migration of p210 with the migration of eIF4G bound to the FMDV IRES, it was ruled out that this newly 
detected protein is identical with eIF4G. Furthermore, mutation analysis revealed that the variable region of the 
3´-UTR is most important for the binding of p210 (Fig. 65). 
The fact that the novel 210 kDa protein binds only to the HCV RNA in the presence of an exact end of the 3´-
UTR opens the possibility to study the mechanism by which HCV IRES-mediated translation is regulated. In this 
context, one important aspect is a possible synergism between the IRES and the 3´-UTR region which is reached 
by the circularization of the mRNA. Cap-dependent translation initiation is strongly enhanced by poly(A) tails 
(Gallie, 1991; Sachs, 2000). This synergism is due to the physical interaction between PABP and eIF4G which 
bind to the ends of the mRNA through their specific recognition of the poly(A) tail and the cap-eIF4E complex, 
respectively (Preiss & Hentze, 1998). Nevertheless, the evidence for RNA circularization during IRES-
dependent initiation is still limited. A slight enhancement of IRES-driven translation by poly(A) tails in vitro has 
been reported (Michel et al., 2000; Michel et al., 2001). Other candidate proteins for a possible circularization of 
the mRNA are the nuclear factor associated with RNA (NFAR) proteins which were found to bind to both the 5´-
UTR and the 3´-UTR of BVDV (Isken et al., 2003). These NFAR proteins might act as a functional bridge 
between both ends of the viral genome (Isken et al., 2003). The NFAR proteins essentially include three types of 
proteins, namely NF90 (nuclear factor 90)/NFAR-1, NF45 (nuclear factor 45) and RHA (RNA helicase A or 
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nuclear DNA helicase II [NDHII]) which form a protein complex (Liao et al., 1998) that considerably augments 
the interaction of the BVDV genome 5´- and 3´-ends (Isken et al., 2003). The molecular mechanisms underlying 
this observation remain to be clarified. In addition, there are also interactions among hnRNP proteins such as 
hnRNP E2, I, K and L which could, in concert with their RNA-binding preferences, possibly mediate 
interactions between the IRES and the 3´-UTR of mRNA (see discussion above). Protein-protein interactions of 
hnRNP proteins have been found to be involved in a variety of RNA-related biological processes (Kim et al., 
2000). 
With the discovery of the 210 kDa protein in this work, a promising new candidate for the stimulation of genome 
circularization adds to the list of candidates. This novel protein may perhaps stabilize the formation of closed-
loop HCV RNA by bridging the 5´- and the 3´-UTR, thereby efficiently promoting ribosome reutilization by the 
IRES. This hypothesis is illustrated in Fig. 69. 
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Fig. 69: Hypothetical closed-loop model of the HCV RNA translation complex. The proteins binding to the 
5´-UTR are supposed to interact with the 3´-UTR of HCV via the novel ~ 210 kDa protein indicated, and this 
interaction may then possibly enhance the reutilization of ribosomes detaching at the termination site to start a 
new round of translation. The gray ovals represent proteins binding to the HCV 5´- and/or 3´-UTR. 
 
 
The second important aspect is a possible switch between translation and viral minus-strand RNA synthesis. The 
replication of positive-strand RNA viruses represents an unresolved mystery: how is the negative-strand RNA 
synthesized in the face of a wave of translating ribosomes moving in the opposite direction? Since each molecule 
of genomic RNA must be used for translation prior to RNA replication (Kuge et al., 1986; Collis et al., 1992; 
Novak & Kirkegaard, 1994), the virus should have a mechanism to down-regulate translation to begin RNA 
synthesis when sufficient amounts of viral replication proteins have been synthesized. Gamarnik and Andino 
found that an RNA element at the very 5´-end of the poliovirus viral genome, the "cloverleaf" RNA, is involved 
in a switch from translation to replication (Gamarnik & Andino, 1998). The cellular Poly(rC)-binding protein 2 
(PCBP2) binds, on one hand, to the IRES downstream of the 5´-terminal cloverleaf and stimulates the initial 
rounds of translation of the viral RNA. When sufficient amounts of the viral polymerase precursor 3CD have 
then accumulated, both 3CD and PCBP2 bind synergistically to two separate stem-loops of the cloverleaf and by 
that, most likely, promote binding of the viral 3D polymerase to the 3´-terminal sequences of the viral genome. 
Gamarnik and Andino proposed that these RNA-protein interactions determine the switch from translation to 
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RNA replication. Interestingly, the RNA phage Qβ uses the interaction of its RNA polymerase with Shine–
Dalgarno sequences to control translation of the core protein (Kolakofsky & Weissmann, 1971b; Weber et al., 
1972; Meyer et al., 1981), suggesting that animal RNA viruses and bacterial phages might use similar 
mechanisms to down-regulate translation. 
Could this strategy be used by other eukaryotic RNA viruses? Until now, no further relevant report on HCV is 
available. Nevertheless, the results presented by Gamarnik and Andino bring us an insight into a general strategy 
by which positive-stranded RNA viruses might use common RNA structures for translation and initiation of 
RNA replication to coordinate these two opposite processes. 
Obviously, with respect to this novel protein detected in this work, some very promising issues are emerging: (i) 
what is the nature of this new protein? (ii) is this protein possibly involved either in a circularization of the HCV 
RNA genome by interacting with the 5´- and the 3´-UTR or in a switch between translation and replication 
during the life cycle of the virus? 
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Appendices 
 
pHCV wt clone map 
 
 
Firefly
HCV-CLX-CMV
5872 bps
1000
2000
3000
4000
5000
Bsg I,104
Age I,155
Tth111I,184
Nru I,269
Stu I,276
Acc I,328
Apa I,461
PspOMI,461
BssHII,479
Blp I,570
Bgl II,613
SexAI,811
Sac II,827
Bbe I,869++
Xba I,884
BsiWI,991
BsrGI,1327
BstEII,1444
Bsu36I,1449
HincII,2139
Pac I,2157
EcoRV,2173
BspMI,2244
SgrAI,2264
BseRI,2377
EcoNI,2450
Afl II,2514
BamHI,2728
Eco ICRI,2748
Sac I,2748
IPci,3109
IAhd,3997
IFsp,4222
IPvu,4369
ISca,4480
IXmn,4597
INde,5483
BISna,5588
IEag,5832
dIIIHin,5849
HCV core
linker 
Luciferase
HCV 3´-UTR
HCV 5´-UTR T7 
 
Molecule Features: 
Type Start      End    Name          Description 
REGION 1 341 HCV 5´-UTR    341 bps 
GENE 342 344   Initiator     3 bps 
GENE 345 606   HCV core      262 bps 
GENE 607 836    linker         230 bp (608-823: ubiquitin, 216 bps) 
GENE 837 2489    Firefly Luciferase    1653 bps 
GENE 2490 2710   HCV 3´-UTR    221 bps 
GENE 2711 4917    pBSII 698#    2207 bps 
GENE 4918 5855    p352           938 bps (5249-5829 is CMV-IE promoter, 581 bps) 
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Interaction of FSAP with HCV RNA 
 
    
 
 
 
RNA–protein complexes 
 
HCV (Hepatitis C Virus) RNA (nt 1–402) was transcribed in vitro from plasmid pHCV-CUL, linearized with 
Aat II, in the presence of [α-32P] UTP using T7 RNA polymerase. The resulting RNA contains the HCV internal 
ribosome entry site (nt 1–342) plus the first 60 nt of the HCV core-protein-coding sequence. For obtaining a 
control DNA fragment using PCR, two DNA oligonucleotides were used to generate an amplified fragment with 
exactly the same limits (HCV nt 1–402). This fragment was internally labelled using [α-32P] dCTP. Binding and 
UV-cross-linking reactions, as described previously (Ochs et al., 2003), were performed in the absence or 
presence of 10 pmol of FSAP (unless otherwise indicated) with 0.7 pmol of RNA in binding buffer (10 mM 
Tris/HCl, pH 7.5, containing 100 mM NaCl, 0.3 mM MgCl2, 2 % glycerol and 1 mM dithiothreitol) in a 10-µl 
reaction volume. Protease inhibitors (50 units/ml aprotinin, 10 mM PMSF and 0.05 mM ZnCl2) were added as 
indicated. Reaction mixtures were incubated for 10 min at 30°C, irradiated with UV light (254 nm) for 30 min at 
0°C and treated with 2 mg/ml RNase for 60 min at 37◦C. After addition of one-third volume of loading buffer 
(125 mM Tris/HCl, pH 6.8, containing 4 % SDS, 10 % 2-mercaptoethanol, 20 % glycerol, 0.02 % Bromophenol 
Blue and 7 M urea), samples were boiled and subjected to SDS/PAGE (12 % gel) followed by autoradiography. 
Alternatively, FSAP was UV cross-linked to [α-32P] UTP-labelled HCV RNA as described above, with the 
difference that samples were not treated with RNase A after UV cross-linking, but incubated in the absence or 
presence of proteinase K. After addition of loading buffer, samples were analysed by SDS/PAGE (6 % gel) 
followed by autoradiography.  
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Figure 5: Binding interactions between FSAP and RNA. (A) Purified human single-chain FSAP 
(scFSAP) was incubated at 30°C for 10 min in the absence or presence of [α-32P] UTP-labelled HCV 
RNA and in the absence or presence of protease inhibitors as indicated. Samples were irradiated with 
UV light (254 nm), treated with 2 mg/ml RNase A at 37°C for 60 min, denatured and separated by 
denaturing SDS/PAGE (12 % gel) which was stained with Coomassie Brilliant Blue (left-hand 
panel). For detection of protein bound to radioactive RNA, X-ray film was exposed overnight (right-
hand panel). Size markers indicate positions of 14C-labelled marker proteins at the left margin. 
Binding of RNA to two-chain FSAP (B) or single-chain FSAP (C) was analysed in an 
electrophoretic mobility shift assay. [α-32P] UTP-labelled HCV RNA (15 nM) was incubated in the 
absence (lane 1) or presence of FSAP at the following concentrations: 0.03 µM (lane 2), 0.1 µM 
(lane 3), 0.2 µM (lane 4), 0.3 µM (lane 5), 1 µM (lane 6), 2 µM (lane 7), and RNA–two-chain FSAP 
(B) or RNA–single-chain FSAP complexes (C) were separated on a non-denaturing 6 % 
polyacrylamide gel followed by exposure of the dried gel to visualize the RNA-containing bands. (D) 
Filter-binding assay with FSAP and HCV RNA in the presence (continuous curve) or absence 
(broken curve) of protease inhibitor. The KD values obtained from the binding curves at 50 % 
maximal binding are indicated (broken lines). 
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To analyse FSAP–RNA complexes by electrophoretic mobility shift assay, binding reactions contained 0.15 
pmol of [α-32P] UTP-labelled HCV RNA in 5 mM HEPES buffer, pH 7.4, containing 145 mM NaCl, 5 mM KCl, 
1.5 mM MgCl2, 3.8 % glycerol, 2 mM dithiothreitol and 0.1 mM EDTA, in a volume of 10 µl. Protease 
inhibitors (50 units/ml aprotinin, 10 mM PMSF and 0.05 mM ZnCl2) were added as indicated. Reaction mixtures 
were incubated for 20 min at 30°C. After addition of 5 µl of 20 % glycerol, samples were resolved on a non-
denaturing 6 % polyacrylamide gel (Konarska et al., 1986). In control experiments, a DNA fragment instead of 
RNA was used, which was generated by asymmetric PCR from the same sequence as the RNA transcript and 
labelled internally during the PCR reaction using [α-32P] dCTP.  
To analyse FSAP–RNA complexes by filter-binding assays, nitrocellulose filters were soaked with washing 
buffer (20 mM Tris/HCl, pH 7.25, 2 mM MgCl2 and 1 mM dithiothreitol) and fixed into a slot-blot apparatus. 
The indicated FSAP concentrations were incubated on the filters in 100 µl of wash buffer for 15 min and then 
aspirated through the filters, followed by incubation with 3 % BSA for 20 min. Binding buffer (100 µl; 10 mM 
Tris/HCl, pH 7.25, 145 mM NaCl, 5 mM KCl, 1.5 mM MgCl2, 3.8 % glycerol, 2 mM dithiothreitol and 0.1 mM 
EDTA) containing 0.15 pmol of [α-32P] UTP-labelled HCV RNA was incubated with each filter well for 15 min, 
and 1 mM PPACK was present for binding assay of single-chain FSAP. The reaction mixtures were aspirated 
through the filters, followed by four wash cycles, and after drying filter pieces corresponding to the slots were 
excised, added to 2 ml of scintillation fluid and radioactivity measured in a scintillation counter. The values 
shown represent means +/- S.D. from 3–5 measurements. For estimation of the dissociation constant KD for the 
reaction  
 
 FSAP + RNAfree ↔ FSAP–RNA equation (1) was used:  
 
                 KD = ([FSAP] × [RNAfree])/[FSAP–RNA]   (1)  
 
 Equation (2) is fulfilled if 50 % binding of RNA to FSAP is achieved, thus obtaining KD =[FSAP].  
 
                 [RNAfree] = [FSAP–RNA]                            (2)  
 
The respective dissociation constants for single- and two-chain FSAP were derived from the sigmoidal binding 
curves at 50 % RNA–FSAP complex formation (see Figure 5D). 
 
 
Conclusions 
 
At plasma concentrations of FSAP of 0.2 µM (Kannemeier et al., 2001), all RNA was bound within FSAP–RNA 
complexes, indicating that FSAP may bind RNA at a threshold close to the FSAP plasma concentration.  
More than one molecule of FSAP may bind to a single RNA template. The dissociation contant KD of the 
binding of RNA to single-chain FSAP (performed in the presence of protease inhibitors to prevent activation) 
(Figure 5D, continuous curve) is 170 nM, whereas the KD for the two-chain FSAP–RNA interaction is 350 nM 
(Figure 5D, broken curve). These values correspond well with the FSAP concentrations required for binding of 
RNA in the shift assays and are compatible with a template mechanism of activation as well. 
Single-chain FSAP provides multiple contacts with RNA, whereas the active two-chain enzyme binds to RNA 
exclusively via its heavy-chain (with approx. 50 % affinity as compared with the single-chain protein), indicative 
of the fact that both forms of FSAP can interact with RNA in a complex that leads to (auto-)- activation of the 
proenzyme. 
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